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Abstract 
Interferons (IFN) are induced by virus, double-stranded ribonucleic acid, antigen 
and mitogen. Recent studies revealed that there are two distinct types of interferon 
families, namely type I and type II I F N . Type I I F N consists of IFN-a, IFN-p, IFN-TU 
and IFN-T. IFN-a and IFN-P are produced by almost all cell types. The actions of 
type I IFN are less cell and tissue specific. Type II IFN, with only one member, IFN-
Y, is primarily an immunoregulatory agent. IFN-y is produced by antigen or mitogen 
activated T-cell and Natural Killer cells. IFN-a consists of many different subtypes. 
In mouse, IFN-a family consists of at least 10 different IFN-a genes. The genes are 
closely clustered on the short arm of chromosome 4. During viral infection, the most 
early produced cytokine is IFN-a/p. Although it has been demonstrated that some 
IFN-a subtypes are more potent in combating vims, the role of individual subtype is 
poorly understood. 
To dissect the roles of each IFN-a subtype, a specific and sensitive method to 
distinguish the subtypes is essential. Due to the great homology between IFN-a 
subtypes in gene and protein level, currently there is no biochemical or biological 
method to distinguish all the IFN-a subtypes. In this project, a set of specific PGR 
primers that could distinguish the mRNA of different murine IFN-a subtypes was 
designed. The specificity and efficiently of subtype specific primers were confirmed 
by the use of specific primers against different IFN-a subtype templates in PGR. 
Using this method, as low as 1 ng of the target IFN-a subtype could be detected and 
distinguished in the excess of other subtypes (containing up to 0.8 x^g). Using this set 
of specific primers and the optimized RT-PCR method, a clear pattern of differential 
expression of IFN-a subtype was observed in poly(I).poly(C) treated or influenza 
viruses (A/NWS/33 and B/Lee/40) infected L929 mouse fibroblasts. 
The expression profile of IFN-p, IFN-y and IFN-a/p receptors were also 
measured using RT-PCR. IFN-a/p receptors were expressed in both poly (I)-poly (C) 
treated L929 or the L929 cells infected by different strains of influenza viruses. 
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Expression of IFN-y was not detected in both infected or poly (I).poly (C) treated L929 
cells. The expression of IFN-P was detected in cells induced by poly(I).poly(C) or 
infected by influenza B/Lee/40. However, the expression of IFN-P was not detectable 
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1.1 The interferon 
In 1957, Isaacs and Lindenmann discovered that the tissues exposed to 
inactivated virus had released a factor that transferred interference to fresh tissues and 
inhibited the growth of other vims. In the experiment, heat-inactivated influenza 
virus was added to the pieces of chicken egg chlorioallantoic membrane. These 
membranes were then washed to remove the unadsorbed virus and were incubated at 
37°C for several hours. Membrane fragments were removed from the culture fluid， 
and fresh membrane fragments that had never exposed to virus were incubated in this 
medium overnight at 37°C. The treated membrane fragments demonstrated resistance 
to influenza infection. Later, the factor that was produced by the virus infected cells 
and interfered the viral replication in the other cells was termed interferon (IFN) 
(Stewart, 1979). 
IFN is a cytokine that is produced by nucleated cells in response to stimuli. 
Cytokines are defined as any soluble secreted regulatory proteins produced by both 
lymphoid and non-lymphoid cells that control the growth, survival, differentiation and 
effector function of tissue cells (Meager 1998; Nicola 1994). Cytokines include 
monokines, chemokines, interleukines, haematopoietic (colony) stimulating factors, 
growth factors, lymphokines and interferons. Cytokines are proteins or glycoproteins 
in nature. Most of the cytokines primarily act on cells in the immediate vicinity of 
their secreting cells. Hence, cytokines act in an autocrine or paracrine manner 
(Meager 1998; Nicola 1994). 
1.1.1 Classification of interferons 
Interferons are classified into two structurally distinct types, namely type I and 
type II IFN. Type I IFN is acid-stable in pH 2 while type II IFN is pH sensitive. Type 
I IFN consists of multiple IFN-a (alpha) subtypes, a single molecular species of IFN-
(3 (beta), IFN-�(omega) and IFN-x (trophoblast) (Sen & Ransohoff, 1997). IFN-o) 
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genes are found in most mammalian species excluding mouse. IFN-T is essential for 
the establishment of pregnancy in cattle and sheep (Cross & Roberts，1991). The 
acid-labile type II IFN (IFN-y) that is structurally and molecularly unrelated to type I 
IFN (Farrar & Schreiber，1993). 
1.1.1.1 Type I IFN 
Type I IFNs are produced after virus infection or by cells after stimulation with 
other inducers. Type I IFNs are produced by almost all cell types and their actions are 
less cell-type or tissue specific. The proteins of type I IFN are similar in size. IFN-a 
has many subtypes. The proteins of IFN-a consist of 165 or 166 amino acids in 
human and mouse, except the mouse IFN-a4 has only 161 amino acids (a short in 
frame deletion of 5 amino acids) (Kelley & Pitha, 1985a). IFN-a proteins consist of 
four conserved cysteines which form two intramolecular disulfide bonds (Cys 1-Cys 
98 and Cys 29-Cys 138). All proteins of IFN-a subtypes share 60% or greater 
homology in amino acid sequence. In general，most of human IFN-a proteins are not 
N-glycosylated. Whereas in mouse, IFN-a contains a putative N-glycosylation site 
(Asn-Ala-Thr) at positions 78-80. IFN-P has 166 amino acids while both IFN-o) and 
IFN-T have 172 amino acids. IFN-p and IFN-a species have 25 to 30% of sequence 
homologous. Human IFN-p protein is N-glysosylated and has three cysteine residues 
(Cys 41-Cys 141，Cys 17 is free) (Sen & Ransohoff, 1993). 
In human and mouse, type I IFN genes share an unusual characteristic that they 
are all intronless. In human, type I IFN genes are all closely clustered on the short 
arm of chromosome 9. Type I IFN consists of IFN-a (HuIFN-a) family with at least 
13 different IFN-a genes, one IFN-P and six IFN-ca genes, five of which are 
pseudogenes. In mouse, type I IFN has at least 10 different IFN-a subtypes and one 
IFN-P. The genes are all clustered on chromosome 4. HuIFN-a and MuIFN-a gene 
share 70% of sequence homology, and HuIFN-a and MuIFN-a shared 70% homology 
in DNA sequences and 40% homology in protein sequences (Sen & Ransohoff，1997). 
2 
1.1.1.2 Type IIIFN 
Type II IFN (immune IFN or IFN-y) is structurally different from type I IFN. 
The production of IFN-y is strictly cell specific. T lymphocyte and Natural Killer 
(NK) cells are the major source to produce IFN-y (Farrar & Schreiber，1993). Human 
IFN-Y is encoded by a single gene, which contains four exons and three introns, 
located on chromosome 12. The mature IFN-y protein contains 146 amino acids with 
23 residues of signal sequence. Unlike IFN-ot，IFN-y contains two N-glycosylation 
sites. Murine IFN-y is located on chromosome 10. The murine IFN-y protein 
contains 133 amino acids with a 22 amino acid signal sequence. Both human and 
mouse IFN-Y exist in homodimer. The homodimer is held together entirely by 
noncovalent forces because the mature proteins are devoid of cysteine. Since there 
are no cysteine in mature IFN-y protein, the protein is heat (56�C) and pH (pH<4 or 
pH>9) sensitive. The activity of IFN-y is also species specific, due to the low level of 
sequence or amino acid homology between species. The DNA and amino acid 
sequence homology between mouse and human IFN-y are 60% and 40% respectively 
(Farrar & Schreiber, 1993). 
1.1.2 Biosynthesis of IFN 
The production of type I IFN can be stimulated by viruses, bacterial 
lipospolysaccharide (LPS), double-stranded RNA (dsRNA) and synthetic dsRNA 
such as polyriboinosinic-polyribocy tidy lie acid [poly(I)-poly(C)]. The production of 
type I IFN is less cell-type specific，it can be synthesized in almost all cell types. 
The transcriptional control of IFN-|3 has been intensively studied due to only a 
single gene of IFN-p. The following figure showed the gene structures of IFN-P. 
PRDIV PRD III PRDI PRDIINRE ——TATA —— 
The human IFN-P gene promoter contains four positive regulatory elements and one 
negative regulatory element within 60 bp. The positive regulatory elements from 5, 
end to 3，end are positive regulatory domains (PRD) IV, PRD III, PRD I and PRD II. 
3 
HMGI(Y) HMGI(Y) 
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\ Complex Transcription 
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Figure 1.1 Model for the IFN-P gene enhanceosome 
Adapted form Du et al； 1993 
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The negative regulatory element (NRE) is structurally overlapping with PRD II in 
IFN-P promoter (Goodbourn & Maniatis, 1988; Nourbakhsh et al, 1993). 
Transcriptional activation of IFN-p gene in response to virus infection requires 
the assembly of a higher-order transcription enhancer complex, enhanceosome to the 
IFN-p promoter (Thanos & Maniatis, 1995). Enchanceosome consists of transcription 
factor ATF-2 homodimers or ATF-2/c-Jun heterodimers (Du et al., 1993), NFKB 
(Visvanathan & Goodbourn，1989; Nourbakhsh et al, 1993)，members of Interferon 
Regulatory Factor (IRF) (Harada et al, 1989; Marie et al, 1998; Sato et al., 1998) and 
the architectural protein high mobility group protein HMG I(Y) (Thanos & Maniatis， 
1992; Du et al., 1993). Once the transcription factors are assembled, the 
enchanceosome is unusually stable and promotes the high levels of IFN-P gene 
transcription (Yie et al, 1999a). The level of transcription generated by all of these 
activators is significantly greater than the sum of the levels generated by individual 
factors designated as transcriptional synergy. 
Upon virus infection, the transcription factors are phosphorylated. HMG I(Y) 
promotes the cooperative binding of the transcription factors to the DNA. ATF-2 
homodimers or ATF-2/c-Jun heterodimers and NF-KB bind to PRD IV and PRD II 
site respectively (Du et al., 1993; Visvanathan & Goodbourn，1989). A member of 
IRF binds to PRD I and PRD III to form the enchanceosome. HMG I(Y) further 
modified the DNA conformation and recruited CBP-RNA polymerase II holoenzyme 
to the basal transcription complex for synergistic activation of IFN-p gene 
transcription (Merika et al., 1998). Figure 1.1 shows the model of IFN-p gene 
enhanceosome. Since the activation of IFN-P gene could be blocked by antisense 
R N A of NFKB, ATF-2, c-Jun and H M G I(Y), all of these genes were required for the 
virus induction of IFN-p gene (Thanos & Maniatis, 1992; Du et al.’ 1993). All these 
proteins were expressed constitutively in most cell types (without infection), therefore 
the induction of the IFN-p gene transcription did not required new protein synthesis 
(Du et al., 1993). 
During infection, the transcription of type I IFN is regulated by the nuclear 
transcription factor, IRF. IRF family consists of at least nine members, IRF-1，IRF-2， 
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IRF-3，IRF-4/Pip/ICSAT, IRF-5, IRF-6，IRF-7，ISGSy and ICSBP (IRF-8) (Mamane 
et al, 1999). IRF-1，IRF-2, IRF-3, IRF-7 and ISGSy are expressed in a variety of cell 
types. IRF-4/Pip/ICSAT and ICSBP are expressed mainly by lymophoid cells 
(Nelson et al., 1993; Weisz et al., 1992; Yamagata et al., 1996). The properties of 
IRF-5 and IRF-6 are still unclear. All members of IRF family share a high protein 
sequence similarity at N-terminal DNA-binding region with five tryptophan repeats 
and bind to a similar DNA motif, term IFN stimulated response element (ISRE), IFN 
consensus element (ICS) and IFN regulatory element (IRF-E or PRD I and PRD III) 
but the carboxyl-terminal regions are much less conserved (Harada et al., 1989; Weisz 
et al.，1992; Mamane et al., 1999). 
PRD I and PRD III act as binding sites for members of IRF family (Harada et al, 
1989). Previous studied demonstrated that IFN-p was activated by the replacement of 
IRF-2 from PRD III-I sites by IRF-1. IRF-1 is a positive regulatory factor and the 
induction of IRF-1 mRNA is increased after virus infection (Harada et al., 1989). The 
function of IRF-2 acts as repressor of transcription rather than an activator (Harada et 
al, 1989). However, the expression level of IFN-P gene in IRF-1 knock-out mice is 
similar to the wild type following NDV infection (Matsuyama et al., 1993). This 
result suggested that there should be another IRF to regulate the expression of type I 
interferons. Recent researches indicate the other members of IRF family such as IRF-
3, IRF-7 are involved in transcriptional induction of IFN-a and IFN-p gene (Marie et 
al； 1998; Juang et al., 1998; Sato et al., 1998). 
Another protein, NFKB, facilitates the gene inducing activity through the PRD II 
site (Visvanathan & Goodbourn, 1989). Upon virus infection, IRF-2 is replaced by 
the other members of IRF, and activates the binding of NFKB to the GC-rich 
sequences at the two ends of PRD II site through contacts in the major groove 
(Thanos & Maniatis et al” 1992). Nuclear factor kappa B (NFKB) (p50/p65 
heterodimer) is an important mediator of immune and inflammatory responses and 
play a role in cell differentiation and apoptosis. Under normal conditions, NFKB is 
inactive and bound to inhibitor of kappa B (IKB) proteins and retented in cytoplasm 
(DiDonato et al” 1997). After receipt a stress signal, such as virus infection, 
stimulated by LPS, tumour necrosis factor (TNF)，interleukin (IL)-l, induces 
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activation of IKB kinase (IKK)P that is probably activated by a dsRNA-dependent 
protein kinase known as PKR (Bonnet et al., 2000; Zamanian-Daryoush et al., 2000). 
The activated IKKp phosphorylates two serine residues in IKB and undergoes 
proteosome-mediated degradation of IKB (Alkalay et al； 1995). As a result, NFKB is 
released from IKB which allow NFKB enters to nucleus and stimulates the gene 
transcription containing NFKB-binding sequence elements (Flory et al., 2000; Wang 
et al., 2000; Zamanian-Daryoush et al., 2000). 
The first step in enhanceosome assembly is the high mobility group (HMG) 
I(Y)-dependent recruitment of the transcription factor NFKB and ATF-2/C-Jun to the 
enhancer mediated by allosteric changes on DNA (Yie et al., 1999a). HMG is a low 
molecular size, non-histone basic nuclear proteins that associate with chromatin 
(Grosschedl et al., 1994). HMG I and HMG Y are generated by alternative splicing, 
they differ only in the presence or absence of 11 amino acid (Johnson et al., 1988). 
The function of these 11 amino acids is unknown, but both proteins contain a serine-
rich and threonine-rich region (Thanos & Maniatis, 1992). HMG I(Y) plays a key 
role in the combinatorial interactions between distinct virus-inducible elements of the 
IFN-p gene promoter (Thanos & Maniatis, 1992; Du et al., 1993). The HMG I(Y) is 
binds to the AT-rich regions within PRD II and to the two AT-rich regions 
immediately flanking PRD IV in the minor groove of DNA (Du et al, 1993; Thanos & 
Maniatis, 1992). The binding of HMG I(Y) to the promoter is governed by protein-
DNA interaction that result in bending on DNA (Falvo et al., 1995; Yie et al., 1999a). 
Thus the HMG I(Y) selectively recruit the binding of NFKB to the PRD II and ATF-
2/c-Jun to the PRD IV site in IFN-P promoter through the protein-protein interaction 
(Thanos & Maniatis, 1992; Yie et al., 1999a; Du & Maniatis，1992). 
The assembly of an enhanceosome efficiently recruits the transcription factor 
(TF)IIB into a template-committed TFIID-TFIIA-USA (upstream stimulatory activity 
complex) (Kim et al., 1998). Subsequently RNA polymerase II holoenzyme was 
recruited through the contact with CREB (cAMP responsive element binding protein) 
binding protein (CBP), leading to synergistic activation of transcription (Yie et al., 
1999b; Kim et al； 1998; Merika et al； 1998). 
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Regulation of the IFN-a gene is less well defined. Unlike IFN-p gene, IFN-a 
genes do not contain any NFKB-binding sites, but contain elements that are related to 
PRD I and ATF-2-binding sites are present (MacDonald et al., 1990). However, the 
mechanism of induction of IFN-a is poorly understood. 
1.1.3 IFN-a/p receptor and signal transduction 
All the type I IFNs (IFN-a, IFN-P and IFN-co) bind to the same receptor, namely 
IFNa/p receptor, for which they compete with the same receptor in binding 
experiment (Flores et al” 1991). IFN-y binds to a distinct type of receptor. IFNa/p 
receptor has two major subunits involve in cell signaling, IFNccRl and IFNaR2c with 
110-kDa and 95-100 kDa respectively (Domanski et al., 1995). Alternative splicing 
lead to IFNaR2 results in three forms, IFNaR2a, IFNaR2b and IFN-aR2c. IFNaR2a 
is a soluble form of the extracellular domain of the IFNaR2 subunit that is originally 
found in urine (Novick et al., 1994). IFNaR2b and IFNaR2c are membrane-
associated and have identical extracellular and transmembrane domains. Compare 
with IFNcxR2c, IFNaR2b possesses only a short intracellular domain. IFNaR2c has a 
long cytoplasm domain, and this is the only form participates in IFN-a/p signalling 
(Domanski et al., 1995; Lutfalla et al； 1995; Kotenko et al, 1999). 
Many cytokines exert its function by binding to their specific receptors and 
through the protein kinases to transfer phosphate groups to target proteins. The two 
major type of kinases are tyrosine kinases and serine/threonine kinase, which are 
capable of phosphorylating (adds a phosphate group) amino acids in target protein. 
Janus Kinase (JAK) 1, tyrosine kinase (Tyk) 2，signal transducer and activator of 
transcription (STAT)l and STAT2 are involved in IFN-a/p signaling. As in mutant 
cell lines that deficient in either of protein are unresponsive to IFN-a, and the 
function can be restored by complementation (Barbieri et al., 1994; Leung et al., 
1995). JAKl and Tyk2 are the members of JAK family that are nonreceptor tyrosine 
kinases (Firmbach-Kraft et al., 1990; Wilks et al” 1991). The activation of STAT is a 
common mechanism for triggering eukaryotic signaling pathways. The STAT 
proteins belong to a family of latent (unphosphorylate) cytoplasmic transcription 
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homology 3 domain, a Src homology 2 (SH2) domains and a single tyrosine 
phosphorylation site near the C terminus (Krishnan et al., 1998). SH2 domain in 
STATI and STAT2 mediate interactions between cytoplasmic proteins by binding to 
phosphorylated tyrosine (Li et al., 1997). STATI with two subunit, STATla and 
STATIP with 91 and 84 kDa respectively, whereas STAT2 with molecular mass 113 
kDa (Schindler et al., 1992a; Fu et al., 1990). The STATla and STATip are identical 
through the first 712 amino acids except for 38 additional amino acids at the carboxyl 
terminus of the STATla that are absent in STATlp (Improta et al., 1994). Either 
STATla or STATI|3 could function as a component of ISGF3 (Fu et al； 1990). SH2 
domain is a protein domain of about 100 amino-acid residues. SH2 domains function 
as regulatory modules of intracellular signaling cascades by interacting with high 
affinity to phosphotyrosine-containing target peptides in a sequence-specific and 
strictly phosphorylation-dependent manner (Krishnan et al., 1998). 
The molecules interacting with IFN-a/p receptor have been demonstrated by 
coimmunoprecipitation. In resting state of IFNct/p receptor, Tyk2 was found to 
associate with cytoplasmic tail of IFNaRl (Colamonic et al., 1994) and JAKl. While 
STATI and STAT2 were found to associate with IFNaR2c (Novick et al” 1994; 
Uddin et al” 1995). IFN-a/p binding drives two receptor components together and 
results in the formation of a heterodimeric receptor. JAKl is then phosphorylated and 
activated Tyk2 by phosphorylation (Gauzzi et al., 1996). Tyk2 then phsophorylates 
the tyrosine residue at position 466 (Tyr^ ^ )^ on IFNaRl (Yan et al., 1996). This 
creates a new ‘docking，site for latent STAT2 to IFNaRl receptor through an 
interaction with SH2 domain (Yan et al., 1996; Li et al., 1997). STAT2 is then 
phosphorylated on Tyr^ ^^  by Tyk2 and then provides a docking site on IFNaRl for the 
SH2 domain of STATI that is subsequently phosphorylated on Tyr^ ^^  by JAKl (Li et 
al., 1997; Improta et al., 1994). STAT2 and STATI are phosphorylated sequentially, 
as a mutant cell line lacking STAT2 was unable to phosphorylate STATI in response 
to IFN-a/p (Leung et al., 1995). The phosphorylated STATI and STAT2 form 
heterodimers via SH2-phosphotyrosine interactions are then dissociated from the 
receptor and translocate nucleus (Fu et al” 1990; Schindler et a/.,1992b). In nucleus, 
STAT1/STAT2 associates with the DNA-binding protein p48 (48 kDa), a member of 
the IRF family, to form a heterotrimeric complex called interferon-stimulated gene 
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factor 3 (ISGF3). The complex binds to interferon-stimulated regulatory elements 
(ISREs, consensus: AGTTTCNNTTTCC) and stimulates the transcription of IFNcx/p 
responsive genes (Fu et al., 1990; Fu et al., 1992). Figure 1.2 summarizes the IFN-
a/p signaling pathway. 
1.1.4 Functions induced by IFN 
1.1.4.1 Antiviral activity of IFN-a/p 
Interferons provide a first line defense of viral infection before the initiation of 
specific immune response. Type I IFNs induce the production of more than 30 
different proteins, only dsRNA-dependent protein kinase (PKR), 2-5A system (2-5 
oligoadenylate synthetase/RNase L system) and Mx proteins are well studied. These 
proteins inhibit the virus replication at different stages of infection. 
1.1.4.1.1 PKR (double-stranded RNA-dependent protein kinase) 
PKR also name as DAI (double-stranded RNA-activated inhibitor), PI kinase or 
p65 and p68 kinase in murine and human respectively. PKR express constitutively in 
many cells, and the levels are greatly increased after the exposure to type I IFN. PKR 
is a major mediator of the antiviral and antiproliferative activities of IFNs (Chong et 
al., 1992; Donze et al., 1995). PKR is a serine/threonine kinase with 515 and 551 
amino acids in mouse and human respectively. PKR has been shown to control the 
transcription and translation induced by IFN and activated by dsRNA (Krust et al” 
1984; Meurs et aL,1990; Feng et al., 1992). PKR in murine and human cells are a 65-
and a 68-kDa protein (p65 and p68) respectively (Feng et al., 1992; Meurs et al； 
1990). PKR contains two conserved binding domains: an N-terminal dsRNA binding 
regulatory domain and C-terminal kinase catalytic domain (Feng et al” 1992; St 
Johnston et al., 1992). The N-terminal of the protein is rich in basic residues that 
mediate dsRNA binding through the ionic bonds to the phosphodiester backbone of 
RNA (Meurs et al., 1990; Green & Mathews, 1992). RNA binding domain located 
within residues 1-170 in N-terminal region (Patel & Sen, 1992). The two RNA 
binding domains within the N-terminus are important for RNA binding, as deletion 
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The C-terminal kinase catalytic domain contains all of the conserved motifs for 
protein serine/threonine kinase activity (Meurs et al., 1990; Green & Mathews, 1992). 
The PKR has two distinct kinase activities; the first involves an 
autophosphorylation (activation) reaction, and the second involves a protein kinase 
activity on exogenous substrates. PKR is present in inactive form that can be 
activated by dsRNA and polyanions heparin (Hovanessian & Galabm，1987). The 
autophosphorylation of PKR requires the presence of dsRNA, but no RNA sequence 
specificity is required for dsRNA to bind to PKR, however there is size of RNA 
requirement. DsRNA duplexes shorter than 30 bp do not activate the enzyme due to 
the instability in binding. At least 50 bp of duplex is required and reaching maximum 
activation at about 85 bp. The efficiency of binding and activation of PKR remains 
unchanged beyond this length (Katze et al, 1991; Galabm & Hovanessian，1987; 
Meurs et al., 1990; Manche et al., 1992). Upon activation, p65 and p68 kinases are 
autophosphorylated on several serine/threonine residues. The response of PKR to 
dsRNA is biphasic. At low concentration -of dsRNA, PKR is activated, while the 
activity is inhibited at high concentration (Manche et al., 1992). The inhibition is due 
to the equilibrium shift to monomer as dsRNA-binding site is saturated. The 
activation of PKR by dsRNA is independent of cAMP and cGMR The activity is 
markedly stimulated by the divalent manganese ions and ATP (Galabm & 
Hovanessian, 1987). Binding of dsRNA to PKR causes a major conformational 
change and making the ATP-binding site becomes accessible. The activated PKR can 
catalyze the phosphorylation of exogenous substrates, and the process is independent 
on dsRNA (Galabm & Hovanessian, 1985). The most well studied substrate for 
activated PKR is the a-subunit of the eukaryotic protein synthesis initiation factor 
(eIF2a) which blocks the translation initiation (Leroux & London，1982). Figure 1.3 
shows the action of PKR on cellular protein synthesis. 
The activated PKR can inhibit protein translation by catalyze the 
phosphorylation of the a subunit of eIF2 on serine 51 (Meurs et al； 1992). eIF-2 is a 
heterotrimer composed of the cc，(3 and y subunits. The protein translation is initiated 
by the binding of eukaryotic initiation factor (elF), eIF4E to the cap structure at the 5, 
end of the mRNA. Subsequently, eIF-4G and eIF-4A/B are bind to form a complex 
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known as eIF-4R The small 40S ribosomal subunit，transfer RNA molecule (tRNA) 
which carries the amino acid methionine (Met) and initiation factor eIF-2 are binds to 
the complex. The initiation of translation is begin when 40S subunit locate in AUG 
initiation sequence in the mRNA. At this point, eIF-2 is released from 40S subunit 
and 60S large ribosomal subunit is bind to the 40S subunit to the formation of 80S 
initiation complex to initiate translation (Latchman，1998). In the initial step of 
translation, GTP binds to eIF-2 and this increases the binding affinity to Met-tRNA. 
After the initiation of protein synthesis, eIF-2.GTP is hydrolysis to eIF-2.GDR In 
order to participate in another round of translational initiation，eIF-2.GDP must 
catalyse by the guanine exchange factor, eIF-2B to eIF-2.GTR The activity of eIF-2 
is important in the regulation of polypeptide chain initiation and is regulated by 
phosphorylation of the a subunit. The activated PKR is phosphorylated the eIF-2a at 
serine 51 to eIF-2(aP) that interacts strongly with eIF-2B (Rowlands et al., 1988). 
The guanine nucleotide exchange activity of eIF-2B is reduced because the affinity of 
eiF-2B for eIF-2(aP).GDP is higher than eIF-2.GDP, eIF-2B is trapped in a complex 
(eIF-2(aP).eIF-2B) in which eIF-2B is nonfunctional (Rowlands et al., 1988). The 
elF-2 cannot be recycle since eIF-2B is less abundant than eIF-2 and prevent the 
recycling of eIF-2, therefore the translation in inhibited (Rowlands et al” 1988; 
Ramaiah et al, 1994). 
PKR can control transcription, in response to viral infection or other inducers, 
such as po ly( I ) .poly(C) , P K R activates IKB kinase ( IKK) , leading to the degradation 
of the inhibitors IKB and release of the transcription factor, NFKB (Bonnet et al., 
2000; Zamanian-Daryoush et aL, 2000). Therefore PKR leads to NFKB-dependent 
gene activation. IKK is a multicomponent enzyme complex with 700 to 900 kDa. 
IKK contains two catalytic subunits, IKKa and IKK|3, which can form homo- or 
heterodimers (Zandi et al., 1997). IKKa and IKKp are both activated by 
phosphorylation on specific serine residues. IKKp is the major effector of IKB 
phosphorylation in response to cytokines (Zamanian-Daryoush et al., 2000). In 
unstimulated cells, NFKB exists as an inactive form by binding with IKB retained in 
the cytoplasm. In response to NFKB inducing signals, IKKp is activated and 
phosphorylate IKB resulting in the release of NFKB (DiDonato et al； 1997). NFKB 
then enters to nucleus and stimulates the gene transcription containing NFKB-binding 
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sequence elements (Zamanian-Daryoush et al., 2000). 
1.1.4.1.2 The 2-5A synthetase/RNase L system (The 2-5A system) 
2-5A system is an IFN-regulated RNA degradation pathway present in the cells 
of higher vertebrates. The 2-5A system plays an inhibitory roles against picornavirus 
(Chebath et al； 1987)，vaccinia virus (Diaz-Guerra et al； 1997)，EMCV (Rysiecki et 
al,, 1989; Coccia et al； 1990) and reovims (Nilsen et al., 1982). The 2-5A system 
consists of two enzyme, 2',5'-oligoadenylate synthetases (2-5A synthetases) and 
ribonuclease, 2-5A dependent RNase (RNase L). The expression of 2-5A synthetases 
and RNase L are increased in cells in response to IFN-a, p or y (Zhou et al； 1993). 
Although they are exist in inactive form (Zhou et al” 1993). 
The 2-5A system can be activated for the degradation of viral and cellular RNA 
by RNase L, the terminal factor in the 2-5A system. The activation of 2-5A RNA 
degradation pathway is shown in figure 1.4. In the presence of cofactor dsRNA, 2-5A 
synthetases polymerizes 2 to 15 ATP molecules to inorganic pyrophosphate (PPi) and 
a series of short oligomers of adenosine with 2' to 5, phosphodiester linkage，2，-5, 
linked oligoadenylates (2-5A) molecules (Zhou et al, 1993). The oligomers 
ppp(A2,p)nA, where n represents the length of adenyl residues which usually formed 
two, three and four (or longer) with the trimeric species is predominant. 2-5A in turn 
binds to RNase L and convert it from inactive to catalytic active form that can 
degrade viral and cellular mRNAs and rRNA，leading to an inhibition of protein 
synthesis in virally infected cells (Carroll et al., 1997; Silverman，1997). The 
activated RNase L cleavages nucleotide of UU，UA, AU，AA and UG, but cannot 
cleavage of nucleotide containing only cytosines (such as CA and AC) (Floyd-Smith 
et al, 1981; Wreschner et al., 1981; Carroll et al., 1996). 
RNase L i s a single-strand specific endoribonuclease that is tightly regulated by 
2-5A. The catalytically active form of RNase L is a homodimer. The binding of 
functional 2-5A to monomeric inactive form of RNase L induces dimerization of the 
enzyme (Dong & Silverman, 1995). The N-terminal half of RNase L contains nine 
ankyrin-like repeats with 2-5A binding activity (Zhou et al., 1993; Dong & 
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Silverman，1997). The C-terminal half contains a cysteine-rich region with protein 
kinase-like domain and endoribonuclease activity (Dong & Silverman，1997). Within 
the seventh and eighth ankyrin repeats are two P-loop motifs，which consists of two 
lysine residues for the binding of 2-5A. Partial deletion of P-loop motifs and 
substitution mutations of the two lysines result in significantly decline in 2-5A 
binding activity (Zhou et al； 1993). The presence of ankyrin repeats functions as a 
potent repressor of RNase L activity. In the absence of 2-5A, the nine ankyrin-like 
repeats interact with the catalytic domain to block ribonuclease activity. The ankyrin 
domain also prevents dimerization by blocking access to the interaction sites. The 
binding of 2-5A to the P-loop motifs present in the seventh and eighth ankyrin repeats 
cause a conformational change in RNase L that releases the ankyrin clamp, thus 
allowing the RNase L to dimerize into its active form (Dong & Silverman，1995). 
1.1.4.1.3 Mx proteins 
The proteins of Mx family are able to inhibit multiplication of several RNA 
viruses including influenza virus. The most extensively studied is MxA protein in 
human and Mxl protein in mouse. However, the mechanism that influences the 
influenza virus replication remains unclear. 
Mx proteins are IFN-inducible, with a molecular mass between 70 to 80 kDa. 
All Mx proteins are highly conserved in the N-terminal containing the GTP-binding 
motif. However they are no similarity in the C-terminal portions. Purified Mxl and 
MXA proteins possess GTPase activity. GTPase plays a role in protein synthesis, 
intracellular signaling, and intracellular vesicle transports. The mutants of GTP-
binding sequences of Mxl and MxA proteins are unable to resist virus replication in 
yiyo or to hydrolyse GTP in vitro. The results suggest that GTPase activity is critical 
for antiviral activity of Mx proteins (Ponten et al., 1997 & Pavlovic et al., 1993). 
Human MxA and mouse Mxl proteins are localized in the cytoplasm and 
nucleus respectively. The nuclear Mxl protein inhibits the primary transcription of 
influenza virus in nucleus as the levels of the longest primary transcripts coding for 
PBl，PB2, and PA were reduced in infected cells expressing Mxl protein. The 
cytoplasmic MxA protein do not inhibit the primary transcription of influenza virus as 
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the primary viral transcripts are polyadenylated and be able to synthesize protein. 
Since MxA protein is located in cytoplasm, therefore it may interfere with either 
intracytoplasmic transport of viral mRNAs to ribosomes and viral protein synthesis， 
or the translocation of newly synthesized viral proteins from the cytoplasm to the 
nucleus (Pavlovic et al, 1992). 
1.1.4.2 Immunomodulatory function of IFN-a/P 
The major immunomodulatory function of IFN-a/p is acting on NK cells. NK 
cells are non-T-cell populations. The cells have the ability to kill virus-infected cells 
(Reiter, 1993). IFN-a/p has been shown to enhance the cytotoxicity, and 
blastogenesis of NK cell and also induces NK cell trafficking from bone marrow to 
secondary compartments (Reiter, 1993; Orange & Biron，1996; Biron, 1997; Salazar-
Mather et al, 1996). IFN-a/p also induced macrophages to synthesize IL-15 in vivo 
and in vitro that may in turn induce bystander proliferation, clonal expansion and 
survival of memory cytotoxic T cells (Tough et al” 1996; Sprent et al., 1999). 
Moreover, type I IFN may regulate the expression of IL-12 receptor and thus 
influence T-helperl (Thl) cell differentiation (de Waal Malefyt, 1997). Influenza A 
virus infected macrophages produced type I IFN and IL-18 that act together to induce 
IFN-Y production and promote Thl cell differentiation (Sareneva et al., 1998). 
1.1.4.3 Inhibition of cell growth 
IFN-a and IFN-a stimulated proteins have been shown to regulate cell growth. 
By cultivating Daudi Burkitt's lymphoma cell with IFN-a, the cyclin D3 and cdc25A 
gene expression is greatly suppressed. Cyclins play an important role in controlling 
and regulating cell cycle. Cyclin D3 is expressed exponentially in growing Daudi 
cells. The cdc25A phosphatase regulates the activities of cyclin E and A. In response 
to IFN-a, the levels of cyclin D3 and cdc25A mRNA and proteins are rapidly reduced 
in Daudi cells and reversibly blocked the cells in a Go-like state (Tiefenbrun et al., 
1996). 
PKR also participates in regulation of cell growth and malignant transformation. 
18 
Expression of a functionally defective mutant of PKR in NIH 3T3 cells resulted in 
malignant transformation (Koromilas et al； 1992; Meurs et al., 1993). Whereas no 
tumor growth was observed for several weeks in mice inoculated with NIH 3T3 cell 
clones expressing either the wild-type recombinant human and murine PKR (Meurs et 
al., 1993). Barber and co-workers also demonstrated that in NIH 3T3 cells 
transfected with mutant PKR proteins lacking RNA binding domain-1 (RBD-1) 
caused malignant transformation that possibly due to the inhibition of translation. 
Phosphorylation of eIF-2a is critical in control of cell proliferation as mutant PKR 
protein cannot phosphorylate eIF-2a. The mutant form of eIF-2a cannot be 
phosphorylated on serine 51 caused malignant transformation of NIH 3T3 cells 
(Donze et al, 1995). Therefore PKR has tumor suppressor properties by regulating 
eIF-2a phosphorylation and inhibit protein translation. 
PKR is also involved in the control of cell growth and proliferation. 
Overexpression of PKR in yeast, Saccharomyces cerevisiae cause a severe inhibition 
of growth due to increased eIF-2a phosphorylation that inhibit polypeptide chain 
initiation (Chong et al., 1992). In human glioblastoma T98G cells, PKR activity is 
tightly regulated through the cell cycle, high levels of PKR kinase activity was 
detected in early G1 and at the Gl/S boundary. The level of PKR declines sharply in 
early S phase (Zamanian-Daryoush et al,1999). 
In human glioblastoma cell line stably transfected with 2-5A synthetase cDNA，a 
reduction in cellular growth rates and an elevated level of 2-5A synthetase enzyme 
activity was observed (Rysiecki et al” 1989). 
1.1.4.4 Control of apoptosis 
The viral proteins NP (nucleocapsid) and NSl (nonstructural) of influenza A and 
B viruses induce apoptosis in cultured cells (Hinshaw et al., 1994; Zhirnov et al., 
1999； Schultz-Cherry et al, 2001). Many researches found that influenza vims can 
induced cell death through the activation of dsRNA activated protein kinase, PKR 
(Takizawa et al., 1996; Der et al., 1997; Srivastava et al., 1998). PKR mediated the 
virus-induced apoptosis through the activation of the Fas-associated death domain-
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containing protein (FADD)/capase-8 death signaling pathway (Balachandran et al； 
1998; Balachandran et al., 2000). The expression of dominant-negative variant of 
PKR in influenza virus infected murine fibroblasts cells was found unable to induce 
infected cells to undergo apoptosis, while cells over expression with functional PKR 
are sensitized to apoptosis (Balachandran et al., 2000). 
RNase L also plays a role in apoptosis, since RNase l / mice show defects in 
apoptosis in several tissues treated with different apoptotic agent (Zhou et al., 1997). 
RNase L mediated apoptosis may be through the degradation of mRNA for cell 
survival factors (e.g. pro-apoptotic factor mRNA) or catalyzes the autodegradation of 
cells (Zhou et al., 1997). 
1.1.5 The significance of IFN system 
In order to study the importance of IFN system, mice bearing a deficient IFN 
system were produced and studied. However, due to the fact that IFN-a consists of 
many subtypes, inactivation of entire type I IFN is not possible. IFN-a/p and IFN-y 
specifically bind to IFN-a/p receptor (IFN-a/(3R) and IFN-y receptor (IFN-yR) 
respectively (Florest et al., 1991). Mice genetically deficient in IFN receptors were 
produced to study the importance of type I IFN in antiviral activity. The IFN-a/p 
receptor null mice (IFN-a/pR。,。)，IFN-y receptor null mice (IFN-yR�,�) and control 
mice were inoculated with different viruses and compared for the antiviral responses. 
Mice devoid of type I IFN receptors were extremely susceptible to vesicular stomatitis 
virus (VSV) infections. The IFN-cc/pR�,�mice died within 3 to 6 days upon infection, 
whereas wild type and IFN-yR^^ ® mice were unaffected. Similar results were obtained 
from mice infected with Semliki Forest virus (SFV), vaccinia virus, lymphocytic 
choriomeningitis virus (LCMV). Results from these studies suggest that IFN-a/p is 
important in controlling viral infection (Miiller et al.’ 1994). 
The antiviral activity was studied in mice lacking type I and/or type II receptors. 
Type I IFN is important in controlling replication of LCMV virus because IFN-yR�如 
mice can efficiently eliminated the virus from most tissues, whereas IFN-a/pRoZ�mice 
can not. IFN-a/p also plays an important role in clearing the vaccinia virus. IFN-
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a/pR�z�mice and mice lacking both type of IFN receptors were not able to eliminate 
the vims even with low infection dose, whereas the wild type and IFN-YR�,�mice 
were able to cope with it (van den Broek et al., 1995). 
Mice without a functional IFN-yR have a decreased resistance to infection with 
intracellular bacteria (Mycobacterium, Listeria) and parasites (Leishmania). Whereas 
mice lacking a functional IFN-a/pR are resistant to Listeria monocytogenes. IFN-a/p 
is produced by virus-infected cells within hours and plays an important role in 
preventing vims spread. IFN-y plays a major role at a later stage of cell-mediated 
immune response. This suggested that the two IFN systems are functionally 
nonredundant, at least in response to some viruses (Miiller et al., 1994; Huang et al., 
1993). 
1.1.6 Subtype of murine IFN-a 
At least 10 IFN-a subtypes have been identified in mouse, IFN-al, IFN-al-9, 
IFN-CX2，IFN-a4, IFN-a5, IFN-cc6, IFN-a7, IFN-a8, IFN-all and IFN-cxB (Shaw et 
al., 1983; Daugherty et al., 1984; Kelley & Pitha，1985a; Zwarthoff et al, 1985; Dion 
et al., 1986; Seif & DeMaeyer-Guignard, 1986; Navarro et al., 1989; Coulombel et 
al； 1991). The genes are characterized based on the screening of mouse genomic 
library. All IFN-a genes contain a variant of the Goldberg-Hogness sequence, 
TATTTAA, at position -94 from the transcriptional start point. 
All mature proteins of murine IFN-a are 166-167 amino acids except IFN-a4. 
Murine IFN-a4 is notable among the IFN-a subtypes because the gene has a 15 bp 
deletion in the coding region at position +379 to +393. The mature protein contains 
onlyl61 amino acids with 5 amino acids in frame deletion corresponding to positions 
103-107 of the other subtypes. Moreover, IFN-a4 gene contains an additional amino 
acid in the signal sequence and a G rich cluster in the promoter (Kelley & Pitha, 
1985a). 
The expression levels of IFN-a subtypes in L929 cells had been measured after 
virus infection or other induction methods. Murine IFN-a4 is the major subtypes 
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expressed in infected mouse fibroblasts L cells determined by mRNA quantitation. 
Using SI nuclease protection assay, 5 IFN-a subtypes were found to express in 
Sendai virus infected L929 cells. IFN-a4 mRNA was the most dominant subtype 
produced in L929 cells and the amount was at least 10 times higher than IFN-ctl， 
IFN-a2, IFN-a5 and IFN-a6 in virus induced cells (Zwarthoff et al., 1985). Other 
studies using mouse L929 cells infected with New Jersey strain of Newcastle disease 
virus (NDV) to determine the expression level of six IFN-a subtypes. The result 
showed that IFN-a4 gene was expressed at a level of 5-folds higher than IFN-a6 and 
IFN-a7 and 10-15 folds higher than IFN-a2 and IFN-cx5, while IFN-cd mRNA 
expression was not detected (Kelley & Pitha，1985b). Bisat and co-worker (1988) 
compared the expression levels of IFN-al，-a4 and -a6 in L929 cells and the 
granulocyte-macrophage cell line FDC-1 cells infected by NDV New Jersey LaSatoa 
strain or induced with poly(I).poly(C). Irrespective of the inducer used, IFN-cx4 
mRNA was consistently expressed at higher levels than either IFN-al or -a6. The 
level of IFN-a4 mRNA in L929 cells were at least 10 to 50 folds higher than the 
levels of IFN-al and -a6 mRNA and 2-folds higher than IFN-al and -a6 in FDC-1 
cells. The expression of IFN-a7, IFN-a8 and IFN-all were not detectable in mouse 
fibroblast cell line infected with NDV using SI protection assay (Coulombel et al, 
1991; Navarro et al., 1989). 
The antiviral activities of IFN-al and -oc4 were extensively studied. Trapman et 
al (1988) demonstrated that the antiviral activity of IFN-a4 was 10 folds higher than 
IFN-al on L929 cells challenged with VSV. In the other studies, L929 cells were 
challenged with encephalomyocardi t i s virus (EMCV), IFN-a4 only had an antiviral 
activity 2-folds higher than IFN-al (Beilharz et al., 1991). Swaminathan et al. (1992) 
demonstrated that the relative antiviral and natural killer cell stimulating activities of 
IFN-al and -a4 were similar on EMCV-infected L929 cells. On the basis of equal 
molar input, IFN-al was estimated to have only 8% of the antiproliferative capacity 
of IFN-a4 (Swaminathan et al., 1992). 
The antiviral activities of three MuIFN-a subtypes (IFN-al, -al-9 and -a4) in 
Wvo were studied in C57B/6 (B6), BALB/c and A/J mice infected with murine 
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cytomegalovirus (MCMV). When comparing to BALB/c mice, the B6 mice were two 
to four-folds more resistance and A/J mice were two-folds more susceptible to 
MCMV infection (Yeow et al” 1998). Mice infected with MCMV shown to replicate 
in the tibialis anterior muscles of mice for at least 6 days and induced an 
inflammatory infiltrate. However, mice expressing the IFN-a transgenes showed a 
marked reduction in the peak titers of virus replication, with less severe inflammation 
in the muscles compared with control mice that were inoculated with blank vectors. 
Moreover, the MCMV titers in tibialis anterior muscles of B6, A/J and BALA/c mice 
transfected with IFN-al transgene had significantly lower MCMV titers than mice 
transfected with IFN-al-9 or IFN-a4 transgene in B6, A/J and BALA/c (Yeow et al., 
1998). 
However, until now, the individual activity of each IFN-a subtype is still 
unknown. 
1.1.7 Production of IFN in response to infection 
The expression of interferons could be induced by vims, bacteria and dsRNA. 
The production of interferons in response to viral and bacterial infection had been 
well studied. The bacteria, Shigella flemeri and Salmonella typhimurium can induce 
the high level of IFN-a/p production in primary human and mouse fibroblasts and in 
mouse embryo-fibroblasts (Hess et al., 1989). Moreover, the human macrophage 
infected by pathogenic Streptococcus pyogenes produced IFN-a after 24 hours 
infection (Minja et al., 2000). 
The Sendai virus could greatly induced the IFN-a and IFN-p production in 
human trophoblasts and lymphoblastoid cells (Toth et al., 1990; Shuttleworth et aL, 
1983； Hoshino et al” 1983). The production of IFN-a could also be detected in cells 
infected by NDV, EMCV and MCMV (Yeow et al, 1998; Navarro et al, 1989; 
Coulombel et al., 1991; Bisat et al., 1988; Kelley & Pitha，1985b; Orange & Biron， 
1996). IFN-a and IFN-y were produced by human peripheral blood lymphocyte that 
exposed to dengue vims-infected cells (Kurane et al., 1986). 
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The direct correlation between the IFN and influenza virus is also demonstrated. 
The production of IFN by cells infected by different strains of influenza virus has 
been also studied. Human mononuclear leukocytes and peripheral macrophages in 
vitro infected by a pathogenic influenza A/Beijing/353/89 (H3N2) produced high 
level of IFN-a (Ronni et al., 1995; Sareneva et al., 1998). It was found that IFN-a 
was detected in the human serum in day 5 to 7 of post-infection with influenza 
A/Brazil/78 (HlNl). However, the IFN-a level was then dropped a non-detectable 
level in day 21 to 23 of post-infection (Green et al., 1982). Influenza A/USSR 
(HlNl) could induced type I IFN production from peripheral blood lymphocytes from 
children and adults (Lazar & Wright，1980). In mice infected by influenza A/HK/68 
virus, IFN-a was detected in lavage fluids and produced by lung lavage leukocytes. 
The IFN titers measured in lavage fluids were directly correlated with lung virus titers 
(Wyde et al., 1982). Influenza A/PR/8/34 also induced IFN-a production in murine 
splenic lymphocytes after 24 hours post-infection (Reiss et al； 1984). As many 
researches studied the production of IFN-a in response to virus infection in different 
cell types, however the subtypes production of IFN-a was not well studied. 
1.1.8 Existing methods to determine the IFN-a subtypes production in 
response to stimulus 
Several methods have been developed for the identification of IFN-a subtypes, 
including SI nuclease protection assay and the use of consensus primer for RT-PCR 
followed by the use of subtype specific oligonucleotides to identify the subtypes. 
Nuclease protection assay is an extremely sensitive method for the detection, 
quantitation and mapping of specific RNA in a complex mixture of total RNA. The 
method make use of single stranded, discrete size of RNA or DNA probe(s) to 
hybridize the RNA samples under the conditions favoring the formation of 
probeitarget hybrids. After hybridization, the sample is digested with RNase or SI to 
digest the single stranded nucleic acid (including unhybridze probe). The digested 
product is subject to gel electrophoresis to obtain the quantitative result (Sambrook et 
al., 1989). Kelley & Pitha (1985b) and Zwarthoff et al. (1985) used SI analysis to 
differentiate the expression of IFN-a genes. Specific probe for murine IFN-al，IFN-
cx2，IFN-a4，IFN-a5, IFN-a6 and IFN-a7 were synthesized and used to detect the 
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expression of IFN-a after the infection of L929 cells by Sendai virus or Newcastle 
disease virus. Up to 10 - 15 \ig of total RNA was used for one subtype detection. 
However SI nuclease protection assay is technically difficult, time consuming and 
requires large amount of RNA. Moreover, the sensitivity of nuclease protection assay 
is low which can only detect the mRNA with to mRNA (Sambrook et al., 
1989). 
Later, Lai et al. (1994) and Hughes et al. (1994), using the molecular method 
reverse transcription-polymerase chain reaction (RT-PCR) and followed by Southern 
analysis to differentiate IFN-a subtypes (IFN-al, IFN-a2, IFN-cx4, IFN-cx5 and IFN-
a6). The idea between two groups of studies is similar. After reverse transcription of 
RNA using oligo(dT)i2.i8, consensus oligonucleotide primers were used to allow 
simultaneous PCR amplification of multiple murine IFN-a subtypes. By the use of 
subtype specific oligonucleotide probes hybridize to polymerase chain reaction 
products to identify the IFN-a subtypes. However due to the properties of PCR, more 
abundant RNA may be predominately amplified when the efficiencies of interaction 
of two sequences of the mRNAs with the primers are equal. As all IFN-a subtypes 
share high sequence homology, by the use of consensus primer to perform PCR, those 
IFN-a subtypes express in low level will not be detected. 
Many other methods can be used to give quantitative analysis RNA, such as 
Northern blotting, dot/slot blots and in situ hybridization. The sensitivity of Northern 
blot and dot/slot blots are low. It limits of detection in the range of 10^ to lO? target 
molecules (Sambrook et al., 1989). Therefore it requires large amount of RNA (often 
requires poly(A)+ mRNA) and they are not sensitive to detect for low abundance of 
RNA. Although nuclease protection assay and in situ hybridization are more sensitive 
and quantitative, these methods are time-consuming, technically difficult and are not 
useful for a simultaneous processing of a large number of samples (Sambrook et al” 
1989). The mentioned methods have several disadvantages and until now there are no 
methods that can identify all murine IFN-a subtypes. In the project, a molecular 
method using reverse transcription-polymerase chain reaction for identify the murine 
IFN-a subtypes will be developed. Similar to other methods to analysis of RNA, RT-
PCR is semi-quantitative that allows the comparison of the relative level of gene 
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expression in different cells, cell lines or tissue. The advantages of using PCR are 
sensitive, and require small amount of RNA (O.l^ xg of total RNA). It can detect low 
abundance mRNAs, and no need to purify poly(A)+ mRNA. It is time saving and less 
material demanding (Ferre et al., 1994). 
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1.2 Influenza virus 
Influenza virus particles are highly pleiomorphic (variable), mostly 
spherical/ovoid in shape and 80-120 nm in diameter, but many forms occur, including 
long filamentous particles. Influenza virus belongs to the family of 
Orthomyxoviridae. The vims contains 8 negative, single stranded RNA and an 
envelope genome. Three types of RNA can be identified in the vims life cycle，the 
single stranded viral genomic RNA (vRNA), viral mRNA and template RNA. Viral 
mRNA and template RNA are plus-stranded RNA which are transcribed from the 
negative strand vRNA by different mechanisms (Lamb & Krug，1996). 
1.2.1 Classification 
The family of Orthomyxoviridae consists of three genera: influenza A, B and 
influenza C. A fourth genus is tick-borne viruses, Thogotavirus, that are structurally 
and genetically similar to influenza A，B and C viruses (Hay, 1998). The 
classification of influenza virus is base on the differences between their nucleocapsid 
(NP), matrix (M) protein, hemagglutinin (HA or H) and neuraminidase (NA or N) 
glycoproteins. 
Influenza A viruses infect a wide variety of mammals, including human，horses, 
pigs, ferrets and birds. The main human pathogen, associated with epidemics and 
pandemicsi. influenza A viruses are divided into serotypes based on the surface 
protein hemagglutinin and neuraminidase. There are 15 known hemagglutinin 
serotypes (H1-H15) and 9 known neuraminidase serotypes (N1-N9). Viruses with 
h a types HI, H2 and H3 and NA types N1 and N2 are the major humans pathogens. 
Influenza B vims is not divided into distinguishable serotypes. Influenza B vims 
causes a mild infection in human population (Lamb & Krug, 1996). 
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Figure 1.5 Structure of influenza A virus particle. 
Adapted from Lamb & Krug, 1996 
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1.2.2 The structure of influenza virus 
Influenza A and B viruses consist of eight RNA segments and influenza C virus 
consists of seven RNA segments varying in length (Desselberger et al., 1980). Each 
RNA segment is independently encapsidated by viral nucleoprotein (NP) and is 
associated with a heterotrimeric RNA polymerase complex (PBl, PB2 and PA) at one 
end of each of the viral RNAs (O'Neill et al., 1995). The subviral particle consisting 
of vRNA, NP and three polymerases is called ribonucleoprotein (RNP). Overlying 
the helical nucleocapsid is a layer of matrix protein, Ml. The RNP and the matrix 
protein Ml assemble together to form the capsid structure. Overlying the matrix 
protein is the viral envelope that derived from the plasma membrane of the infected 
cell during the budding process. The lipid membrane contains three proteins: a 
membrane-channel protein, M2 and two spikes glycoproteins, the rod-shaped 
hemeagglutinin (HA) and the mushroom shaped neuraminidase (NA) (Ruigrok, 
1998). The HA is uniformly distributed on the virion while the NA occurs in a 
discrete patches. The ratio of HA to NA varies but is usually 4-5 to 1 (Murti & 
Webster, 1986). The structure of influenza A virus is shown in figure 1.5. 
1.2.3 The Viral genome and proteins 
The RNA genomes of influenza A and B viruses comprise eight segments 
whereas influenza C comprises seven segments. 
The three largest RNA segments encode the components of the RNA 
polymerase, PB2, PBl and PA by segment 1，2 and 3 respectively in influenza A, B 
and C. PB and PA are stand for polymerase basic and acidic protein respectively as 
PB2 and PBl are found to be basic and PA to be acidic on isoelectric fousing gel 
(Yamashita et al.’ 1989). 
Segment 4 encodes the hemagglutinin (HA) of influenza A and B viruses and a 
hemagglutinin-esterase fusion (HEF) protein of influenza C. The name of 
hemagglutinin because the ability of the virus to agglutinate erythrocytes by 
attachment to specific sialic acid glycoprotein receptors. Influenza C vims contains 
only a single glycoprotein, HEF that possesses both the receptor binding and 
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membrane fusion activities of the hemagglutinin and the receptor destroying activity 
of neuraminidase (Nakada et al., 1984; Herder et al； 1988). 
Segment 5 encodes the nucleoprotein (NP) bind ssRNA with high affinity but 
little or no sequence specificity. The NP is a major structural protein associated with 
virus RNA to form the ribonucleoprotein (RNP) (Portela & Digard, 2002). 
Segment 6 of influenza A and B viruses encodes neuraminidase (NA); there is no 
equivalent RNA segment in influenza C, the corresponding function being fulfilled by 
the HEF protein. The NA is a homotetramer. Segment 6 of influenza B virus encodes 
two proteins, NA and NB (Robert et al, 1996). NB is a component of vims envelope 
of influenza B (Betakova et al., 1996). The NB protein plays a role on ion channel 
activity with an analogous function as M2 protein of influenza A virus in vims 
uncoating (Sunstrom et al., 1996). 
Each segment 7 of influenza A and B and segment 6 of influenza C also encode 
for two proteins. Segment 7 of influenza A encodes the matrix protein Ml that 
constitutes the most abundant polypeptide in the virion. The M2 protein is a minor 
component of virions that has ion channel activity (Pinto et al., 1992). For the 
influenza B vims, segment 7 encodes matrix protein Ml and BM2 protein. The 
function of these proteins is unknown. Segment 6 of influenza C virus encodes Ml 
and CM2 protein with unknown function. The CM2 protein of influenza C is 
structurally analogous to influenza A vims M2 and influenza B virus NB proteins 
(Pekosz & Lamb, 1997). The M2 protein is a homotetrameric proton channel that 
function together with HA in uncoating the virus RNP during endocytosis，and 
modulates the pH of the trans Golgi. The ion channel activity of M2 protein can be 
blocked by the antiviral drug amantadine (Pinto et al., 1992). 
The RNA segment 8 of influenza A and B virus and the segment 7 of influenza C 
virus encode two proteins, NSl and NS2. NS is stand for non-structural because the 
NSl protein is only abundantly expressed in influenza virus-infected cells. Although 
the NS2 protein was originally defined as nonstructural protein, recent studies 
indicated that NS2 protein exists in virions and associates with the Ml protein. The 
NS2 protein of influenza A, B and C mediates the export of vRNPs and now is called 
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as nuclear export protein (NEP) (Richardson & Akkina, 1991; Yasuda et al” 1993; 
Paragas et al” 2001). 
1.2.4 Replicative cycle of influenza virus 
1.2.4.1 Virus adsorption, entry and uncoating 
Influenza virus enter into the cell by binding of sialic acid on the cell surface that 
serve as receptors for the HA protein in influenza A and B viruses and the HEF 
protein of influenza C vims. Different influenza viruses have different specificity for 
sialic acid linked to galactose by a2,6- or a2,3-linkages. After binding, the virus 
particle is engulfed by receptor mediated endocytosis through clathrin-coated pits into 
endocytotoic vesicles. The acidic pH within endosomes triggers the fusion of viral 
and endosome membranes. The fusion protein in influenza A is HA, the fusion 
potential of the HA is activated at pH 5-6 depending on the strain of virus. At the 
acidic pH，the HAO monomers is irreversibly cleaved into HAl and HA2 polypeptides 
by trypsin-like enzymes in the endosome and trigger the membrane fusion through 
HA2 (Steinhauer et al., 1991; Chen et al., 1998). The vims is then uncoating by 
dissociation of Ml from RNPs. The uncoating of the capsid is necessary to allow 
entry of RNPs into the nucleus and initiation of replication because the RNPs cannot 
enter into nucleus in associated with Ml protein (Grambas & Hay, 1992; Bui et al., 
1996). The RNPs enter into nucleus by active process whereas the Ml protein enters 
into nucleus also but independents on RNP after it dissociate from the RNP structure 
(Martin & Hdenius, 1991). The uncoating of influenza virus is mediated by the M2 
channel in the virus membrane. After the membrane fusion, M2 channel is open in 
response to the low pH in the endosome. M2 protein mediated an influx of the H+ 
into the virion and result in trigger nucleocapsid disassembly (Zhirnov，1990). 
1.2.4.2 Transcription and replication of vRNA 
Virus consists of two types of RNA complementary to each of the virus genome 
RNAs，the viral mRNA and template RNA. Double strand (+/-) replicative 
intermediate structures can be isolated from the nucleus of infected cells. Viral 
mRNA and template RNA are (+) sense and find in infected cells. The viral mRNA is 
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a incomplete genome transcript that lack the sequences complementary to the 16 
nucleotides at 5, end of the vims RNA and polyadenlyated at 3, end (Hay et al” 1977; 
Hay et al” 1982). The viral mRNAs are exported from the nucleus to cytoplasm and 
used for protein synthesis. The viral mRNA is transcribed and replicated by the 
trimeric viral RNA polymerase complex consisting of PBl，PB2 and PA polymerase. 
PB2 protein of the polymerase complex is first bind to the capped 5，end region of 
newly synthesized host cell mRNA. The host mRNA is then cleaved 10-13 bases 
from the cap by the endonuclease activity of PB2 which are then used as a primer to 
prime transcription of virus-specific mRNAs (Shi et al, 1995). The transcriptase PBl 
then catalyzes nucleotide addition in the initiation and elongation of the RNA 
transcript (Nakagawa et al； 1996) and PA that the actual role is less well understood. 
Robertson et al. proposed that the poly(A) tails of viral mRNAs are synthesized by 
reiteratively copying of the short stretch of U residues in the virion RNA template by 
the viral transcriptase complex. Poon et aL confirmed this model as replacing the 
short stretch of U residues with A, it direct the synthesis of products with poly(U) tails 
instead of poly(A) both in vivo and in vitro. Moreover, interrupting the U track 
abolishes polyadenylation in vitro. The template RNA is a complete, non-
polyadenylated sense full copies of vRNA which serve as template for the synthesis 
of progeny (-)sense RNA. Synthesis of template RNA is depend on protein synthesis 
because in the addition of actinomycin D that inhibit protein synthesis during 
infection, only small amount of template RNA is accumulated (Barrett et al., 1919). 
1.2.4.3 Synthesis of viral proteins 
The early and late phase of gene expression are identified in viral life cycle. The 
early phase follows primary transcription and represents an initial stage of vRNA 
replication and amplification of mRNA production. Viral mRNAs are transported 
into the cytoplasm and translated, NSl and NP proteins are synthesized preferential 
relatively early in infection and transported to the nucleus to regulate the replication 
and transcription of viral RNAs. The virion structural components, HA, NA and Ml 
proteins are synthesized in greater amounts during the late phase. The NSl protein 
regulates the splicing of M and NS mRNA to the M2 and NS2 mRNAs respectively. 
PBl，PB2, PA and NP are synthesized in relatively large amounts during both periods 
of infection. These proteins are transported into the nucleus to assemble RNP 
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complex. Ml and NS2 proteins are also transported into the nucleus and associated 
with newly synthesized RNPs (Hay et al., 1977). The viral structural protein, HA, 
NA, M2, NB and HEF are transported to the apical surface of infected cells through 
trans-Golgi vesicle. The HA molecules may undergo structural change in exposed to 
the low pH of the trans-Golgi vesicle and result in failure of virus assembly. The M2 
channel can regulated the pH of the vesicle to reduced acidity that allow transfer of 
functional, native HA to the cell surface of infected cells (Steinhauer et al., 1991). 
1.2.4.4 Packaging and budding of progeny vims 
The mechanism of packaging a segmented genome of influenza viruses is not 
known. The influenza structural proteins on the plasma membrane are assembled into 
virions. Virus particles are released from the cell surface by budding with unknown 
mechanism. The NA acts enzymatically to cleaves the sialic acid and facilitating the 
release of fully formed virion from the infected cells and preventing self-aggregation 
of the vims (Lamb & Krug, 1996). 
1.2.5 Viral inhibition of the IFN response 
Viruses have developed different methods to against the antiviral effect of IFN, 
such as interference the IFN-a signaling and against the deleterious effect on IFN-
induced protein. Sendai virus and paramyxovirus simian virus 5 can block the IFN-a 
signaling by partial inhibition of activation of Tyk2 and proteasome-mediated 
degradation of STATl (Komatsu et al., 2000; Young et al., 2000). Moreover, Sendai 
virus synthesised C proteins could induce STATl instability or prevent the synthesis 
of STATl in response to the virus infection or IFN treatment (Garcin et al., 2000). 
Many viruses developed strategies to minimize the deleterious effects on protein 
synthesis caused by the dsRNA-activated PKR that are induced by interferon. By 
inhibit the phosphorylation of PKR, eIF-2a could not be phosphorylated and in turn 
could not inhibit protein translation. Vaccinia virus produces specific kinase 
inhibitory factor (SKIP) to inhibit the activation of PKR (Whitaker-Dowling & 
Youngner, 1984; Akkaraju et al., 1989). The human immunodeficiency virus (HIV-1) 
encode 如-responsive region (TAR) could down regulated PKR and decreased the 
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cellular amount of PKR in HIV infected cells (Roy et aL, 1990; Roy et al., 1991). 
Adenovirus encode RNA polymerase III product, VAl RNA inhibited cell activation 
of the PKR by blocking the dsRNA binding site of PKR in cell by VAl RNA 
(Kitajewski et al., 1986; Mellits et aL, 1990). Poliovims induced degradation of PKR 
although which remains highly phosphorylated (Black et al； 1989). Influenza virus 
IPK T 
activated cellular protein with molecular weight 58,000 dalton, p58 ，that was 
present in normal cell as an inactive form to repress phosphorylation of eIF-2a by an 
activated PKR (Lee et al, 1990; Lee et al” 1992). Moreover, the NSl protein of 
influenza virus could block the activation of PKR in vitro by sequestering dsRNAs in 
nucleus (Lu et aL, 1995). 
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1.3 Aim of study 
During viral infection, the most early produced cytokine induced by viral dsRNA 
is IFN-a/p. A direct correlation between the level of IFN-a/p and influenza vims was 
observed in influenza virus infected mice and human (Wyde et al., 1982; Green et al., 
1982; Reiss et al., 1984; Sareneva et al” 1998). The IFN-a/p system plays an 
essential role in the innate immune response to viral infection. The significance of 
IFN-a/p was demonstrated on IFN-a/pR'^' null mice that could not impair the viral 
infection (Miiller et al., 1994). IFN-a also played roles in cell proliferation and 
immunomodulation (Chong et al., 1992; Tiefenbrun et al., 1996). 
In mouse, there are at least 10 different IFN-a subtypes. The reason for the 
multiplicity of IFN is unknown. The expression level and antiviral activity of few 
IFN-a subtypes were studied previously. The murine IFN-a4 was expressed at higher 
level and with a greater antiviral activity in response to viral infection (Beilharz et al., 
1991; Swaminathan et al., 1992; Yeow et al., 1998). To analyze the role of IFN-a 
subtypes, an effective method capable to distinguish each IFN-a subtype is required. 
Previously, several methods have been developed for the identification of IFN-a 
subtypes, including SI nuclease protection assay and the use of consensus primer for 
RT-PCR followed by the use of subtype specific oligonucleotides to identify the 
subtypes (Kelly & Pitha, 1985; Zwarthoff et al., 1985; Lai et al., 1994; Hughes et al., 
1994). For the SI nuclease protection assay, the method is technically difficult, time 
consuming, requiring a large amount of RNA and low sensitivity (detect the mRNA 
with 10^ to 106 mRNA) (Ferre et al., 1994). The method developed by Lai et al and 
Hughes et al using consensus primers to allow simultaneous PCR amplification of 
multiple murine IFN-a subtypes after reverse transcription and followed by the use of 
subtype specific oligonucleotide probes hybridize to PCR products for identification 
of IFN-a subtypes. Due to the intrinsic properties of PCR reaction, more abundant 
RNA may be predominately amplified when the efficiencies of interaction of two 
sequences of the mRNAs with the primers are equal. Since all IFN-a subtypes share 
high sequence homology, those IFN-a subtypes expressed in low level could not be 
detected using the consensus primers. 
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Until now, there is no reliable method to distinguish all the IFN-a subtypes, in 
this project, a molecular method using reverse transcription-polymerase chain reaction 
(RT-PCR) based method was developed to identify the murine IFN-a subtypes. The 
method involved reverse transcription of total RNA using oligo (dT)i2-i8 and followed 
by PCR using the subtype specific primers for identifying IFN-a subtypes. The 
subtype specific primers were tested to ensure the efficiency and specificity. This 
method is sensitive and provides a fast and effective means to differentiate the IFN-a 
subtypes. This method also provides a high sensitivity to detect low expressed level 
of IFN-a subtypes. 
The subtype specific primers developed in this project will be used to identify 
the subtypes production in cells infected by different strains of influenza vims. 
Influenza virus is a major cause of morbidity and mortality worldwide. By analyzing 
the expression profiles of IFN-a subtypes in infected cells, hopefully the roles of 
individual subtype in response to viral infection can be delineated. In addition to the 
IFN-a subtypes, the expression levels of IFN-y, IFN-P and the IFN-a/p receptor will 
be also measured using RT-PCR. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Overall procedures 
A molecular method using reverse transcription-polymerase chain reaction (RT-
PCR) was developed to identify murine IFN-a subtypes. Total RNA was reverse 
transcribed using oligo(dT)i2-i8 as a primer and followed by PCR using the subtype 
specific primers for identifying IFN-a subtypes. 
The specific primers for amplifying the whole coding region and subtype 
specific primers of IFN-a genes were designed using the “oligo” computer program. 
For the purpose to study the specificity of subtype specific primers, whole coding 
sequence of all IFN-a subtypes were amplified from mouse genomic DNA as IFN-a 
genes contain no introns. The mouse genomic DNA was isolated from fibroblasts 
L929 cells. The amplified fragments of IFN-a genes were subcloned into the 
multiple cloning site of pBluescript SK II (-) vector (figure 2.1) and confirmed by 
sequencing. The specificity of subtype specific primers was tested by PCR using 
subtype specific primer against different IFN-a subtype DNA template. Mispriming 
of IFN-a subtypes may be occurred due to high sequence homology between IFN-a 
subtypes, the concentration of Mg2+ and annealing temperature were carefully 
adjusted to reduce the chance of mispriming and increase the specificity of PCR 
amplification. Moreover, PCR using high ratio of non-target genes to target gene 
were performed to test if any bias will be happened when amplifying the target 
subtype with subtype specific primer in the excess of other templates. 
After the tests on subtype specific primers, a well-known inducer was added into 
L929 cells to determine the possibility of using the subtype specific primer for detect 
the expression of different IFN-a subtypes. A great variety of synthetic compounds 
are able to induce interferons. The synthetic polyribonucleotides are the most widely 
active inducers in vivo and in vitro (Stewart, 1979). Among the polyribonucleotides, 
the double-stranded homopolymer ribonucleotides pair poly(I)-poly(C) 
(polyinosinic.polycytidylic acid) is the well studied and used nonviral interferon 
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inducer (Trapman, 1979; Vonk et al” 1981; Machida et t?/.，1984; Cheung et al., 1989). 
Mouse fibroblasts cell line L929 were induce by poly (I).poly (C) to produce IFN-a. 
However, poly(I)-poly(C) is toxic and can be attack by nucleases. Therefore, during 
the induction, poly(I).poly(C) was added together with diethylaminoethyl (DEAE)-
dextran. The purpose of adding DEAE-dextran during induction is used to increase 
the stability of poly(I).poly(C) complex, enhance the binding of poly (I).poly (C) to cell 
and nucleic acid uptake by cells in order to enhance the interferon inducing ability 
(Stewart, 1979; Friedman, 1981). After confirmed the specificity and efficiency of 
subtype specific primers by different experiments, the IFN-a subtypes expression in 
L929 cells infected with influenza A/NWS/33 (HlNl) and B/Lee/40 viruses were 
determined by the means of RT-PCR. The expression of IFN-p, IFN-y and IFN-a/p 
receptor in induced cells were also studied using RT-PCR. 
After induction, total RNA were isolated by the method of guanidium 
thiocyanate-cesium chloride (GT-CsCl) ultracentrifugation (Chirgwin et al., 1979) 
and performance the RT-PCR. RNA was used as a template for reverse transcription 
to complementary DNA (cDNA) using oligo(dT)i2-i8 as a primer. The cDNA was 
then used as the template for PGR, using subtype specific primer to study the 
expression profile of IFN-a subtypes after poly(I).poly(C) induction and influenza 
infection. Following PCR, the products were analyzed by agarose gel electrophoresis. 
The amplified cDNA was identified by the size of the PCR product, which is 
predicted from the nucleotide sequence available on the Entrez Nucleotides gene 
bank. 
As RNA extraction and reverse transcription often have rather variable yields, it 
is necessary to normalize the amount of the synthesized cDNA in various samples. 
Housekeeping genes are expressed at reasonably constant levels in cells and cell lines. 
Because of the PCR amplification process reaches a plateau at high cycle numbers, 
the measurements of the level of gene expression must be performed in the 
exponential stage during the amplification. In the present study, a housekeeping gene, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), is the control for measuring 
the efficiency of RT-reactions, and for the normalization of the amount of RNA 
obtained from the samples (Chelly & Kahn, 1994; He et al； 1995). Moreover, for the 
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identification of IFN-a subtypes, it is necessary to set up two controls for PGR. One 
containing plasmid DNA with IFN-a genes to confirm the successful of PCR，and the 
other containing all ingredients except using RNA alone to eliminate the possibility of 
genomic DNA contamination in the RNA samples. 
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2.2.1 Cell line，bacterial strain and vector 
Cell line 
L929 was obtained from Dr. K. N. Leung (Department of Biochemistry, The Chinese 
University of Hong Kong). Mouse L929 fibroblasts were grown in monolayer in 
RPMI1640 supplemented with 10 % FCS, 2 mM glutamine and 1 % antibiotics (PSN 
or PSF) at 37�C in a 5 % CO2 atmosphere. 
Bacterial Strains 
Escherichia coli (DH5a) for preparation of competent cell, kindly prepared by Mr. C. 
S. Lo. 
Plasmid 
pBluescript SK II (-) Strategene AA0005 
2.2.2 Chemicals 
2-Mercapto-ethanol Sigma M7154 
5-bromo-4-chloro-3-indolyl-p-D-galactoside (X-gal) Amresco 7240-90-6 
Agar (Bacteriological grade) A) ax 863 
Ampicillin Sigma A9518 
Cesium chloride - optical grade (ultra-pure) GibcoBRL 15507-015 
Diethylaminoethyl (DEAE) dextran Amersham Pharmacia 
17-0350-01 
Diethyl pyrocarbonate (DEPC) Sigma D5758 
Ethanol, absolute Ajax 214 
Ethylenediamine-tetraacetic acid (EDTA) Sigma ED2SS 
Glycerol Sigma G5516 
Guanidine thiocyanate Sigma G9277 
Isopropyl-p-D-thiogalactopyranoside (IPTG) Sigma 16758 
Seakem LE agarose BMA 50004 
(Biowhittaker Molecular Applications) 
Sodium bicarbonate Sigma S5761 
Sodium chloride Sigma S9625 
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Tris-acetate EDTA buffer Ameresco 796 
Tryptone Oxoid L42 
Yeast extract Oxoid L21 
2.2.3 Culture Media, Buffer and other Solutions 
RPMI1640 (Powder) GibcoBRL 23400-021 
Dulbecco's phosphate-buffered saline GibcoBRL 21600-010 
Fetal bovine serum GibcoBRL 16000-044 
Trypsin-EDTA GibcoBRL 25200-056 
Antibiotic-antimycotic (PSF) GibcoBRL 15240-062 
PSN antibiotic mixture GibcoBRL 15640-055 
2.2.4 Reagents and nucleic acids 
1 kb plus DNA ladder™ GibcoBRL 10787-026 
ATP Pharmacia 27-1006-01 
M-MLV reverse transcriptase; GibcoBRL 28025-013 
5 X first-strand buffer; dithiothreitol (DTT) 
Pd(T)i2-i8 Pharmacia 27-7858-01 
Platinum® Pfx DNA polymerase GibcoBRL 11708-013 
Poly(I)-Poly(C) Pharmacia 27-4729 
RNaseOUT (Recombinant ribonuclease inhibitor) GibcoBRL 10777-019 
Sma 1,10 X buffer J Promega R6221 
T4 DNA ligase Promega M1804 
ThermoprimePLus d n a polymerase Advanced Biotechnologies 
AB-0301 
Ultrapure dNTPs sets (2'-deoxynucleoside 5'- Pharmacia 27-2035-03 
triphosphate) 
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2.2.5 Reaction kits 
DRhodamine terminator cycle sequencing kit Perkin Elmer 403044 
Qiaex II gel extraction kit Qiagen 20021 
Wizard® Plus SV minipreps DNA purification system Promega A1460 
2.2.6 Solutions 
5.7 M cesium chloride Dissolve 96.0 g CsCl in 100 ml with 0.01 M EDTA 
(M.W. = 168.37) (pH 8.0). Treated with DEPC and then autoclave. 
Complete RPMI1640 medium The complete medium was prepared by 
supplementing plain RPMI medium with 1 % 
antibiotics (PSN or PSF). 
50 mg/ml DEAE-dextran Dissolve 100 mg of DEAE-dextran in 2 ml ddHzO 
and sterilize by autoclave. 
DEPC-treated water DEPC was added to Milli-Q water with final 
concentration of 0.1% and was then shake 
vigorously. After treating overnight, the solution was 
autoclaved to degrade the remaining DEPC in water. 
0.5 M EDTA Dissolve 18.61 g EDTA in 100 ml dcfflbO. Adjust 
(M. W. = 372.24) pH to 8.0 using NaOH. Treated with DEPC and then 
autoclave. 
Guanidinium thiocyanate Dissolve 50 g of Guanidinium Thiocyanate in 10 ml 
homogenization buffer; 1 M Tris-HCl (pH 7.5), and add DEPC-treated water 
4.0 M Guanidinium to 100 ml. Filter the solution through a Whatman No. 
Thiocyanate, 0.1 M Tris-Cl 1 filter or equivalent. This solution is stable and can 
(pH 7.5)，1 % (3- be store indefinitely at room temperature. Just before 
mercaptoehtanol use, add p-mercaptoethanol to a final concentration 
of 1 % (0.14 M). 
LB (Luria Bertani) Dissolve 10 g tryptone, 5 g yeast extract, 10 g NaCl 
agar plate and 20 g bactoagar in 1 liter ddHsO. Sterilize by 
autoclaving. 100 ^ig/ml of ampicillin was then added 
to the medium at 50°C. 
LB (Luria Bertani) 10 g tryptone, 5 g yeast extract and 10 g NaCl in 1 
broth liter ddHiO. Sterilize by autoclaving. A final 
concentration 100 [ig/ml of ampicillin was then 
added to the medium at 50°C. 
Poly(I)-Poly(C) Sterilized PBS was added to the vial to the final 
concentration with 2 mg/ml. The mixture was heated 
to 50°C to obtain complete solubilization of 
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Poly(I)-Poly(C). The solution was cool to room 
temperature slowly to insure proper annealing. 
Poly(I).Poly(C) was stored at 4 � C until use. 
RPMI1640 medium Powder form of RPMI 1640 medium supplemented 
with 2 mM L-glutamine and 25 mM HEPS buffer 
with sodium biocarbonate. The powder form of 
RPMI 1640 medium supplemented with 25 mM 
HEPES and 2 mM L-glutamine were dissolved in 
Milli-Q water and buffered with 25 mM sodium 
bicarbonate. The pH value of the medium was 
adjusted to 7.2 and then filter sterilized through 0.22 
(im Millipore filter. The medium was stored at 4�C 
until use. 
3 M sodium acetate Dissolve 123.04 g NaOAc in 500 ml DEPC treated 
(M.W. = 82.03) ddHiO. Adjust the pH to 5.2 using glacial acetic 
acid. Treated with DEPC and then autoclave. 
2.2.7 Solutions of reaction kits 
5x first-strand buffer 250 mM Tris-HCl, pH 8.3 at room temperature, 375 
mM KCl, 15 mM MgCb 
lOx buffer J 100 mM Tris-HCl; pH 7.5，500 mM KCl; 70 mM 
MgCl2； 10 mM DTT at 37°C 
lOx One-Phor-All buffer 100 mM Tris-acetate, pH 7.5; 100 mM magnesium 
acetate; 500 mM potassium acetate 
lOx reaction buffer IV 200 mM (NH4)2S04; 750 mM Tris-HCl, pH 8.8 at 
25�C; 0.1% (v/v) Tween® 20 
Buffer PE Secret formula 
Cell lysis solution 0.2 M NaOH and 1% SDS 
Cell resuspension solution 50 mM Tris-HCl, pH 7.5; 10 mM EDTA; 100 fxg/ml 
RNase A 
Column wash solution 170 ml of 95% ethanol was added before use. Final 
concentration: 60mM potassium acetate, 8.3 mM 
Tris-HCl, pH 7.5, 40 i^M EDTA, pH 8.0 and 60% 
ethanol 
Neutralization solution 4.09 M guanidine hydrochloride; 0.759 M potassium 
acetate; 2.12 M glacial acetic acid, pH 4.2 
QXl Secret formula 
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QIAEX II Secret formula 
Template suppression reagent Secret formula 
(TSN) 
Terminator ready reaction mix A-dye terminator labeled with dichloro[R6G]; 
C-dye terminator labeled with dichloro[TAMRA]; 
G-dye terminator labeled with dichloro[R110]; 
T-dye terminator labeled with dichloro[ROX]; 
AmpliTaq DNA polymerase, FS，with thermally 
stable pyrophosphatase; MgCl�； Tris-HCl buffer, pH 
9.0 
2.2.8 Major equipments 
Bench-top microcentrifuge Eppendorf 5415D 
DNA sequencer PE Applied Biosystems 
ABI Prism 310 genetic 
analyzer 
Gel documentation system Bio-Rad GS-670 
HorizonTM 20.25 gel electrophoresis apparatus and power Gibco 1069BD 
Supply 
SpeedVac concentrator Savant SCllO 
Thermal cycler MJ research PTC-200 
Ultracentrifuge Beckman XL-80 
Spectrophotometer Eppendorf 6131 000.012 
2.2.9 Primers 
Sequencing primers  
Primer Primer sequence 5，— 3， 
T3 CTC GAA ATT AAC CCT CAC TAA AGG  
^ GAA TTG TAA TAG GAC TCA CTA TAG G  
GADPH primers for normalization of RNA samples  
Primer Primer sequence 5，- 3， Size (bp) 
Upper ~ A C C ACA GTC CAT GCC ATC AC 452 
Lower |TCC ACC ACC CTG TTG CTG TA |  
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Primer sequences for amplifying the IFN-fS，IFN-y and IFN receptor by RT-PCR 
“ S i z e 
Primer sequence 5，- 3， (bp) 
“ ^ “ Upper AGG AAC TGG CAA AAG GAT GGT G 354 
IFN-Y Lower GTG CTG GCA GAA TTA TTC TTA TTG  
IFN-aRl (within Upper AGC CTC CCC GCA GTA TTG ATG 侧 
coding region) Lower TCG GAA TGT TCT AAA TGT CAC CTA  
IFN-aRl (in 3，- Upper TCT GGG TTC GGG TGT GCT TTC 354 
UTR region) Lower GAG AGA TGA AAG AGT GCC AAC TA  
Upper ATG GAT GAG CCT GGG GAC AAC 嫩 
IFN-aR2c Lower ATG ACC CCT GTA AAC AAT CCT GA  
Upper ATT TGA GAT CGT TGG CTT TAG AGA 331 
IFN-aR2a Lower AAA CAA TAG TGC AAA TTT TAA AAA CCT  
Upper TCA CCT ACA GGG CGG ACT TCA 44I 
IFN-P Lower GCC TGC AAC CAC CAC TCA TTC  
2.2.10 Cell lysate 
The cell lysates were prepared from the L929 cells infected by A/NWS/33 (ATCC 
VR-219H1N1) at 35 HAU/10^ cells for 6 or 9 hours. Cell lysates were also prepared 
from the L929 cells infected by B/Lee/40 (ATCC VR-101) at 45 HAU/10^ cells and 
90 HAU/10^ cells for 6 or 24 hours. The cell lysates were stored at -70°C until use. 
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2.3 Methods 
2.3.1 Design of IFN-a whole coding region and subtype specific primers using 
OLIGO™ ver 5.0 
The specific primers for amplifying the whole coding region and subtype 
specific primers of IFN-a genes were designed using the computer program 
OLIGO™ ver 5.0. The IFN-a genes were obtained from the GenBank database and 
used in the program. The upper and lower primers were chosen within the sense and 
anti-sense sequence of the genes respectively. The primers were selected that are not 
mispriming on the other subtypes, not self-complementary and the upper and lower 
primers do not contain complementary bases to form primer-dimer. The melting 
temperature of upper and lower primers was more or less the same. 
2.3.2 Construction of plasmid DNA with the whole coding region of IFN-a 
gene 
2.3.2.1 Isolation of genomic DNA from L929 cells (Blin & Stafford 1976) 
For the purpose to study the specificity of subtype specific primers, murine 
genomic DNA is used to amplify the genes for the analysis. L929 cells were cultured 
in 150 cm^ culture flask and grown to confluent (approximate 5 x 10 cells). The 
culture medium was discarded and the cells were collected by trypsinization . The 
collected cells were washed twice with 15 ml PBS and recovered the cells by 
centrifugation for 10 minutes at 5000 x g. The cells were resuspended in 1 ml of TE 
buffer (pH 8.0) at a concentration of 5 x lO? cells/ml. The solution was transferred to 
50 ml falcon tube. 10 ml of extraction buffer [10 mM Tris-HCl (pH 8.0)，0.1 M 
EDTA (pH 8.0)，20 \ig/m\ pancreatic RNase and 0.5 % SDS] was added to cell 
suspension and incubated at 37�C for 1 hour. Proteinase K was then added to a final 
concentration of 100 \ig/m\ and incubated at 50�C for 3 hours and swirled 
periodically. The solution was then cooled to room temperature. Equal volume of 
phenol-chloroform-isoamyl alcohol (25:24:1) was added to the solution and gently 
mixed for 10 minutes. Two phases were separate by centrifugation at 5000 x g for 15 
minutes at room temperature. Viscous aqueous phase was transferred to a clean 15 ml 
2 Trypsinization - 5 ml of prewarmed 0.25% w/v trypsin solution was added into flask and incubated 
for 1 to 2 minutes until the cells were lifted off of the flask. 30 ml of complete medium was then added 
to stop the reaction. The cells were collected by centrifugation for 10 minutes at 5000 x g. 
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centrifuge tube and the extraction was repeated with phenol-chloroform-isoamyl 
alcohol twice. After the third extraction with phenol-chloroform-isoamyl alcohol, the 
aqueous phase was transferred to a new centrifuge tube and 0.1 volume of 3 M 
NaOAc (pH 7.0) and 2 volume of absolute ethanol were added. The tube was swirled 
until the solution was thoroughly mixed. Cotton like DNA sample was then 
transferred to another 50 ml centrifuge tube and washed twice with 10 ml of 70 % 
ethanol. The pellet was dried overnight. 1 ml of ddHiO was added to the dried pellet 
to dissolve the DNA. It normally takes 24 to 48 hours at room temperature. The 
quantity and quality of genomic DNA were determined by measured OD 260 and OD 
280. 0.5 \ig of genomic DNA was then loaded on 0.8 % agarose gel with 0.25 [xg/ml 
ethidium bromide and run with 1 x TAB buffer. After gel electrophoresis, the gel was 
visualized under UV illumination. The DNA was then stored at 
2.3.2.2 Amplification of whole coding region of IFN-a subtypes 
For the amplification of whole coding region of IFN-a subtypes, primers were 
designed based on the IFN sequences obtained from the GenBank. Approximately 
0.25 - 0.3 i^g of mouse genomic DNA was used as a template to amplify the whole 
coding region of IFN-a subtypes. The amplification conditions were tested by 
varying the concentration of MgSCU if amplified using platinum Pfx DNA 
polymerase or varying the MgCl2 concentration if the genes were amplified by 
ThermoprimePLus d n A polymerase. By the use of Thermoprime^^^^ DNA 
polymerase, 50 fxl of master mix containing 1 x reaction buffer IV (10 x, Advanced 
Biotechnologies), 0.2 mM of each dNTP, varying concentration of MgCl2 (as 
indicated in the Results), 2.5 units Thermoprime^^"^ DNA polymerase and 50 pmole 
each of upper and lower primers were added. By the use of Platinum pfx DNA 
polymerase, 50 x^l of master mix containing 1 x reaction buffer, 0.3 mM of each 
dNTP, varying concentration of MgSCU (as indicated in the Results), 1.25 units of 
Platinum pfx DNA polymerase and 50 pmole each of upper and lower primers were 
added. The PCR was performed by initial denaturation at 94�C for 2 minutes for 
template denaturation. The thermal cycle profile was: denaturation at 94�C for 1 
minutes, annealing at 56°C for 1 minutes and extension at 72�C for 2 minutes and the 
cycle was repeated additional for 39 times. 5 of amplified products were 
electrophoresed on a 0.8 % Ix TAE agarose gel with 0.25 \ig/m\ ethidium bromide to 
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confirm the successful amplification of genes from genomic DNA. 
2.3.2.3 Preparation of plasmid DNA 
(Wizard® Plus SV Minipreps DNA Purification System) 
Single, well-isolated colony containing pBluescript SK II (-) plasmid or 
recombinant plasmid was inoculated into 10 ml of LB medium with 100 \ig/m\ 
ampicillin. The culture was incubated overnight ( � 1 6 hours) at 37�C with vigorous 
shaking. Ten ml of bacterial cultured was collected by centrifugation for 10 minutes 
at 5000 X g. The supernatant was then pour off and the tube was inverted to remove 
excess media on paper towel. The cell pellet was then resuspened in 250 \il of Cell 
Resuspension Solution by vortexing. The cell suspension was then transferred to 1.5 
ml eppendorf tube. 250 of Cell Lysis Solution was then added into tube and mix 
by gentle inversion to lyse the cells. 10 [i\ of Alkaline Protease Solution was added 
and mixed by gently inverting the tube several times and then incubated at room 
temperature for exactly 5 minutes. 350 ！il of Wizard® Plus SV Neutralization 
Solution was added to neutralized the cell lysate with immediate gentle inversion. 
The neutralized lysate was then centrifuged at 14,000 x g for 10 minutes. 
Approximately 850 pi of cleared lysate was transferred to the Spin Column and 
centrifuged at 14,000 x g for 1 minute, the flowthrough was discarded. 750 \i\ of 
Column Wash Solution was added to the Spin Column and centrifuged at 14,000 x g 
for 1 minute and the flowthrough was discarded. The wash was repeated with 250 \il 
of Column Wash Solution and centrifuged at 14,000 x g for 2 minutes. The Spin 
Column was transferred to a new eppendorf tube and the plasmid DNA was eluted by 
100 \i\ of ddHiO to the Spin Column. The tube was centrifuged at 14,000 x g for 1 
minute. The quality and quantity of plasmid DNA was determined by measures the 
optical density at OD 260 and 280. 
2.3.2.4 Restriction digestion of the vector pBluescript SK II (-) with Sma I 
Blunt end digestion of vector DNA was prepared for the blunt end ligation of 
IFN-a genes fragments generated from PCR. 1 \ig of plasmid DNA was blunt end 
digested by 4 units of Smal in 20 \i\ final volume of Ix J buffer (Promega). The 
digestion mix was incubated at 25�C for 1 hour. 10 \il of digestion mix was 
electrophoresed on 0,8% Ix TAB agarose gel with 0.25 fxg/ml ethidium bromide. 
48 
2.3.2.5 Purification of DNA fragments from agarose gel 
(QIAEX II Gel Extraction Kit) 
After agarose gel electrophoresis, the linearized plasmid DNA prepared from 
2.3.2.4 and the DNA fragments amplified from PCR prepared from 2.3.2.1 were 
observed under UV illumination and the DNA bands were excised from the gel with a 
clean，sharp scalpel. The slice of agarose gel was transferred into 1.5 ml eppendorf 
tube and 500 \i\ of buffer QXl was added to solublize the agarose gel. 10 of 
resuspended QIAEXII was added and mixed by vortexing. The tube was incubated at 
50°C for 10 minutes and mixed every 2 minutes to keep QIAEXII in suspension. 
After ten minutes incubation, the tube was spun for 30 seconds and the supernatant 
was carefully removed. The pellet was washed with 500 of Buffer QXl once，spun 
for 30 seconds and removed the supernatant. The pellet was then washed with 500 \i\ 
of Buffer PE twice, spun for 30 seconds and the supernatant was removed. The pellet 
was air-dried for 15 minutes or until the pellet became white. The DNA was eluted 
by the added of 20 [xl of dHzO and resuspended the pellet by vortexing. The tube was 
incubated at room temperature for 5 minutes and centrifuged for 30 seconds. The 
supernatant was pipetted carefully into a clean eppendorf tube. 
2.3.2.6 Blunt end ligation 
(Adapted from Sambrook et al., 1989) 
1:5 or 1:3 ratio between vector and insert prepared in 2.3.2.3 and 2.3.2.2 were 
used for setup ligation reaction. The appropriate amount of insert and vector were 
added into eppendorf tube, 2.5 of One-Phor-All buffer (lOx, Promega), 2 of 10 
mM ATP, 14 Weiss Unit of T4 DNA ligase were made up to 25 \i\ with sterile dHzO. 
The reaction mix was incubated at 16�C for 18 hours. 
2.3.2.7 Transformation 
An aliquot of competent cells (200 i^l) was thawed on ice and 10 [i\ of ligation 
product prepared in 2.3.2.6 was then added to the tube and mixed gently. The tube 
was incubated on ice for 30 minutes and then heat-shocked at 42�C for exactly 2 
minutes. The tube was chilled on ice immediately and kept for 2 minutes at least. 
800 of LB broth was added to tube and incubated at 37�C for 1 hour with shaking. 
The appropriate amount of culture was spread onto LB agar plates containing 100 
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Hg/ml ampicillin and pre-spread with 8 of 0.5 M IPTG and 50 [il of 20 mg/ml X-
gal and incubated at 37°C overnight. 
2.3.2.8 Screening by polymerase chain reaction 
At least 10 white colonies were picked randomly from plates. Each colony 
picked was subcultered on a master plate and at the same time resuspended in 100 
ddHzO. The master plate was incubated at 37°C overnight and store at 4°C until use. 
The suspension was boiled for 10 minutes. The plasmid cloned with the IFN-a gene 
was confirmed by PGR using 10 of the suspension as template. 40 of master 
mix containing 1 x reaction buffer IV，0.2 mM of each dNTP，1.5 mM MgCl2，2.5 
units ThermoprimePLUs d n a polymerase and 50 pmole each of upper and lower 
primers were added into template. The PCR was performed by initial denaturation at 
94°C for 2 minutes for template denaturation. The thermal cycle profile was: 
denaturation at 94�C for 30 seconds, annealing at 56�C for 30 seconds and extension 
at 72�C for 2 minutes and the cycle was repeated additional for 29 times. 5 fxl of 
amplified products were electrophoresed on 0.8 % Ix TAE agarose gel with 0.25 
fxg/ml ethidium bromide to confirm the successful ligation of whole coding sequence 
of IFN-a gene. 
2.3.2.9 DNA sequencing 
ABI Prism™ dRhodamine Terminator Cycle Sequencing Ready Reaction Kit 
was used for all cycle sequencing reactions. T3 and T7 sequencing primer were used 
for partial sequence of the DNA insert as Smal cloning site is flanking between the T3 
and T7 promoter. 0.5 jig of plamsid DNA was mixed with 8 \i\ of Terminator Ready 
Reaction Mix, and 2 \i\ of 1.6 pmole/fxl T3 or T7 sequencing primer and made up to 
final volume of 20 jil with sterile ddHzO in PCR tube. The thermal cycle profile for 
sequencing was: denaturation at 94�C for 10 seconds, annealing at 50�C for 5 seconds 
and extension at 60°C for 4 minutes and the cycle was for 25 times. The sequencing 
product was purified by added into eppendorf tube with 2 \i\ of sodium acetate (pH 
4.6) and 50 x^l of 95 % ethanol. The tube was mixed and placed on ice for ten minutes 
to precipitate the extension product. The product was then precipitate by 
centrifugation at 14,000 rpm for 30 minutes at 4�C. The supernatant was then 
discarded. The pellet was rinsed with 200 fxl of 70 % ethanol and centrifuge at 14,000 
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rpm for 5 minutes at 4�C. The supernatant was removed as much as possible and the 
pellet was dried under vacuum. The pellet was dissolved in 12 \i\ TSR and boiled for 
2 minutes and chilled on ice immediately. The entire sample was transferred to a 0.2 
ml sample tube and capped it with a septum. The samples were loaded to the ABI 
Prism 310 Genetic Analyzer according to the User's Manual. The nucleotide 
sequences were analyzed using the NCBI standard nucleotide-nucleotide BLAST 
(BLASTN) in the Entrez Browser provided by the US National Center for 
Biotechnology Information (www.ncbi.nlm.nib.gov/BLAST/). 
2.3.3 Test on IFN-a subtype specific primers 
2.3.3.1 Determination of the specificity of IFN-a subtype specific primers by 
PGR 
In order to test the specificity of subtype specific primers, PGR using subtype 
specific primer against different IFN-a subtypes was performed. Nine different PCR 
reactions were set, each with different IFN-a subtype plasmid DNA as template. 
Varying MgCli concentration and annealing temperature were used to determine the 
PCR condition for the subtype specific primer. The master mix containing 1 x 
reaction buffer IV, 0.2 mM of each dNTP, varying concentration of MgCl】，1.25 units 
ThermoprimePLus d n a polymerase and 50 pmole each of upper and lower primers 
were added into 0.1 jig of template DNA. The PCR was performed by initial 
denaturation at 9 4 � �f o r 2 minutes. The thermal cycle profile was: denaturation at 
94°C for 30 seconds, annealing at varying temperature for 30 seconds and extension at 
72°C for 1 minute and the cycle was repeated for 30 times. 5 \xl of amplified product 
from the positive reaction and 10 ！il of amplified product from the negative reactions 
were electrophoresed on a 1 % agarose gel with 0.25 \ig/m\ ethidium bromide. After 
gel electrophoresis, the gel was visualized under UV illumination. 
2.3.3.2 Determination of the amplification of a particular subtype in the 
presence of excess of other templates 
In order to test if any bias will be happened when amplifying specific subtype 
with subtype specific primer in the excess of other subtype templates. Two similar 
sets of PCR reactions were set up, the test and the negative control. In the test group, 
1 ng of a target IFN-a subtype plasmid DNA and 10 ng or 100 ng of each of the other 
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non-target IFN-a subtype plasmid DNA were added. The negative control reaction 
was similar to the test group but without the target IFN-a subtype plasmid DNA. The 
PGR condition used for subtype specific primer was the same as in 2.3.3.1. The 32 \il 
of master mix containing 1 x reaction buffer IV, 0.2 mM of each dNTP, defined 
concentration of MgClz, 2.5 units Thermoprime^^^^ DNA polymerase and 50 pmole 
each of upper and lower primers were added into template. The PGR was performed 
by initial denaturation at 94�C for 2 minutes for template denaturation. The thermal 
cycle profile was: denaturation at 94�C for 30 seconds, annealing at defined 
temperature for 30 seconds and extension at 72�C for 1 minute and the cycle was 
repeated for 30 times. 5 fxl of amplified product from the test and 10 of the 
amplified product from the negative control were electrophoresed on a 2 % Ix TAB 
agarose gel with 0.25 \ig/m\ ethidium bromide. After gel electrophoresis, the gel was 
visualized under UV illumination. 
2.3.4 Induction of expression of IFN in fibroblast L929 cells 
2.3.4.1 By chemical agents Poly(I) Poly(e) and DEAE 
Confluent L929 cells ( � 1 . 5 x lO?) were incubated with Poly(I).Poly(C) and 
DEAE dextran (20 \ig/m\ and 100 ！ig/ml), the untreated cells and cells induced by 
DEAE dextran (100 ^ig/ml) alone were act as controls. The cells were incubated with 
different chemicals for 6 and 9 hours. The untreated L929 cells and the induced cells 
were harvested by washing the cells once with PBS. Then 4 M guanidium 
thiocyanate solution was added into the cells and cell lysates were collected and 
stored at -70°C until use. 
2.3.4.2 By infection with influenza virus (A/NWS/33 and B/Lee/40) 
The infection of L929 cells with vims A/NWS/33 and B/Lee/40, and the 
preparation of cell lysate were kindly performed by the colleagues in Dr. N. K. Mak's 
research laboratory in the Department of Biology, Hong Kong Baptist University. 
The L929 cells were cultured overnight and the cells were washed twice with PBS. 
Viruses were diluted in PBS (with calcium and magnesium). L929 cells were exposed 
to A/NWS/33 (35 HAU/10^ cells) or B/Lee/40 (45 HAU or 90 HAU per 10^ cells). 
The cells were incubated with vims for 1 hour and then the excess viruses were 
removed by washing twice with 10 ml PBS. Fresh medium was then added into the 
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culture and incubated for 6 and 9 hours for A/NWS/33 or 6 and 24 hours for 
B/Lee/40. The uninfected L929 cells and the infected cells were harvested by 
washing the cells once with PBS and lysed with 4 ml 4 M guanidium thiocyanate 
solution. Cell lysates were collected and stored at -70°C until use. 
2.3.5 Detection of IFN-a subtypes expression 
2.3.5.1 Isolation of total RNA by guandidium thiocyanate 一 cesium chloride 
ultracentrifugation 
The frozen cell lysate was thawed by incubating at 65�C water bath. The thawed 
cell lysate was further incubated at 65�C for 5 minutes and then chilled on ice 
immediately. The cell lysate was passed through a 20 g syringe needle in order to 
shear the DNA molecules in the cell lysate. Approximately 2.5 ml of the cell lysate 
was layered on 1.5 ml 5.7 M cesium chloride cushion in a DEPC-treated ultra-
centrifuge polyallomer tube (Beckman 328874). The samples were then centrifuged 
in a SW60 Ti rotor in a ultracentrifuge (Beckman) at 32000 rpm for 18 hours at 18°C. 
After centrifugation, the supernatant was removed by aspiration under vacuum. 
The tube was inverted quickly and drained for a while to remove excess supernatant 
and allow the RNA pellet to dry. Afterwards, the bottom 0.5 cm of the tube 
containing the clear RNA pellet was cut off with a sterile scalpel blade. The RNA 
was then rinsed out and resuspended very carefully to a new eppendorf tube with a 
total of 400 \x\ of DEPC-treated ddHzO. 45 ！il of 3 M sodium acetate (pH 4.8) and 1 
ml of absolute ethanol were added and centrifuged at maximum speed for 30 minutes 
to precipitated RNA. The RNA pellet was washed with 70 % ethanol to remove any 
residual salts. The pellet was then vacuum dried and 50 \i\ of DEPC-treated ddHzO 
was added to resuspend RNA pellet. RNA samples were stored at -70°C until use. 
The quantity and quality of RNA samples were measured by absorbance at 260 
and 280 nm. The samples were diluted by the used of 10 mM Tris-HCl (pH 7.5). 
Pure preparation of RNA should give an OD260:OD280 value between 1.90 - 2.10. 
53 
2.3.5.2 Synthesis of first strand cDNA 
3 \ig of total RNA in 30 \i\ DEPC ddHzO was incubated at 65�C for 5 minutes 
and then chilled on ice immediately. A mixture of a total volume of 30 \il containing 
200 U of Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase, 0.2 mM 
of each dNTP, 0.1 jjig oligo (dT)i2-i8，1 x first-strand buffer (5 x, GibcoBRL), 10 mM 
dithiothreitol and 40 U RNaseOUT (GibcoBRL). The reaction mixture with final 
volume of 60 pi was incubated at 37�C for 1 hours. The reaction mixture was then 
diluted 10-folded with ddHzO after the RT reaction. The diluted samples were boiled 
for 5 minutes to denature the first strand DNA from the RNA template and then 
chilled on ice immediately for 2 minutes. The diluted samples were stored at -20°C 
until use. 
2.3.5.3 Normalization of RNA samples 
After RNA extraction and reverse transcription, the amount of total RNA in 
different samples were normalized by detecting the expression level of the 
housekeeping gene, GAPDH transcript by RT-PCR. GAPDH gene transcripts were 
amplified in each RNA sample for 15 cycles while the PCR was still in exponential 
phase. The 30 of master mix containing 1 x reaction buffer IV, 0.2 mM of each 
dNTP, 1.5 mM of MgCl2, 1.25 units Thermoprime^^^^ DNA polymerase and 25 
pmole each of upper and lower primers was added into 20 fxl of template containing 
boiled cDNA reverse-transcribed from 0.1 x^g total RNA. The PCR was performed by 
initial denaturation at 94°C for 2 minutes for template denaturation. The thermal 
cycle profile was: denaturation at 94�C for 30 seconds, annealing at 56�C for 30 
seconds and extension at 72�C for 30 seconds and the cycle was repeated 15 times. 20 
of amplified products were electrophoresed on a 1 % Ix TAB agarose gel with 0.25 
fxg/ml ethidium bromide. After gel electrophoresis, the gel was visualized under UV 
illumination. The relative amounts of the GAPDH transcript in various RNA samples 
were compared by examining the intensity of the bands. The input amount of 
template was adjusted until all the bands were shown with similar intensity. 
2.3.5.4 RT-PCR amplification of the IFN-a subtypes 
For the detection of the IFN-a subtypes in the induced cells, 30 of master mix 
containing 1 x reaction buffer IV, 0.2 mM of each dNTPs, 1.25 units 
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THERMOPRIMEPLUS D N A polymerase and 50 pmole each of upper and lower primers in 
the defined MgCk concentration were added into 20 [il of boiled RT-product 
containing normalized first strand cDNA sample derived from 0.1 \ig total RNA. It is 
because IFN-a contains no intron, a reaction containing RNA alone (without reverse 
transcription), was set as the negative control. Plasmid DNA of particular IFN-a 
subtype was used as template for the positive control in the PCR reaction. The PCR 
was performed by initial denaturation at 94�C for 2 minutes for template denaturation. 
The thermal cycle profile was: denaturation at 94�C for 30 seconds, annealing at 
defined temperature for 30 seconds and extension at 72�C for 1 minutes and the cycle 
was repeated 30 times. 20 of amplified products were electrophoresed on 2 % 
agarose gel with 0.25 \ig/m\ ethidium bromide. After gel electrophoresis, the gel was 
visualized under UV illumination. 
2.3.5.5 RT-PCR amplification of IFN-y, IFN-a receptor 1，IFN-a receptor 2 
(transmembrane and soluble form) and IFN-P 
The primers sequence for the detection of IFN-p, IFN-y and IFN-a receptors are 
shown in section 2.2.8. 20 boiled first strand cDNA sample was added to 30 \i\ of 
master mix containing 1 x reaction buffer IV，0.2 mM of each dNTPs, 1.5 mM MgCl2， 
1.25 units ThermoprimePLus d n a polymerase and 50 pmole each of upper and lower 
primers. A cDNA derived from concavilan A (conA) stimulated spleenocytes was 
used as positive control. A negative control using RNA alone was performed to 
ensure no genomic DNA contamination. The PCR was performed by initial 
denaturation at 94�C for 2 minutes for template denaturation. The thermal cycle 
profile was: denaturation at 94°C for 30 seconds, annealing at 56�C for 30 seconds 
and extension at 72�C for 30 seconds and the cycle was repeated 30 times. 20 of 
amplified products were electrophoresed on 2 % Ix TAE agarose gel with 0.25 fxg/ml 





3.1 Designing of primers for IFN-a genes 
The primers for amplifying the whole coding region of IFN-a subtypes were 
designed for amplification of IFN-a genes from mouse genomic DNA isolated from 
L929 cells. The amplified fragments were cloned and used as template to test the 
specificity of subtype specific primers. The subtype specific primers were designed 
for identification of the subtype expression in stimulated L929 cells. 
3.1.1 Design of IFN-a primers for amplification of whole coding region 
The primers were designed using the computer program OLIGO™ ver 5.0 
described in section 2.1. The upper and lower primers for amplifying the whole 
coding region of IFN-a genes were chosen that could amplify all the sequence 
published in Entrez nucleotides gene bank (Table 3.1). Moreover, the primers should 
not be priming for the other subtypes. The accession number of IFN-a genes and the 
priming sites of the primers on the genes were shown in the appendix B. 
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Table 3.1 Sequences of primers for amplifying the whole coding region of 
IFN-g subtypes.  
‘ Tm Size 
Subtypes Primer sequence 5，- 3， （。C) (bp) 
lUpper IaTA TGT AAA TTT CAA GTA AGG ACA G T 6 6 ^^^^ 
I FN -a l j^wer ATG CCT GAT CCC TGA ACA GTG T ^  
Upper TAG CCA GAC CCA AGC AGA GAA T 66 
I F N - a l - 9 b w e r A C A AAT GGA ATG GAA GGA TAA CAG  
Upper AGA GTG AAG TAA AGA AAG TGA AAA G 6 6 名。？ 
IFN-CC2 b w e r ATA AAA TGA GAT GCA GTT TCT AGT C 66 
Upper CCC ACA CTT TAG TTT TTT GAC AGA 66 施？ 
IFN-CX4 L w e r CTG TCT CGA AAA ACC AAA CCA AAA ^  
Upper GTC CTA AAA TCA TCA GAT AAA TAG C 66 ^^^^ 
Lower GAG TCA GGT GGA TTT CTT AGT TG ^  
Upper TTA GTT ATA TGT AAT TCT CTA CTG G A 6 6 工 ⑷ 
IFN-CX7 Lower ATT GTA TGA TAT TTT TGA GAT GGT AG 66 
Upper CAC TGC CCA GTG GAC TTT AAA T 64 丄彻 
IFN-ct8 j^wer TTA TGC TGT ATG CTC TAA TGT TAA AA 66 
Upper AGC CCC CAG GAT GCC ATG AC 66 ^^^^ 
I F N - a l l L w e r GGA CTG GCT TAT GAG GCT ATT AT 66 
Upper TAG TCA TGT GTG TGC TGT AAG AAT 66 廳 
I FN-aB |bwer |ATG ACT GGT ATC TTT GAG ATG GTA 66 
The melting temperature (Tm) of primers was calculated as: 2°C (A+T) + 4°C (G+C). 
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3.1.2 Design of IFN-a subtype specific primers 
The primers were designed using the computer program OLIGO™ ver 5.0 
described in section 2.1. The upper and lower subtype specific primers were chosen 
within the sequence of mRNA or within the 5，and 3，untranslated region of IFN-a 
gene described in Entrez nucleotides gene bank (Table 3.2). Importantly, the subtype 
specific primers should not be mispriming on the other subtypes. The priming sites of 
the primers on the genes were shown in the appendix B. 
Table 3.2 Sequences of the IFN-a subtype specific primers for identifying the 
subtype expression in stimulated cells by RT-PCR.  
“ “ Tm Size 
Subtype Primer sequence 5' - 3' (bp) 
Upper AAA GAA ATG TAA GAA AGC TTT TGA T G A 6 1 腳 
脈 - a l Lower TAG ACT TTG GCT CAG GAC TCA TTT 68 
Upper CCT GAT GGT CTT GGT GGT GAT AA 66 ^^^ 
IFN-oil-9 j^wer CAG TTC CTT CAT CCC GAC CAG ^  
Upper ACA GTC CAG AGA GCC ATC AAC C 533 
Lower TCT CTC CAC ACT TTG TCT CAC AC 68 
Upper CAG AGA GCG ACC AGC ATC TAG 66 初 
IFN-a4 Lwer AAC ACG GGT TTG CAT ATT GAG AAG ^  
Upper AGA TTG AGC AAG GAG GAG TGA C 66 ^39 
IFN-a5 Lower TAA ATA AAC AAA CAA ATA AGA AAG GAC 66 
Upper AGC CCA GAA GAC CAG CAG CAT T 545 
脈 - « 7 Lower CCT AAT CCT GGA GAT CCT CTC TA ^  
Upper TCT GAT GCA GCA GGT AGA GAT AC ^^^ 
IFN-a6/8 Lower CAA ATG GTG CAG ATA CAA AAG TGG ^  
U p p e r C T G G C A A G A T T G A G T G A A G A G A A G G C T 8 0 2 2 9 
IFN-all Lower ATA AAC AAA CAA ATA AAT AAC AAA TAG GTG CG 80 
Upper GCT AGG CTC AGC ACT TTC CTA A 66 ^^^ 
IFN-cxB | t TC TCT CCA CTG GGT CTC AGA C 68 
The melting temperature (Tm) of primers was calculated as: 2 � C (A+T) + 4°C (G+C). 
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3.2 Cloning of the IFN-a subtype genes 
3.2.1 Purification of genomic DNA purification 
Mouse genomic DNA was isolated from the L929 cells using phenol-chloroform 
extraction described in section 2.3.2.1. Absorbance of UV light at 260 nm and 280 
nm were measured to determine the yield and purity of genomic DNA sample (Table 
3.3). The genomic DNA sample was electrophoresed on 0.8% agarose gel and shown 
in figure 3.1. 
Table 3.3 Spectrophotometric analysis of genomic DNA isolated from L929 
cells.  




QD260:OD280 |I.78 _ 
The yields of DNA sample was calculated as OD260 x 50 ^xg/ml x dilution factor, 




Figure 3.1 Agarose gel electrophoresis of genomic DNA. 0.5 \ig of genomic 
DNA was electrophoresed on a 0.8 % agarose gel (S). The major size of the genomic 
DNA was over 12 kb and no significant RNA contamination was observed on sample. 
M: 1 kb plus DNA marker (GibcoBRL). 
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3.2.2 PCR conditions used for amplification of whole coding region of mlFN-
a subtypes 
The whole coding region of IFN-a subtypes were amplified from mouse 
genomic DNA by PCR. For highest PCR fidelity, high-fidelity platinum Pfx DNA 
polymerase was used in PCR reaction. However, due to the difficulty in optimizing 
the PCR conditions for few subtypes, Thermoprime^^^^ DNA polymerase was used 
for those subtypes cannot be successfully amplified by Pfx DNA polymerase. The 
annealing temperature and Mg2+ concentration used for amplification of whole coding 
region of IFN-a subtypes were shown in table 3.4 and 3.5. The amplification of 
whole coding region of IFN-a subtypes was described in section 2.3.1.2. The PCR 
products were electrophoresed on 0.8 % agarose gel and shown in figure 3.2. 
Table 3.4 The PCR conditions used for amplification of whole coding region 
of IFN-g subtypes by Pfx DNA polymerase.  
Annealing MgSO* 
Subtype Temperature (�C) concentration (mM) Size (bp) 
IFN-al 56 - 1.5 1474 
IFN-al-9 56 1.0 
IFN-a2 56 一 1.0 §22 
IFN-a7 56 一 1.0 1143 
IFN-a8 56 — 1.5 
IFN-aB 56 1.5 1103 
Approximately 0.25 - 0.3 ^g of genomic DNA was used as a template to amplify the 
whole coding region of IFN-a subtypes as described from section 2.3.2.2. 
Table 3.5 The PCR conditions used for amplification of whole coding region 
of IFN-a subtypes by the use of Thermoprime^^^^ DNA 
polymerase.  
Annealing MgCh 
Subtype Temperature ("C) concentration (mM) Size (bp)  
IFN-CC4 56 ^ ^  
IFN-CX5 — 56 — 1.5 ^  
56 1.5 2205 
Approximately 0.25 — 0.3 pg of genomic DNA was used as a template to amplify the 
whole coding region of IFN-a subtypes as described from section 2.3.2.2. 
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Figure 3.2 Amplification of whole coding region of IFN-a subtypes from 
mouse genomic DNA by PCR. 0.25 to 0.3 \ig mouse genomic DNA and specific 
primers for each IFN-a subtype (as shown in table 3.1) were used in PCR as 
described in 2.3.2.2. 5 of PCR products were electrophoresed on a 0.8 % agarose 
gel. The size of the IFN-a subtype genes was shown in table 3.1. The PCR 
fragments of IFN-a subtypes were boxed. M: 1 kb plus DNA size marker 
(GibcoBRL). 
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3.2.3 Subcloning the whole coding region of IFN-a genes from amplified 
fragments 
The whole coding region of IFN-a genes amplified from the mouse genomic 
DNA were subcloned into the vector pBluescript SK II (-) described in 2.3.2.6. At 
least 10 white colonies were picked randomly from the LB agar plates containing 
ampicillin, IPTG and X-gal for each subtype and confirmed the clone harbouring the 
IFN-a gene insert by PCR described in section 2.3.2.8. The clones with correct size 
of the insert were selected and the plasmid DNA were prepared as described in 
section 2.3.2.3. Cycle sequencing reaction was performed to determine the DNA 
sequence of the IFN-a gene as described in section 2.3.2.10. Each of the recombinant 
plasmid was sequenced in both directions, using either the T3 or T7 primer listed in 
section 2.2.8. The DNA sequences were analyzed using the NCBI standard 
nucleotide-nucleotide BLAST (blastn) in the Entrez Browser provided by the US 
National Center for Biotechnology Information. The alignment of the DNA sequence 
of each clone IFN-a genes with the published sequence using CLUSTAL X multiple 
sequence alignment was shown in Appendix C. 
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3.3 Optimization of specific amplification condition for subtype 
specific primers by cross-PCR 
All IFN-a genes contain no intron and share high sequence homology. The 
specific conditions used of each pair of subtype specific primers that would not cross 
amplification of other subtypes templates were determined. For each pair of subtype 
specific primers, 9 different PCR reactions were set up, each with different IFN-a 
subtype DNA template. By varying the annealing temperature and MgClz 
concentration, a specific condition used by the subtype specific primers was 
determined. A positive result of expected PCR-amplified product was shown in the 
PCR with the corresponding IFN-a subtype template, while all the other PCR 
reactions containing other IFN-a subtypes as template showed negative results. Table 
3.6 showed the specific conditions used for subtype specific primers. Figure 3.3 
showed the results of PCR to determine the specific conditions used for subtype 
specific primers. 
Table 3.6 Specific PCR conditions for mIFN-a subtype specific primers. 
Annealing MgCh 
Subtype Temperature ("C) Concentration (mM) 
IFN-al ^ 1：^   
IFN-al-9 — 6 8 
IFN-a2 _72 1：5  
IFN-a4 — 60 1：5  
IFN-a5 —56 1-5 
IFN-CX7 —68 1:5 . _ 
IFN-OC6/8 — 6 8 1：5  
IFN-all —64 1:0 
IFN-gB 166 |0.8  
Under the specific annealing temperature and MgCh concentration to perform PCR 
for 30 cycles to identify IFN-a subtypes. 
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Figure 3.3 (to be continuous....) 
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Figure 3.3 The specificity of subtype specific primer determined by PCR. 
PCR were preformed with the IFN-a subtype specific primers and the corresponding 
IFN-a subtype template or with the other subtype template as described in 2.3.3.1. 5 
of PCR products from the specific subtype and 10 of PCR products from the 
other subtypes were electrophoresed on a 1 % agarose gels. Specific conditions of 
subtype specific primers and the size of PCR products were shown on gel photos. M: 
Ikb plus DNA marker (GibcoBRL), a l , al-9, a2, a4，aS, cc6/8, al, a l l , aB: 
indicate the subtype template used in the PCR reaction. 
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3.4 Determination of the amplification of a particular subtype in 
the excess of other templates 
To test if any bias would happen when amplifying specific subtype with specific 
primers in the excess of other templates, PCR was performed with 1 ng of target IFN-
a subtype and 80 ng to 800 ng of all other non-target IFN-a subtypes as described in 
section 2.3.3.2. Similar PCR reaction was set up except without the target IFN-a 
subtype as a control to ensure specificity of the subtype specific primers. The PCR 
conditions of primer were described in table 3.6. The results showed that the subtype 
specific primers could successful identify the particular subtype even in the excess of 
other non-target IFN-a subtypes (Figure 3.4). The specificity of primers was also 
confirmed because all the control shows the negative results. 
By this method, subtype specific primer can differentiate the target IFN-a 
subtype in the excess of other subtypes (concentration up to 0.8 ^g) even the 
concentration of target subtype is as low as 1 ng. 
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Figure 3.4 (opposite page) Successful amplification of a target IFN-a 
subtype in the excess of other non-target templates using specific primers. PCR 
was performed with target and non-target templates in a ratio of 1:80 to 1:800 as 
described in 2.3.3.2. Each sample was amplified for 30 cycles under the condition 
described. The sizes of PCR products were shows in gel photos. 5 \x\ of PCR product 
from positive PCR and 10 of PCR products from negative control were 
electrophoresed in 2 % agarose gel. Note that for IFN-a4，the PCR products were 
diluted 5 fold for electrophoresis. M: 1 kb plus DNA marker (GibcoBRL); a: positive 
control using the cloned IFN-a gene as template; b: target to non-target subtype 
templates was 1:80; c: only 80 ng each non-target subtype templates; d: target to non-
target subtype template was 1:800; e: only 800 ng each non-target subtype templates. 
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3.5 Determination of the gene expression in poly (I), poly (C) 
treated L929 cells 
The specificity of subtype specific primers was tested. In order to test the 
possibility of using these subtype specific primers to differentiate the expression of 
different subtypes in stimulated L929 cells, the potent interferon inducers, 
poly(I)-poly(C) was used to induce IFN-a production in fibroblasts cell line. For 
enhancing the interferon production, DEAE-dextran was added together with 
poly(I).poly(C). Besides the cell alone as control, the DEAE-dextran alone was used 
to induce L929 cells to exclude the induction of IFN-a by DEAE-dextran. The 
mRNA expression of IFN-P, IFN-y and IFN-a/p receptor were also measured using 
RT-PCR. 
3.5.1 Spectrophotometric analysis of total RNA 
Total RNAs of L929 cells at various time points after different induction were 
isolated by the method of guanidium thiocyanate-cesium chloride gradient as 
described in section 2.3.5.1. Optical density at 260 nm and 280 nm were measured to 
analyze the yield and purity of the RNA samples. The ratio of OD260 to OD280 among 
the samples was roughly around 2.0. A solution of RNA that has an OD260 of 1.0 in a 
cuvette with a 1-cm path length has a concentration of 40 ^xg/ml. Tables 3.7 - 3.10 
showed the yield and purify of the RNA samples collected. The concentration of 
RNA was calculated as OD260 x 40 \ig/m\ x dilution factor, where the dilution factor 
was 100. 
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Table 3.7 L929 cells induced with poly(I) poly(C)-DEAE dextran (20 i^g/ml 
and 100 |Lig/ml) at various time points. First induction.  
Time after induction (Hours)  
0 6 I 9 
OD260 _ 1.220 1.135 — 0.917 
OD280 — 0.594 0.554 0.450 
OD260/OD280 2 .05 2.05 — 2.04 
Cone. 4.879 4.539 3.668 
Table 3.8 L929 cells induced with poly(I) poly(C)-DEAE dextran (20 \ig/m\ 
and 100 ^ig/ml) at various time points. Second induction.  
Time after induction (Hours)  
0 6 I 9 — 
OD260 _ 1.288 1.155 1.184 
OD280 0.623 _ 0.569 0.586 
OD260/OD280 2 .07 — 2.03 ^  
Cone, (ng/pil) 5.151 4.622 1 4.734 
Table 3.9 L929 cells induced with DEAE dextran alone (100 \ig/m\) at 
various time points. First induction.  
Time after induction (Hours)  
0 6 I 9 — 
O D ^ — 1.220 1.231 0.962 
OD280 0.594 0.598 0.469 
OD260/OD280 2.05 2.06 ^  
Cone. (iig/\x\) 4.879 4.922 3.846 
Table 3.10 L929 cells induced with DEAE dextran alone (100 ^g/ml) at 
various time points. Second induction.  
Time after induction (Hours)  
0 6 I 9 — 
OD260 1.288 1.592 1.569  
OD280 0.623 0.776 
OD260/OD280 2.07 ^  
Cone, (ng/^1) 5.151 6.369 6.275 
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3.5.2 Agarose gel electrophoresis of RNA 
The RNA samples were analyzed by gel electrophoresis. A sharp 28S and 18S 
RNA bands were shown in gels. No degradation and genomic DNA contamination 
were observed on RNA samples (figure 3.5). 
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Figure 3.5 RNA samples of L929 cells induced by poly (I) poly (C)-DEAE 
dextran. 1 fxg of total RNA from each sample was electrophoresed on a 1 % agarose 
gel. Lane 1, cells control. Lane 2 and 3，L929 induced by 20 \ig/m\ poly(I).poly(C)-
100 ^ig/ml DEAE dextran for 6 and 9 hours respectively; lane 4 and Sand L929 
induced by 100 \xg/ml DEAE dextran only for 6 and 9 hours respectively. M: 1 kb 
plus DNA marker (GibcoBRL). 
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3.5.3 Normalization of RNA sample 
The amount of total RNA among various samples were normalized by detecting 
the expression level of housekeeping gene in each RNA sample analyzed by RT-PCR. 
GADPH gene transcripts were amplified in each RNA sample for 15 cycles as 
described in section 2.3.4.3. The PCR products were electrophoresed on 2 % agarose 
gel with ethidium bromide. The expression level of GAPDH was constant among the 
RNA samples of L929 cells at different time point after induced by poly(I).poly(C)-
DEAE dextran and DEAE dextran alone. 
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Figure 3.6 Normalization of the amount of RNA samples by detection of the 
gene expression of GADPH analyzed by RT-PCR. The GAPDH gene transcripts 
were amplified for 15 cycles in equal volume of cDNA derived from 0.1 ^g of total 
RNA of L929 cells (a), L929 induced with poly(I)-poly(C)-DEAE dextran for 6 hours 
(b) and 9 hours (c), and L929 induced with DEAE dextran for 6 hours (d) and 9 hours 
(e). 10 \xl of PCR products were analyzed on a 2 % agarose gel with 0.25 \ig/m\ 
ethidium bromide. The size of the PCR product of GAPDH gene transcript was 452 
bp. M: 1 kb plus DNA marker (GibcoBRL). 
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3.5.4 Detection of IFN-a subtypes mRNA in L929 cell induced with 
poly(I) poly(C)-DEAE dextran 
To detect the expression of IFN-a subtypes after the cells were induced by 
poly(I).poly(C)，a RT-PCR was performed using total RNA derived from L929 cells 
induced with or without poly(I)-poly(C)-DEAE dextran (20 |ig/ml and 100 \ig/m\), 
and 100 ^ig/ml DEAE-dextran for 6 and 9 hours induction. The result indicated that 
poly(I)-poly(C) induced the L929 cells to express IFN-al，-al-9, -ct4，-a6/8, - a l l 
and -aB. While DEAE-dextran did not induce any IFN-a expression (Figure 3.7). 
However the poly(I)-poly(C) was unable to induce the expression of IFN-a2, -a5，and 
-al. Using the IFN-a subtypes specific primers enabled us to detect the differential 





Figure 3.7 (to be continuous …） 
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Figure 3.7 (to be continuous ...) 
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Figure 3.7 RT-PCR analysis of the expression of the IFN-a subtypes after 
L929 cells were induced by poly(I) poly(C)-DEAE dextran (20 \ig/m\ -100 i^g/ml) 
after 6 and 9 hours induction. cDNA derived from 0.1 \ig of total RNA prepared 
from cell control (a), poly(I).poly(C) induced for 6 hours (b)，poly (I)-poly (C) induced 
for 9 hours (c), DEAE-dextran induced for 6 hours (d) or DEAE-dextran induced for 
9 hours (e), was used for the detection of different IFN-a subtypes expression by PCR 
as described in section 2.3.5.4. Panel A showed the RT-PCR results from 
poly(I)-poly(C) induced samples, while panel B showed the RT-PCR results from 
DEAE-dextran induced samples. Panel C showed RT-PCR results from 
poly(I)-poly(C) induced samples using RNA as template, while panel D showed the 
RT-PCR results from DEAE-dextran induced samples using RNA as template. 
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3.5.5 Detection of IFN-y, IFN-a/p receptor and IFN-p expression in 
poly (I) poly (C) -DEAE dextran or DEAE dextran treated L929 cells 
The expression of IFN-y, IFN-a/p receptor and IFN-p in poly(I)-poly(C) induced 
L929 cells were analyzed by RT-PCR as described in section 2.3.4.5. The IFN-a/p 
receptor 1 (IFN-aRl)，IFN-a/p receptor 2 transmembrane form with long cytoplasmic 
domain (IFN-aR2c) and IFN-a/p receptor 2 soluble form (IFN-aR2a) were expressed 
in the L929 cells despite the induction of poly(I).poly(C) or DEAE-dextran. IFN-y 
was not induced by poly (I).poly (C) or DEAD-dextran. While IFN-p was expressed in 
a very low level in L929 cells but highly up regulated by poly(I)-poly(C). 
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A - Poly(I)-Poly(C)-DEAE dextran 
H H H I H I H H M I 
Figure 3.8 (to be continuous •••) 
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Figure 3.8 The expression levels of IFN-y, IFN-a/p receptor and IFN-p after 
L929 cells were induce by poly(I) poly(C)-DEAE dextran. cDNA derived from 0.1 
^g of total RNA prepared from cell control (a), poly(I).poly(C) induced for 6 hours 
(b), poly(I).poly(C) induced for 9 hours (c)，DEAE-dextran induced for 6 hours (d) or 
DEAE-dextran induced for 9 hours (e)，was used for the detection of IFN-y, IFN-a/p 
receptor and IFN-P expression by PCR as described in section 2.3.5.5. Panel A 
showed the RT-PCR results from poly(I).poly(C) induced samples, while panel B 
showed the RT-PCR results from DEAE-dextran induced samples. Panel C showed 
RT-PCR results from poly(I).poly(C) induced samples using RNA as template, while 
panel D showed the RT-PCR results from DEAE-dextran induced samples using RNA 
as template. 
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3.6 Measurement of gene expression in L929 cells infected with 
influenza virus 
Virus infection had been demonstrated to induce interferon production in 
the infected cells. In this section, the expression profiles of different IFN-a subtypes, 
IFN-Y, IFN-P and IFN-a /p receptors in the influenza A and B infected L929 cells 
were analyzed. 
3.6.1 Spectrophotometric analysis of total RNA 
Total RNA of L929 cells at various time points after virus infection were isolated 
by the method of guanidium thiocyanate-cesium chloride gradient as described in 
section 2.3.5.1. Absorbance of UV light at 260 nm and 280 nm were measured to 
analyze the yield and purity of the RNA samples (table 3.11 - 3.16). The ratio of 
OD260 to OD280 among the samples was roughly around 2.0. A solution of RNA that 
has an OD260 of 1.0 in a cuvette with a 1-cm path length has a concentration of 40 
^ig/ml. Tables 3.11 - 3.16 showed the yield and purify of total RNA samples. The 
concentration of RNA was calculated as OD260 x 40 ^xg/ml x dilution factor, where the 
dilution factor was 100. 
Table 3.11 L929 cells infected with A/NWS/33 (35 HAU/10^ cells) at various 
time points. First infection.  
Time after infection (Hours)  
0 6 I 9 — 
^ 2 6 0 — 1.002 0.834 “ 0.753 
OD280 0.485 0.405 0.368 
OD260/OD280 2.07 2.06 2.05 
Cone. (ixg/\il) 4.009 3.336 ^ 3.014 
Table 3.12 L929 cells infected with A/NWS/33 (35 HAU/10^ cells) at various 
time points. Second infection.  
Time after infection (Hours)  
^ 0 6 I 9 一 
OD260 一 1-058 0.783 0.944 
OD280 一 0.514 0.381 
OD260/OD280 一 2.06 ^ ^ 
Cone, (pig/pil) 4.232 3.132 ^HIA  
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Table 3.13 L929 cells infected with B/Lee/40 (45 HAU/10^ cells) at various 
time points. First infection.  
Time after infection (Hours)  
0 1 — 6 I 24 
OD260 — 1.099 0.538 1.193 
^ 2 8 0 — 0.540 — 0.263 0.584 
OD260/OD280 _ 2.04 2.05 2.04 
Cone. (\ig/[il) 4.397 2.152 4.772 
Table 3.14 L929 cells infected with B/Lee/40 (45 HAU/10^ cells) at various 
time points. Second infection.  
Time after infection (Hours)  
0 6 I 24 
^ 2 6 0 — 0.644 0.529 0.883 
OD280 一 0.315 0.257 0.428 
^26O/OD280 2.05 2.06 2.06 
^ c . (\xg/\il) 2.575 2.115 3.532 
Table 3.15 L929 cells infected with B/Lee/40 (90 HAU/10^ cells) at various 
time points. First infection.  
• Hours  
0 I 6 I 24 
OD260 1.099 0.492 — 0.967 
^ 2 8 0 0.540 0.240 0.472 
^26O/OD28O _ 2.04 ； 2.05 2.05 
^ c . (n^iil) 4.397 1.970 3.869 
Table 3.16 L929 cells infected with B/Lee/40 (90 HAU/10^ cells) at various 
time points. Second infection.  
Hours  
0 I 6 I 24 
^ 2 6 0 一 0.644 0.532 0.714 
^ 2 8 0 一 0.315 0.258 0.347 
OD260/OD280 2.05 — 2.06 2.06 
^ c . (vi^iil) 2.575 2.129 2.857 
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3.6.2 Agarose gel electrophoresis of RNA samples 
1 \ig of each RNA sample was analyzed by electrophoresis on 1 % agarose gel. 
A sharp 28S and 18S RNA bands were shown in gels. No degradation and genomic 
DNA contamination were observed on RNA samples (figure 3.9 and 3.10). 
• 
Figure 3.9 RNA samples of L929 cells infected with 35 HAU/10^ cells 
A/NWS/33. 1 pg of total RNA was electrophoresed on a 1 % agarose gel. Cells 
control (lane 1), L929 infected with A/NWS/33 at 6 hours (lane 2) and 24 hours (lane 
3) post-infection. M: 1 kb plus DNA marker (GibcoBRL). 
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Figure 3.10 RNA samples of L929 cells infected with B/Lee. 1 ng of total RNA 
was electrophoresed on a 1 % agarose gel. Cells control (lane 1)，L929 infected with 
B/Lee/33, 45 HAU/10^ cells at 6 hours (lane 2) and 24 hours (lane 3) post-infection 
and infected with 90 HAU/10^ cells at 6 hours (lane 4) and 24 hours (lane 5) post-
infection. M: 1 kb plus DNA marker (GibcoBRL). 
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3.6.3 Normalization of RNA samples 
The amount of total RNA among various samples were normalized by detecting 
the expression level of the housekeeping gene GAPDH transcript in each RNA 
sample analyzed by RT-PCR. GADPH gene transcripts were amplified in each RNA 
sample for 15 cycles while the PCR was still in exponential phase, as described in 
section 2.3.4.3. The PCR products were electrophoresed in a 1 % agarose gel with 
ethidium bromide. The expression level of GAPDH was constant among the RNA 
samples of L929 cells at different time point after infected by A/NWS/33 and 
B/Lee/40 (figure 3.11 A and B). 
M a b e M a b c d e 
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A - A/NWS/33 B — B/Lee/40 
Figure 3.11 Normalization of the amount of RNA samples by the detection of 
the gene expression of GADPH analyzed by RT-PCR. The GAPDH gene 
transcripts were amplified for 15 cycles in equal volume of cDNA derived from 0.1 
^g of total RNA of L929 cells. 10 of PCR products were loaded on 1 % agarose gel 
and electrophoresed. The size of the PCR product of GAPDH gene transcript was 
452 bp. A, L929 cell control (a), L929 infected with 35 HAU/10^ cells A/NWS/33 at 
6 hrs post-infection (b) and 9 hrs post-infection (c). B, L929 cell control (a), L929 
infected with 45 HAU/10^ cells B/Lee/40 at 6 hrs post-infection (b) and 24 hrs post-
infection (c), L929 cells infected with 90 HAU/10^ cells B/Lee/40 at 6 hrs post-
infection (d) and 24 hrs post-infection (e). 
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3.6.4 Detection of IFN-a subtypes mRNA in L929 cell infected with 
A/NWS/33 virus 
To detect the expression of IFN-a subtypes after the cells were infected by 
A/NWS/33, RT-PCR was performed using total RNA derived from L929 cells 
infected with or without A/NWS/33 infection at 6 and 9 hours post-infection. In the 
A/WNS/33 infected L929 cells, the expression of IFN-al, -a4，-cc6/8, - a l l and -aB 
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Figure 3.12 (to be continuous •••) 
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Figure 3.12 RT-PCR analysis of the expression of the IFN-a subtypes after 
L929 cells were infected by A/NWS at 35 HAU/10^ cells at 6 and 9 hours post-
infection. cDNA derived from 0.1 \ig of total RNA prepared from cell control (a), 
A/NWS/33 infected at 6 hours post-infection (b)，A/NWS/33 infected at 9 hours post-
infection (c), was used for the detection of different IFN-a subtypes expression by 
PCR as described in section 2.3.5.4. Panel A showed the RT-PCR results from 
A/NWS/33 infected samples. Panel B showed RT-PCR results from A/NWS/33 
infected samples using RNA as template. 
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3.6.5 Detection of IFN-a subtypes mRNA in L929 cells infected with 
influenza B/Lee/40 virus 
To detect the expression of IFN-a subtypes after the cells were infected by 
B/Lee/40, a RT-PCR was performed using total RNA derived from L929 cells 
infected with or without B/Lee/40 infection for 6 and 24 hours post-infection. In the 
B/Lee/40 infected L929 cells, only IFN-a4 were expressed at 24 hours post-infection 
and the expression level was higher at a higher dose of infection (90 HAU/10^ cells) 
(Figure 3.12). 
Figure 3.13 (to be continuous ".) 
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Figure 3.13 RT-PCR analysis of the expression of the IFN-a subtypes after 
L929 cells were infected by B/Lee/40 at 45 HAU/10^ cells and 90 HAU/10^ cells 
after 6 and 24 hours infection. cDNA derived from 0.1 \xg of total RNA prepared 
from cell control (a), 45 HAU/10^ cells B/Lee/40 at 6 hours of post-infection (b)，45 
HAU/10^ cells B/Lee/40 at 24 hours of post-infection (c)，90 HAU/10^ cells B/Lee/40 
at 6 hours of post-infection (d)，90 HAU/10^ cells B/Lee/40 at 24 hours of post-
infection, was used for the detection of different IFN-a subtypes expression by PCR 
as described in section 2.3.5.4. Panel A showed the RT-PCR results from B/Lee/40 
infected samples. Panel B showed RT-PCR results from B/Lee/40 infected samples 
using RNA as template. 
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3.6.6 Detection of IFN-y, IFN-a/p receptor and IFN-P expression in L929 cells 
infected with A/NWS/33 and B/Lee/40 
1 i 
The expression of IFN-y, IFN-a/p receptor and IFN-|3 in A/NWS/33 and 
B/Lee/40 infected L929 cells were analyzed by RT-PCR as described in section 
2.3.4.5 (Figure 3.14). A/NWS/33 and B/Lee infection did not alter the expression 
level of IFN-a/p receptor 1, transmembrane form receptor 2 and soluble form of 
receptor 2. A/NWS/33 infected L929 cells did not express any IFN-y and IFN-p. The 
expression of IFN-P was significant increased in cells infected by B/Lee/40 at 24 
hours of post-infection. 
A-A/NWS/33 
Figure 3.14 (to be continuous •••) 
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Figure 3.14 The expression levels of IFN-y, IFN-a/p receptor and IFN-P after 
L929 cells were infected with A/NWS/33 and B/Lee/40. cDNA derived from 0.1 
^g of total RNA prepared from cell control (a), 35 HAU/10^ cells A/NWS/33 at 6 
hours of post-infection (b)，45 HAU/10^ cells B/Lee/40 at 24 hours of post-infection 
(c)，90 HAU/10^ cells B/Lee/40 at 6 hours of post-infection (d) or 90 HAU/10^ cells 
B/Lee/40 at 24 hours of post-infection (e), was used for the detection of IFN-y, IFN-
a/p receptor and IFN-P expression by PCR as described in section 2.3.5.5. Panel A 
showed the RT-PCR results from A/NWS/33 infected samples, while panel B showed 
the RT-PCR results from B/Lee/40 infected samples. Panel C showed RT-PCR 
results fromA/NWS/33 infected samples using RNA as template, while panel D 




During viral infection, the most early produced cytokine is IFN-a/p. In mouse, 
there are at least 10 different IFN-a subtypes. The functional role of individual IFN-
a subtypes is poorly understood. To dissect the roles of different subtypes, it is 
essential to have an effective method to distinguish the subtypes. However, due to the 
great homology between IFN-a subtypes in gene and protein level, currently there is 
no biochemical or biological method to distinguish all the IFN-a subtypes. 
Previously, SI nuclease protection assay was used to detect the differential expression 
of several, not all, IFN-a subtypes. However, this method is labor intensive, required 
large amounts of RNA and not particularly sensitive for low levels of IFN-a 
expression. 
A molecular method using reverse transcription-polymerase chain reaction 
(RT-PCR) to identify the murine-IFN-a subtypes was developed. The RNA samples 
were reverse transcribed using oligo(dTi2-i8) as a primer, followed by PCR using the 
subtype specific primers for identifying the IFN-a subtypes. Murine IFN-a consists 
of 10 subtypes; IFN-al, -al-9, -a2, -a4，-a5，-a6, -al, -cc8, - a l l and -cxB. The 
subtype specific primers for all IFN-a subtypes were designed except IFN-a6. It is 
because IFN-a6 and IFN-a8 are different in one nucleotide and amino acid only. 
The subtype specific primers were designed based on the IFN-a sequences 
obtained from GenBank. The primers were picked that showed low possibility to 
misprime with other subtypes. The conditions required for the subtype specific 
primers for generation of a specific product against their target subtype were 
optimized by varying the annealing temperature and Mg2+ concentration. The 
annealing temperature is important in determining the specificity of the reaction. In 
general, higher annealing temperatures result in more stringent conditions for primer 
annealing and more specific products. The specificity of primers may also be 
increased by reducing the free Mg2+ concentration. In PCR reaction, Mg2+ ions form 
a soluble complex with dNTPs, which is essential for dNTPs incorporation by 
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polymerase. Excess Mg2+ concentration may result in accumulation of nonspecific 
products. Therefore more stringent conditions by the increased of annealing 
temperature and decreased the Mg2+ concentration were used to overcome the 
nonspecificity of primers. 
The subtype specific primers under the defined annealing temperature and Mg2+ 
concentration are specific to the target IFN-a subtype using specific primer against 
different IFN-a subtypes in PCR. Moreover, the excess of other templates does not 
bias the amplification of a target subtype. This method overcome the problems 
generated by Lai et al. (1994) and Hughes et al (1994), as they using consensus 
oligonucleotide primers to allow simultaneous PCR amplification of multiple IFN-a 
subtypes. Followed by the use of subtype specific oligonucleotide probes hybridize to 
PCR products to identify the IFN-a subtype. By the properties of PCR, more 
abundant RNA may be predominately amplified when the efficiencies of interaction 
of two sequences of the mRNAs with the primers are equal (Wang et al., 1989; 
Gilliland et al” 1990; Kozbor et al., 1993). As all IFN-a subtypes share high 
sequence homology, by the use of consensus primer to perform PCR, those IFN-a 
subtypes express in low level will not be detected. By this method, the subtype 
specific primers were used to identify the individual IFN-a subtype in different RT-
PCR reaction. Moreover, those subtype specific primers could differentiate the target 
IFN-a subtype from the excess of other subtypes (containing up to 0.8 \xg of plasmid 
DNA) even the target subtype is as low as 1 ng of plasmid DNA. This method 
provides a simple, fast and effective method to identify IFN-a subtypes produced by 
cells even the genes are expressed at very low levels. The results of the expression 
profile of different IFN-a subtypes and other interferons were summarized in table 
6.1. 
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Table 6.1 A summary on the expression profile of IFN-a subtypes, other 
IFNs and IFN-a/P receptor.  
Induction or 1 IFN-a subtypes IFN IFN-a/p receptor 
Hrs  
infection a l | a l - 9 | a 2 | a 4 | a 5 al «6/8 a l l a B y P cxRl aR2c 
Poly(I)-poly(C) 6 ~ ~ + + - ^ + + - + * * * 
9 + + - + - - + + + - + * * * 
A/NWS/33 (35 6 + - - - * ^ * 
HAU/10^ cells) ~ ~ 9 + - + * * ^ 
B/Lee/40 (45 6 ： - T 了 ：TTT"：* * ^ 
HAU/10^ cells) - - - T 了了 * ‘ * ^ 
B/Lee/40 (90 6 - - - - - - - - “ _ _ * * * 
HAU/10^ cells) - - - T T T " ! ^ * * ^ 
L__L_J — — — J  
* constitutively expressed in cells, + induced after induction or infection, - did not 
induced after induction or infection 
In order to test whether the subtype specific primers have the ability to 
differentiate the expression of IFN-a subtypes after the L929 cells were stimulated, a 
well known IFN-a inducer, poly(I)-poly(C) was used to induce the IFN-a production 
in L929 cells. The expression profile was compared with influenza virus infected 
L929 cells. After poly (I).poly (C) treatment, the expression of IFN-al, -al-9, -cx4,-
cc6/8, - a l l and -aB were increased after the L929 cells were induced for 6 and 9 
hours (Figure 3.7). From the results, it showed that the IFN-a subtype specific 
primers could identify the subtype production in the induced cells sample and not all 
the IFN-a subtypes were expressed under stimulation. Our result was in agreement 
with previous studies (Bisat et al., 1988). In Bisat's experiment, only 3 IFN-a 
subtypes could be analyzed using nuclease protection method. The expression of 
IFN-al, -cx4 and -oc6 mRNA in L929 cells were induced by poly(I).poly(C� 
However, our result indicate that IFN-al-9, - a l l and -aB were also induced by 
poly(I).poly(C). 
Although the IFN-a subtypes are closely related genes, they are differentially 
expressed upon stimulation. Their promoters are therefore under different regulatory 
mechanisms. It had been shown that IFN-a was the major cytokine expressed in the 
virus infected cells to combat the virus infection with other cells (Stewart, 1979). 
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However, the role of different IFN-a subtypes in controlling the virus infection was 
not known. With the designed specific primers for IFN-a subtypes mRNA, our next 
goal was to analyse the relationship of IFN-a subtypes and virus infection. We used 
the mouse L929 cells and the influenza virus strain A/NWS/33 and B/Lee/40 as the 
model for this study. Influenza A viruses are more pathogenic than influenza B 
viruses. Influenza A viruses evolved faster than influenza B viruses (Yamashita et al., 
1988). Influenza A viruses undergo antigenic shift occasionally and results in a new 
influenza A vims. Compared to influenza A/NWS/33 virus, influenza B/Lee/40 vims 
growths with lower HA and virus titer in MDBK tissue culture and forms smaller 
plaques in cells (Muster et al., 1991). 
Distinct expression profiles of IFN-a subtypes were obtained when L929 cells 
were infected by different strain of influenza viruses. When the L929 cells were 
infected with A/NWS/33, the expression level of IFN-al, -cx4, -a6/8，-all and -aB 
were increased at 6 and 9 hours of post-infection (Figure 3.12). Whereas B/Lee/40 
infected L929 cells only expressed IFN-a4 at 24 hours of post-infection (Figure 3.13). 
For the cell control prepared at 24 hours, the expression level of IFN-al was detected 
in very low background level by means of RT-PCR. 
Differential expression profile of IFN-a subtypes in influenza virus infected cells 
was not previously reported. Using SI nuclease protection assay, Zwarthoff and co-
worker (1985) reported that the expression levels of IFN-al, -al, -a4，-a5 and -cx6 
were increased in Sendai vims infected L929 cells. For NDV infected L929 cells, 
expressions of IFN-al, -a2, -cx4, -a5, -oc6 and -al were increased (Kelly & Pitha， 
1985b; Bisat et al., 1988). In general, the expression level of IFN-a4 mRNA is 
higher than the other IFN-a subtypes. Moreover, the antiviral activity and 
antiprofilerative capacity of IFN-a4 on L929 cells are higher than IFN-cxl (Trapman 
et al., 1988; Beilharz et al., 1991; Swaminathan et aL, 1992). 
The expression profiles of IFN-a subtypes in cells induced by poly(I).poly(C) 
and A/NWS/33 were similar. IFN-al, -cc4，-cx6/8, - a l l and -aB were commonly 
induced to express after induction. However IFN-a2 and -oc8 were not detected in 
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mouse fibroblast C243 cell line after induced by poly(I)-poly(C) (Navarro et al., 
1989). IFN-a7, -a8 and - a l l were not detected in L929 cell after induced by 
poly (I)-poly (C) (Coulombel et al” 1991). The differences in the subtypes expression 
may be due to the use of different cell line and the use of a less sensitive method (SI 
or RNase protection assay) to detect the IFN-a mRNA. 
Influenza A/NWS/33 vims and influenza B/Lee/40 vims induced different IFN-a 
subtypes in fibroblast L929 infected cells. The difference in expression profile of 
IFN-a subtypes by different strains of viruses maybe due to the virulence (or 
pathogenicity) of the virus. Influenza A virus is highly pathogenic in mammals than 
influenza B. Recently it was found that influenza A/NWS/33 vims had unusual 
virulence properties that the NA could promote the HA cleavage in infected cells 
(Goto & Kawaoka, 1998). Influenza B/Lee/40 virus only induced the expression of 
IFN-CX4. Although influenza A/NWS/33 and B/Lee/40 induced different IFN-a 
subtypes, the subtype IFN-a4 was commonly induced. Previous studies indicated that 
IFN-a4 was expressed in a higher level than other subtypes in the virus infected 
fibroblast L929 cells and IFN-a4 had a higher antiviral and antiprofilerative activity 
(Kelly & Pitha，1985b; Bisat et al” 1988; Trapman et al., 1988; Beilharz et al., 1991; 
Swaminathan et al, 1992). Therefore, IFN-a4 subtype may play an important role in 
viral infection. 
IFN-a induced genes has been divided into two groups: an immediate-early 
response gene and delayed response gene (Marie et al, 1998). The immediate early 
response genes were induced rapidly after viral infection and without the need for 
ongoing protein synthesis. The delayed response genes were induced more slowly 
and required cellular protein synthesis. Among the multiple IFN-a subtypes, IFN-ct4 
and IFN-P were induced most rapidly without the requirement for ongoing protein 
synthesis (Marie et al., 1998). 
The transcription of immediate-early response gene and delayed response gene 
were mediated by the transcription factor IRF-3 and IRF-7 respectively (Marie et al” 
1998; Sato et al., 2000). The IRF-3 was known to regulate the gene expression of 
type I IFN (Schafer et al” 1998; Juang et al., 1998; Yoneyama et al, 1998). Because 
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the expression of IFN-a/p gene was impaired in IRF-3 knock-out cells in response to 
NDV infection (Sato et aL, 2000). The IRF-3 was constitutively expressed in various 
tissues and not induced by virus infection or IFN treatment (Au et al., 1995). In 
uninfected cells, IRF-3 protein was localized in the cytoplasm. In response to virus 
infection, IRF-3 was phosphorylated on serine and threonine residues at the C-
terminal and translocated to the nucleus from cytoplasm (Sato et al., 1998). In 
nucleus, the activated IRF-3 bound to the PRD I site to activate the transcription of 
IFN-a4 and IFN-P which were rapidly and directly induced in responses to virus 
infection. The secreted IFN-a4 and IFN-|3 proteins bound to IFN-a/p receptor on 
neighbouring cells and activated the Jak-STAT signal transduction pathway. The 
transcription factor ISGF3 was activated and bound to the ISRE sequence in the IRF-
7 promoter to up-regulate IRF-7 gene expression. Then the IRF-7 was synthesized 
and activated by phosphorylation in response to virus infection and facilitating 
production of delayed response genes (Marie et al., 1998). Both IRF-3 and IRF-7 
were cooperate with each other for the full procurement of the normal mRNA 
induction profile of IFN-a subtype in the late phase of induction (Sato et al., 2000). 
In our study, IFN-a4 was induced to express at 24 hours after infection of B/Lee/40 in 
L929 cells. It was contradict to the previous observation that IFN-a4 was the 
immediate early response gene upon virus infection. The IFN-a4 was detected within 
4 hours of NDV infection in mouse immortalized embryo fibroblasts cells (Marie et 
al., 1998). Since vims infection was not just induced the expression of IFN-a but 
also the expression of other interferons (Farrar & Schreiber，1993; Sen & Ransohoff， 
1993). We therefore also investigated the expression of IFN-y, IFN-P and IFN-a/p 
receptors. 
The expression of IFN-y, IFN-aRl, IFN-aR2a (soluble form), IFN-ccR2c 
(membrane associated form with long cytoplasmic domain) and IFN-p in 
poly(I).poly(C) induced and influenza A and B viruses infected L929 cells were also 
measured (Figure 3.8 & 3.14). No IFN-y was detectable in L929 cells after induction 
or infection. The expression of IFN-y was strictly cell specific T lymphocyte and 
natural killer cells were the major source to produce IFN-y (Farrar & Schreiber， 
1993). The L929 cell is a mouse fibroblast cell line that cannot be produced IFN-y 
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under stimulation. IFN-aRl, IFN-aR2a and IFN-aR2c were constitutively expressed 
in L929 cells and were not up or down regulated upon vims infection. The IFN-P was 
greatly induced in cells induced by poly(I).poly(C) and influenza B/Lee/40 virus 
(Figure 3.8 & 3.14B). Whereas no significant increased in the expression of IFN-P in 
influenza A/NWS/33 infected L929 cells (Figure 3.14A). 
The difference in IFN-P expression might due to the NSl protein of influenza A. 
N F K B was participated in the transcriptional activation of IFN-p gene (Visvanathan & 
Goodbourn, 1989). NSl protein was present in infected cells only and not 
incorporated into the virion and named as non-structural protein, NS protein (Lamb & 
Krug, 1996). Large amount of the NSl protein of influenza A virus was synthesized 
in infected cells. The NSl protein with RNA-binding/dimerization domain at N-
terminus and an effector domain in C-terminal half (Qian et al., 1994). The NSl 
protein is functional as dimer structure (Qian et al., 1994). 
N F K B was one of the transcription factor involve in the activation of I F N - P 
transcription. In response to virus infection，the activated IKB kinase |3 (IKXP) 
phosphorylates IKB and releases N F K B from NFKB/IKB complex. This results in 
IFN-P (and NFKB-dependent) gene activation (Bonnet et al., 2000; Zamanian-
Daryoush et al., 2000). PKR could activate IKKp. The PKR was located in 
cytoplasm that produced in response to IFN and activated by dsRNA dependent. The 
influenza virus lacked the NSl (delNSl) gene was unable to growth in cells with 
functionally IFN system. While the influenza A deNSl virus was permissive to 
growth in PKR deficient mice that represent the NSl protein was able to counteract 
the PKR-mediated antiviral response (Bergmann et al., 2000). The binding of dsRNA 
by RNA-binding domain of NSl protein prevented the activation of dsRNA-
dependent protein kinase PKR (Lu et al., 1995) thus inhibited the activation of NFKB 
pathway and the expression of IFN-p (Wang et al., 2000). The NSl protein blocked 
the activation of PKR by sequestering viral dsRNA in the nucleus, thereby dsRNA 
might not be accessible for the activation of PKR in cytoplasm (Lu et al., 1995). 
Therefore no significant increase in the expression of IFN-p in influenza A/NWS/33 
virus infected L929 cells might be due to the NSl protein prevented the activation of 
PKR and eventually inactivate the IFN-P transcription. The inactivation of PKR also 
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lead to the inhibition of the phosphorylation of the a subunit of eukaryotic translation 
initiation factor 2 (eIF2) hence impaired the translation process (Lu et al., 1995). The 
NSl RNA-binding domains were similar between influenza A and B viruses. 
However, many IFN-induced proteins were efficiently transcribed in the influenza B 
infected cells. Therefore the NSIB (NSl protein of influenza B) RNA-binding 
domain could not bound to dsRNA and could not sequestered dsRNA molecules in 
the nucleus at early times of infection (Yuan & Krug, 2001). Thus the IFN-P 
expression was not inhibited in influenza B/Lee/40 infected cells. The expression of 
IFN-P together with IFN-a4 might be sufficient to eliminate the influenza B/Lee/40 
virus infection. 
In this project, murine IFN-a subtype specific primers were designed and 
evaluated. The primers were formed to be useful to detect subtype expression. This 
method provides a simple, fast and effective means to detect the expression of IFN-a 
subtypes by cells even the genes are expressed at a very low level. Using this 
powerful method, the expression profiles of IFN-a subtypes in the L929 cells induced 
by poly(I)-poly(C) and infected by different strains of influenza virus were 
constructed. The differentially expression profile on IFN-a subtypes under different 
stimulate, indicated that the IFN-a subtypes genes were under different regulatory 
mechanism and different subtypes may play a different role upon virus infection. In 
the future, this detection method may be used to study the relationship between 
expression of IFN-a subtypes and the types of virus infection in the host. Since there 
were no detail studies on the anti-viral drugs and the expression of IFN-a subtypes, 
we proposed to analyses the potential of anti-viral drugs on the induction of IFN-a 
subtypes. IFNs are currently used in the treatment of many infectious and malignant 
diseases, either using natural or recombinant IFN. IFN-cx has been successfully used 
in therapy of hairy cell leukaemia, chronic myelogenous leukaemia, basal cell 
carcinoma and heptatis B virus (Meager, 1998). However, some patients show 
adverse effects to the drug and the administrations of IFN-a products are expensive. 
As certain antiviral drugs can effectively induce IFN-a subtypes, if successfully 
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APPENDIX 
A. Details of manufacturer's solution 
Antibiotic-Antimycotic (PSF) GibcoBRL 15240-062 
10,000 units/ml penicillin G sodium, 10,000 \ig/m\ streptomycin sulfate and 25 fxg/ml 
amphotericin B as Fungi zone in 0.85% saline 
PSN antibiotic Mixture GibcoBRL 15640-055 
5 mg penicillin, 5 mg streptomycin, 10 mg neomycin /ml utilizing penicillin G 
(sodium salt). Streptomycin sulfate & neomycin sulfate in 0.85% saline 
Trypsin-EDTA GibcoBRL 25200-056 
0.25% Trypsin, 1 mM EDTA-4Na prepared with 2.5 g Trypsin (1:250) and 0.38 g 
EDTA.4Na/L in HBSS without Ca’+ & Mg2+ 
B. Primers information 
The accession number of IFN-a genes in Entrez nucleotides gene bank were shown as follow. 
The priming regions of the primers for amplifying the whole coding region of IFN-a genes 
were bold and shown in table. Whereas, the priming regions of subtype specific primers for 
identify the subtype expression in stimulated cells were bold and italic and list in tables. 
IFN-al 
Accession no.: X01974 
Priming region  
Start  
Whole coding region primer 35 1508 
Subtype specific primer |l01 \959  
1 a gac ta t t t t acagaaaact t t g a t t t a t a ctaaatatgt aaatttcaag taaggacagt 
61 t ta tcagtac tg taacagt t aatgaaagtt caaattagga aaagaaatgt aagaaagctt 
121 t tgatgagga ccagtgaaag aggaagcaat aatgaaaacc acaatggt t t agaaaacacc 
181 cagacgcaag cagagaatga gttaaagaaa gtgaaaagac aagtggaaag tgatggaagg 
241 gcattcagaa agtaaaaacc agtgt t tgcc c tat t taaga cacattcacc caggatggtc 
301 ttcagagaac ctagagggga aggatcagga ccaaacagtc cagaagacca gaagctttgg 
361 caacactcac catggctagg c t c t g t g c t t t cc tga tgg t cctggcggtg atgagctact 
421 ggccaacctg ctctctagga tgtgacctgc ctcagactca taacctcagg aacaagagag 
481 cct tgacact cctggtacaa atgaggagac tc tcccctc t ctcctgcctg aaggacagga 
541 aggactttgg attcccgcag gagaaggtgg atgcccagca gatcaagaag gctcaagcca 
601 t ccc tg tcc t gagtgagctg acccagcaga tcctgaacat cttcacatca aaggactcat 
661 c t gc tgc t t g gaatgcaacc ctcctagact cattctgcaa tgacctccac cagcagctca 
721 atgacctgca agg t tg tc tg atgcagcagg tgggggtgca ggaatttccc ctgacccagg 
781 aagatgccct gctggctgtg aggaaatact tccacaggat cactgtgtac ctgagagaga 
841 agaaacacag cccctgtgcc tgggaggtgg tcagagcaga agtctggaga gccctgtct t 
901 cctctgccaa tg tgctggga agactgagag aagagaaatg agtcatgagc caaagtgtag 
961 aggactcttc cagactagaa cactgtacct c tc tgctcat atctctgtca tctcaaaact 
1021 g t ca t t ca t t ttggcaggaa ttcaaacaat t tgcctaaat a t t tc tg taa aggcacttgt 
1081 t c t c t t t caa t t cag t t c ta tg tatacatg tatgtatgca t g ta t g ta t g ta tgc t t g ta 
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1141 c g t a t t t a t t t a t t t a t t t a t t t g t g t t t a t t t a t t c a c t t a t t t aac ta t c t g t g t ga t 
1201 gtaacatata t tgcagcata a t t tgg taaa g t t a t g t t t t t t a taaa t ta t tactaaatg 
1261 t a a c t t g t t t t a t t t g t t c a t t c t t t a a t t a t t t taaaa t t t t a t g t t g t g tatactggt 
1321 a t t t t t c a g t aaagaaatta tatacataat caagcttcca ag ta t tg tag tacatatgac 
1381 a t tgca tag t gttcaggcga t t a g a t t t a t t t c tca tcca t t c a t g g t t a at tcctacgt 
1441 c t t t t c t t t t c t cc t g t ga t c g t a t t c t t c tgaatgccca gacaacacac tgttcaggga 
1501 tcaggcataa gatct 
IFN-al-9 
Accession no.: M13660 
Priming region  
Start End  
Whole coding region primer 5 952 
Subtype specific primer |211 |596  
1 aaaataccca gacccaagca gagaatgtgg taaagaaagc gaaaagacca gtgggaagta 
61 tggagagggc atttggaaaa tgaaaattag tgttttgccc tatttaagac acatctacat 
121 aggatggtct tcagagaacc tagaggggaa ggttcaggac caaacagccc acaagagcag 
181 cagcatcttc aagactcata atggctaggc cctttgattt actgatggtc ttggtggtga 
241 taagctactg gtcaacctgc tctctaggat gtgacctgcc tcaaactcat aacctcagga 
301 acaagaaaat cttgacactc ctggcacaaa tgaggagact ctcccctctc tcttgcctga 
361 aggacagaaa ggactttgga ttcccccagg agaaggtgga tgcccagcag atccaggagg 
421 ctcaagccat ccctgtcctg agtgagctga cccagcagat cctgaccctc ttcacatcaa 
481 aggactcatc tgctgcttgg aatgcaaccc tcctagactc attctgcact ggcctccacc 
541 agctgctcaa tgacctgcaa ggctgtctga tgcagctggt cgggatgaag gaactgcccc 
601 tgacccagga agactcccag ctggctatga agaaatatt t ccacaggatc actgtgtacc 
661 tgagagagaa gaaacacagc ccctgtgcct gggaggtggt cagagcagaa gtctggagag 
721 ccc tg tc t tc ctcagttaac t tgctggcaa gactgagtga ggagaaggag tgagtcctga 
781 accaaaatgg agaggactct cctggactag gacactgtac ctcactgtgc aaattctggc 
841 atctcaaaaa ta tcagtcat t t t t g ca t ga attgaaagaa gttgcctaga tgcagtaatg 
9 0 1 t g c t t t g c t g t g t c t a t c t g t a a a g t c a c t g t t a t c c t t c c a t t c c a t t t g t t t g t t t a t 
IFN-a2 
Accession no.: X01969 
Priming region  
Start Ei^  
Whole coding region primer 4 
Subtype specific primer |l44 1776 
1 c a g a g a g t g a agtaaagaaa gtgaaaagag aattaggaag caaggggagg gtat t tggaa 
61 aggagaaact t g t g t t t g t c cctat t taag atagatgcac acagcaggct tctcagagaa 
121 cctagaggag aagactcaaa cacacagtcc agagagccat caacctctgc aagacccaca 
181 atggctagac t c t g t g c t t t cctcgtgatg ctgatagtga tgagctactg gtcaatctgt 
241 t c tc taggat gcgatctgcc tcacacttat aacctcagga acaagagggc cttgaaggtc 
301 ctggcacaga tgaggaggct cccct t tc tc tcctgcctga aggacaggca ggactttgga 
361 t t c c c c c t g g agaaggtgga taaccagcag atccagaagg c t c a a g c c a t c c c t g t g c t g 
421 cgagatctta ctcagcagac cttgaacctc ttcacatcaa aggcttcatc tgc tgct tgg 
481 aatgcaaccc tcctagactc attctgcaat gacctccacc agcagctcaa tgacctgcaa 
541 acctgtctga tgcagcaggt gggggtgcag gaacctcctc tgacccagga agacgccctg 
601 c tggctgtga ggaaatatt t ccacaggatc actgtgtacc tgagagagaa gaaacacagc 
661 ccctgtgcct gggaggtggt cagagcagaa gtctggagag ccctg tc t tc ctcagtcaac 
123 
721 t tgc tgccaa gactgagtga agagaaggag tgagtgtgag acaaagtgtg gagagacctc 
781 c c c t g g a c t a g a a a c t g c a t c t c a t t t t a t aagctc 
IFN-a4 
Accession no.: X01973 
Priming region  
Start End  
Whole coding region primer 3 1469 
Subtype specific primer |454 |1210  
1 c c c c c a c a c t t t a c t t t t t t g a c a g a a a t a t t t a t g t a a a t a g t a t a a a t a a a a c a a a a a 
61 ggt tgtaaaa taaattacaa aactttaaaa tacagtcata gggtaaat t t t g t g t t t g ca 
121 g tagatgtgc ag t t t tcaca cagagactgt a ta tc tg tgg ag tag tgg t t aatgacaatt 
181 t aag tg taat ttaaagagaa accctggaga g t agc t t t c t gagggcagca gtgaaactga 
241 aagcaatgat tgaacccaca tccccagggg gggaggggag gggaggacaa aatcccagac 
301 acaagcagag agtgaagtaa agaaagtgaa aagagaattg gaaagcaagg ggagggtatt 
361 ccgaaaggag aaact tctat t t g t c cc t a t ttaagagaga tgtacacagc aggctctcag 
421 agaacctgta ggagaagact caaacccaca gcccagagag cgaccagcat ctacaagacc 
481 cacaatggct aggctctgtg c t t t cc t ca t gatcctagta atgatgagct actactggtc 
541 agcc tg t tc t c taggatgtg acctgcctca cacttataac ctcgggaaca agagggcctt 
601 gacagtcctg gaagaaatga gaagactccc ccctc t t tcc tgcctgaagg acaggaagga 
661 t t t t g g a t t c cccttggaga aggtggataa ccaacagatc cagaaggctc aagccatcct 
721 tg tgctaaga gatcttaccc agcagat t t t gaacctcttc acatcaaaag acttgtctgc 
781 t a c t t g g a a t g c a a c t c t c c t a g a c t c a t t c t g c a a t g a c c t c c a t c a g c a g c t c a a t g a 
841 tctcaaagcc t g tg tga tgc aggaacctcc tctgacccag gaagactccc tgc tggc tg t 
901 gaggacatac ttccacagga tcactg tg ta cctgagaaag aagaaacaca gcctctgtgc 
961 ctgggaggtg atcagagcag aagtctggag agccctctct tcctcaacca acttgctggc 
1021 aagactgagt gaggagaagg agtgagtcct gagacaaagt gtggagagga c t t t t c t gga 
1081 ccagaacact gcatctcact t tataagctc tcct t taaaa actctcataa c t t t ca ta ta 
1141 tgagtacaaa caacctgcat agatg t t tca gcaatcttga gcaat tc t tc tcaatatgca 
1201 aaaccgtgtt t g ta tc tgaa t c ca t t t g c t c t t t c t t a t t t g t t t g t t t g t t t a t t t a t t 
1261 t a t t t a t t t a t t t a t t t a t t g tgctat taa ta taa t t taa ggtaat tatg t t aaa ta t t t 
1321 cagtctcata t t t t t a a t a t a tca tg t ta t ca t t t g taa t t a a c t t a t t t tctattcaaa 
1381 taaa t t t ga t tcataagaca c t taggat ta g t taa t t t ga t a t c t c c t t t t t t t t t t t t t 
1441 t t t t t t t t t g g t t t g g t t t t t c g a g a c a g g g t t t c t c t g t atagccttgg ctgtcctgga 
1501 actcact t tg tagaccaggc tggcctcgaa ctcagaaatc cacctgcctc tgcctcccga 
1561 gtgctgggat taaaggcatg cgccaccacg cccgg 
IFN-a5 
Accession no.: X01971 
Priming region  
Start End  
Whole coding region primer 5 1947 
Subtype specific primer \1233 11462 
1 g a t g g t c c t a a a a t c a t c a g a t a a a t a g c t aacatacatt gaggattaaa ataaattgta 
61 ta taaat t ta t a t t agac t t aatgaaggca actcgagaaa cccaatt t ta ggac t t t t ta 
121 t t t t t t t a c t t t ta tcgaga cagggt t tc t c tgtatagtc ctggctgtcc tggaacacag 
181 t t tg tacacc t t t ac t t caa g ta ta t taat tgagagacac ttgcaacaat accttgcatt 
241 a t ta t t taca t ac t t t g taa acaatacaaa taaaacaaaa attgtcaatc aatatagtta 
124 
301 a c g t t t a c a g a a t a t a t t a c a g g a a a t t t t g a t t t a c a a t a a a t a t g t a a a t t a c a a a c a 
361 aagacagtt t a t t gg tgc tg gaacagttaa tgaaaattca aattaggaag aaaaaccctc 
421 aaaaccagct t t g gg ta t gg agcagtgaaa gaggaagcaa taatggaaat ctcaatgggt 
481 tagaaaaatg cccaaacaca agtggagaat gagttaaaga aagtgaaaag acaagtggaa 
541 agtgatggaa gggcattcag aaagtaaaaa c t a g t g t t t g ccctat t taa gacacatcca 
601 cccaggatgg tcttcagaga acctagaggg gaaggatcag aaccaaacag cccagaagac 
661 cagcagcatt ggcaacattc accatggcta ggctctgtgc tttcctgatg gtcctgccgg 
721 tgctgagcta ctggccaacc tgctctctag gatgtgacct tcttcagact cataacctca 
781 ggaacaagag agccttaacc ctcctggtaa aaatgaggag actctcccct ctctcctgcc 
841 tgaaggacag aaaggacttt ggattcccac aggagaaggt gggtgcccag cagatccagg 
901 aggctcaagc catccctgtc ctgagtgagc tgacccagca ggtcctgaac atcttcacat 
961 caaaggactc atctgctgca tggaatgcaa ccctcctaga ctcattctgc aatgaagtcc 
1021 atcagcagct caatgacctc aaagcctgtg tgatgcaaca ggtcggggtg caggaatctc 
1081 ccctgaccca ggaagactcc ctgctggctg tgaggaaata cttccacagg atcactgtgt 
1141 acctgagaga gaagaaacac agcccctgtg cctgggaggt ggtcagagca gaagtctgga 
1201 gagccctgtc ttcctcagtt aacttgctgg caagattgag caaggaggag tgactcctga 
1261 gacaaagtgt ggagaggact tttctgaacc agaacactgc atctcacttt ataagatctc 
1321 ctttaaaaac tctcataact ttcacatatg agtacaaaca acctgcacag atgtttcagc 
1381 aatcttgagc gatcattttc aatatgtaaa accatgttgg tatctgaatc cacttgtcct 
1441 ttattatttg tttgtttatt t a t t t a t t t a t t a t t c t g c t t t t a a t a a t t taaggtaatt 
1501 atgctaaatc t t c ag t c t t a t a t t t t t a a t t tagcaat ta t ta tg tgcaa t t aac t t a t t 
1561 t t g t a t t caa ataaatt tgc attataagac act tgggat t t g t t a a t t t g g t a t c t c t t t 
1621 aacattatca a a t a t t t t t a acattagagc atactgcata agtactgtac aaatgaacag 
1681 t t tccaaata ccagagagga tacacacata cactgcacag tat t tagaca aacatcaaac 
1741 a ta t t cc tc t t c tc tgca tg t a g t g t t c c t cggaacgtgt agacaccatg ctgtgcagta 
1801 gaaaaccaga gaaacct t t t g t t t g t t t g t t t g g t t t g g g t t t t g t t t t g t t t t g t t t t t 
1861 gagtcagggt t t t t c t g t g t agccctggct gtcctggaac t cac t t t a ta gacaggctgg 
1921 c c t c c a a c t a a g a a a t c c a c c t g a c t c t g c ctcccaagtg ctggaattaa aggcatgtgc 
1981 caccactgct ggccaaacca gagaatcttg c tccat tata t 
IFN-a7 
Accession no.: M13710 
Priming region  
Start  
Whole coding region primer 5 1147 
Subtype specific primer |453 |1Q97  
1 aggattagtt atatgtaatt ctctactgga atctacatga gtgctgggaa accaatgaga 
61 tactcatgtg tgtgctgtaa gaatactgat gactgagcca ttcaacagcc attaagaaca 
121 tattttgggt gaaattcttt tcattcttta tattagatta gattttacat acatgataca 
181 cacacacata tagtgaaatt taatgaaaat tcagtccgtg gctttgttga gaagagcaga 
241 gaaagttgac acaataatga aaacgaaaat gattgataaa aaaaatgccc agacacaaaa 
301 cgaaaatgag ttaaagaaag cataaaaaga attggaatga gaggggaaga cattccaaaa 
361 aaaaaataga aactagtgt t t t t c t c c t a t ttaagacaca ttcaccaggg atggtcttca 
421 gagaacctag aggggaagga tcaggaccaa acagccaaga agaccagcag cattggcaac 
481 attcaccatg gctaggctct g t gc t t t cc t ga tgg t tc tg gcggtgatga gctactggcc 
541 aacctgt tg t ctaggatgtg accttcctca gactcataac ctcaggaaca agagagcctt 
601 aaccctcctg gtaaaaatga ggagactctc ccctctctcc tgcctgaagg accggaagga 
661 c t t t g g a t t t ccccaggcaa aggtggatgc ccagcagatc caggaggctc aagccatccc 
721 t g tcc tgag t gagctgaccc agcagatcct gaacatcttc acatcaaagg actcatctgc 
781 t gc t tggaat gcaaccctcc tagactcagt ctgcaatgac ctccaccagc agctcaatga 
841 cctgcaaggc tg tc tgatgc aggaggtggg ggtgcaggaa c t t tccctga cccaagaaga 
901 c tccctgctg gctgtgagga aatacttcca caggatcact g tg t tcctga gagagaagaa 
961 acacagcccc tgtgcctggg aggtggtcag agcagaaatc tggagagccc t g tc t tcc tc 
1021 agccaacttg ctggcaagac tgagtgagaa gaaggagtga gtcctgagac aaagtagaga 
1081 ggatctccag gattaggaca c t g c a c c t c t c t g t c c a g a t t c t a c c a t c t c a a a a a t a t c 
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1141 a t a c a a t t t t gca t taa t tg aagcaagttg cctagatgct tctgcag 
IFN-a8 
Accession no.: D00460 
Priming region  
Start ^ M  
Whole coding region primer 24 1523 
Subtype specific primer |920 |l3Q3  
1 c t g g g a t t a a a g t g g t g c a c c a c c a c t g c c c a g t g g a c t t t a a a t a t t t t a a a g t a t a c c 
61 t t t a c t t c aa t g t t t a t t a a ttgagagaca cttgaaacaa tacc t tgcat t a t t a t t t ac 
121 a t ac t t t g t a aacaatacaa ataaaacaaa aat tgtcaat tcaatatagt taa tg t t tac 
181 aaaatacatt acagggaatt t t ga t t t aca ataaatatgt aaattataaa caaagacagt 
241 t ta t t ggagc tgaaatagt t a t tgaaagt t caaattagga agaaaaaccc tcaaaaccaa 
301 c t t t g g g t g t ggagcagtaa agaggaagca ataatgaaaa tctcaatggg ttagaaaaat 
361 gcccaaacac aagtggagaa tgagttaaag aaaatgaaaa gacaagtgga aagtgatgga 
421 agggcattca gaaagtaaaa ac tag t g t t t gccctat t ta agacacattc acccaggatg 
481 gtct tcagag aacctagagg ggaaggatca agatcaaaca gcccagaaga ccagaagcat 
541 tggcaacatt caccatggct aggctctgtg c t t t c c t ga t ggt tctggcg gtgctgagct 
601 actggccaac c t gc tc tc ta ggatgtgacc tgcctcagac tcataacctc aggaacaaga 
661 gagccttaac cctcctggta aaaatgagga gactctcccc tc tc tcc tgc ctgaaggaca 
721 gaaaggactt tggat tccca caggagaagg tgggtgccca gcagatccag gaggctcaag 
781 ccatccctgt cctgactgag ctgacccagc aaatcctggc cctcttcaca tcaaaggact 
841 catctgctgc t tggaatgca accctcctag actcat tc tg caatgacctc caccagctgc 
901 tcaatgacct gcaaggctgt ctgatgcagc aggtagagat acaggcactt cccctgaccc 
961 aggaagactc cctgctggct gtgaggacat acttccacag gatcactgtg ttcctgagag 
1021 agaagaaaca cagcccctgt gcctgggagg tggtcagagc agaagtctgg agagccctgt 
1081 c t t c c t c a g c c a a g t t g c t g gcaagactga atgaggacga g t g a g t c c t g agaccaagtg 
1141 tggagagacc tccctggact agaacactgc acctgcactt tataagctcc ctt tacaact 
1201 c tcat tacct tcagtgtgaa cacaatcaac ctgccaagac gctgcagcaa tattgagcaa 
1261 t t a t t t t c a g catgtatagc cacttttgta tctgcaccat t t g t c t c t a t t t a t t t a t t t 
1321 a t t a t t t a t g t a t t c t g c t a t taa ta taa t t t aagg ta t t t a t g t taaa t c t t cag tc t t 
1381 a t a t t t t t a a t t t c t caaa t ta tcatg tgc aattaactta t t t t g t a t t c aaataaattt 
1441 gcattataag acacttggga t t t g t t a a t t t g g t a t c t c t t t aaca t ta t caaatat t t t 
1501 t a a c a t t a g a g c a t a c a g c a taaatattgc acaaatgaaa a 
IFN-all 
Acession no.: M68944 
Priming region  
Start [End 
Whole coding region primer 31 2235 
Subtype specific primer 1375 |l6Q3  
1 aagcttgaac ataaggatt t t tgcatacat a g c c c c c a g g a t g c c a t g a c aatcatagga 
61 taaatagcta atatacagtg atggcataac taacc t t t ta tgaaaattaa ta t tagagt t 
121 agtggaggta atatttaaaa aaccttaatt t t t agcc tc t aaaaatttga aaattttgaa 
181 tcattacatc ag ta tga t t t ttgtagacaa aggg t t t t c t ctgtgaggtc ctcatagtcc 
241 tggaacttgc tc tg tagact aggctggcct tgaactcaga cacccatctg cctct tctga 
301 gattaaactg tgaagcatca cgtccagacc acaacaatac t t c tacc t ta aaaacatttt 
361 gcattatact t t a c t t t t t g acacaaatat t ta tg taaat ggtataaata aaataaaaaa 
421 taattgtaaa ataaattaca ctaacttaaa tacaatcata gaggaaattt t g t g t t t gcc 
126 
481 atagatgtgt aaatttctca cagagactct atatctgtgg agtagtggtt aatgaccatt 
541 taagtctaat ttaaagtgaa accctgtaga gtagctttct gagggcagca atgaaagaga 
601 aagcaatgat ggaacccaca tgcctggggg gggggggaac ccagatacaa gcagagagtg 
661 aagtaaagaa agtgaaaaga gaattgggaa gcaaggggag ggtatttaca aaggagaaac 
721 ttgtgtttgt ccctatttaa gatagatgca cacagtaggc ttgtcagaga acctggagga 
781 gaagactcaa acacacagtc cagagagcca tcaatatctg caagacccat aatggctagg 
841 ctctgtgctt tcctcatgat cctgatagtg atgagctact ggtcaacctg ctctctagga 
901 tgcgatctgc ctcacactta taacctcagg aacaagaggg ccttgaaggt cctggcacaa 
961 atgaggagac t c t c c c c t c t c t c c t g c c t g aaggacaggc a g g a c t t t g g a t t t c c c c t g 
1021 gagaaggtgg atgcccagca gatcaagaag gctcaagcca tccctgtgct gcgagatctt 
1081 acccagcaga tcttgaacct cttcacatca aaggcttcat ctgctgcttg gaatgcaacc 
1141 ctcctagact cattctgcaa tgacctccac cagcagctca atgacctgca aggctgtctg 
1201 atgcagcagg tgggggtgca ggaacctcct ctgacccagg aagacgccct gctggctgtg 
1261 aggatatact tccacagcat cactgtgttc ctgagagaga agaaacacag cccctgtgcc 
1321 tgggaggtgg tcagagcaga agtctggaga gccctgtctt cctcagttaa cttgctggca 
1381 agattgagtg aagagaaggc ttgagtcctg agaccaagtg tggagagtcc tcccctggac 
1441 tagaacactg catctcactt tataagctct ccttttaaac tctcattact ttcagtatga 
1 5 0 1 atacaatcaa cctgcctatt gtttcagaat attgagcaat tattttccgt atgtaaaacc 
1561 atggctgtat ccgcacctat ttgttattta tttgtttgtt tatttatttg tttgtttgtt 
1621 t a t t t a t g c t a t tagtataa t t t aagg ta t t t a t g t t aaa t c t t t caa tc t c a t a t t t t t 
1681 tcataataca aa t ta tca t t tctat taaac t t a t t t t a t a ttcaaataaa t t t g c t t t a g 
1741 aagatact t t gaat tagt ta a t t t gc ta tc tg taacat ta t caaa ta t t t t taacattaa 
1801 agcctacact ataaatat tg tacaaatgga cagtttccaa atatcagaga agatagacac 
1861 atacactaca cag ta t t tag acaatcctta a g t a t t t t t a t a t t t t c t t t ccagtatgca 
1921 g t a t t c t t c t ggatgtatag acagcatgct gtgcagtaga gagaaaaaga atct tgctcc 
1981 t g t c t t a t t c c t ta t tccac tttgaccaaa ta t tccc tgg atcaattcag t a t c t g a t t t 
2041 cccggatgtc ataccaatca tccactc t ta tcat taatga gc t t ca t t g t t t t g g g t t c t 
2101 aaatatgcgt gagatcatgt aaagtaatgg agaagagatc aagaaaaatg agtagcctgc 
2161 cgatatagca gagaaaagca agacaagaag aacctgggaa taaaccccac t c a t a a t a g c 
2221 c t c a t a a g c c a g t c c t g g g a agaattc 
IFN-aB 
Accession no.: L38698 
； Priming region  
Start ^ M  
Whole coding region primer 29 1131 
Subtype specific primer |477 |1Q68  
1 g a a t t c a c a g g a g t g c t g g g a a a c c a g g t a c t c a t g t g t g t g c t g t a a g a a t a c t g a t g a 
61 ctgagccatt caacagcttt taagaacata ttttgggtga aattattttc attctttata 
121 ttagatgagt aaattttata tacatgatac acacatacac acacatatag tgaaagttaa 
181 tgaaaattca ttcagtggag aagttctaaa tatctttgtt gaaaagagca gagaaagttg 
241 acacaataat gaaaactaaa atgattgata aaaaaatgcc cagacacaaa atgaaaatga 
301 gttaaagaaa gcgaaaacag agttggaaag agaggggaag acattcagaa aatagaaact 
361 cgtgtttttc tcctatttaa gacacattca cccaagatgg tcttcagaga acctagaggg 
421 aaaggataag aaccaaacag cccagaagac cagcagcatt ggcaatattc accatggcta 
481 ggctcagcac tttcctaatg gtcctggcag tgatgagcta ctggtcaacc tgccctctag 
541 gatgtgacct gcctcagact cataacctca ggaacaagag agccttgaca ctcctggtac 
601 aaatgaggag actctcccct ctctcctgcc tgaaggacag gaaggacttc ggattccccc 
661 aggagaaggt ggatgcccag cagatccagg aggctcaagc catccctgtc ctgactgagc 
721 tgacccagca gatgctgacc ctcttcacat caaaggcttc atctgctgct tggaatgcaa 
781 ccctcctaga ctcattctgc aatgacctcc accagcaact caatgacctg aaaacctgtc 
841 tgatgcagca ggtgggggtg caggaatttc ccctgaccca ggaagactcc ctgctggctg 
901 tgaggaaata cttccacagc atcactgtgt acctgagaga gaagaaacac agcccctgtg 
961 cctgggaagt ggtcagagca gaagtctgga gagccctgtc ttcctcagcc aagttgctgg 
1021 caagtctgag tgaggagaag gagtgagtct gagacccagt ggagagaatc tcctggacta 
127 
1081 g g a c a c t g c a c c t c t c t g c c c a g a t t c t a c c a t c t c a a a g a t a c c a g t c a t t t t g a c a t g 
1141 aat tgaaaca a g t t g c c t a g a t g c t t c t g c ag 
C. Homology search of sequencing on putative plasmid with 
known sequences 
Each of the recombinant plasmid was sequenced in both directions, using either the 
T3 or T7 primer. The DNA sequences obtained from sequencing were matched with 
the known sequences in the Entrenz Nucleotide gene bank database using blastn 
program provided by NCBI. The alignment of the DNA sequence of each cloned 
IFN-a gene with the published sequence was showed in below. 
a l - T3 primer 
Q u e r y G C A T C T C A C T G C T C T G A T - T C T G A A A T C C C A A A A C T 
IFN-al AGGACTCTTCCAGACTAGAACACTGTACCTCTCTGCTCATATCTCTGTCATCTCAAAACT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y GTCACTCATTTTGGCAGGAATTCAAACAATTTGCCTAAATATTTCTGTAAAGGCACTTGT 
IFN-al GTCATTCATTTTGGCAGGAATTCAAACAATTTGCCTAAATATTTCTGTAAAGGCACTTGT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TCTCTTTCAATTCAGTTCTATGTATACATGTATGTATGCATGTATGTATGTATGCTTGTA 
IFN-al TCTCTTTCAATTCAGTTCTATGTATACATGTATGTATGCATGTATGTATGTATGCTTGTA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CATATTTATTTATTTATTTATTTATTTATTTATTTATTTGTGTTTATTTATTCACTTATT 
工 F N _ C X 1 C G T A T T T A T T T A T T T A T T T A T T T G T G T T T A T T T A T T C A C T T A T T 
• * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TAACTATCTGTGTGATGTAACATATATTGCAGCATAATTTGGTAAAGTTATGTTTTTTAT 
I F N - a l T A A C T A T C T G T G T G A T G T A A C A T A T A T T G C A G C A T A A T T T G G T A A A G T T A T G T T T T T T A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AAATTATTACTTAAATGTAACTTGTTTTATTTGTTCATTCTTTAATTATTTTAAAATTTT 
工FN_(X1 AAATTATTACT-AAATGTAACTTGTTTTATTTGTTCATTCTTTAATTATTTTAAAATTTT 
ic-fc-k-k-k****** * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query ATGTTGTGTATACTGGTATTTTTCAGTAAAGAAATTATATACATAATCAAGCTTCCAAGT 
IFN-Oil A T G T T G T G T A T A C T G G T A T T T T T C A G T A A A G A A A T T A T A T A C A T A A T C A A G C T T C C A A G T 
Query ATTGTAGTTACATATGACATTGCATAGTGTTCAGGCGATTAGATTTATTTCTCATCCATT 
I F N - a l A T T G T A G T - A C A T A T G A C A T T G C A T A G T G T T C A G G C G A T T A G A T T T A T T T C T C A T C C A T T 
• * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y C A T G G T T A A T T C C T A C G T C T T T T C T T T T C T C C T G T G T A T C G T A T T C T T C T G A A T G C C C A G 
IFN-al C A T G G T T A A T T C C T A C G T C T T T T C T T T T C T C C T G T G - A T C G T A T T C T T C T G A A T G C C C A G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y A C A A C A C A C T G T T C A G G G A T C A G G C A T G G  
I F N - a l ACAACACACTGTTCAGGGATCAGGCATAAGATCT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * 
128 
a l -T7 primer 
Q u e r y C C T G C A G C C C A T A T G T A A A T T T C A A G T A A G G A C A G T 
IFN-al AGACTATTTTACAGAAAACTTTGATTTATACTAAATATGTAAATTTCAAGTAAGGACAGT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTATCAGTACTGTAACAGTTAATGAAAATTCAAATTAGGAAAAGAAATGTAAGAAAGCTT 
I F N - a l T T A T C A G T A C T G T A A C A G T T A A T G A A A G T T C A A A T T A G G A A A A G A A A T G T A A G A A A G C T T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTGATGAGGACCAGTGAAAGAGGAAGCAATAATGAAAACCACAATGGTTTAGAAAACACC 
IFN-Cxl TTGATGAGGACCAGTGAAAGAGGAAGCAATAATGAAAACCACAATGGTTTAGAAAACACC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CAGACGCAAGCAGAGAATGAGTTAAAGGAAAGTGAAAAGACAAGTGGAAAGTGATGGAAG 
IFN_al C A G A C G C A A G C A G A G A A T G A G T T A A A G - A A A G T G A A A A G A C A A G T G G A A A G T G A T G G A A G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GGCATTCAGAAAGTAAAAACCAGTGTTTGCCCTATTTAAGACACATTCACCCAGGATGGT 
工FN-CXI G G C A T T C A G A A A G T A A A A A C C A G T G T T T G C C C T A T T T A A G A C A C A T T C A C C C A G G A T G G T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CTTCAGAGAACCTAGAGGGGAAGGATCAGAACCAAACAGCCCAGAGGACCAGCAGCATTG 
IFN-al CTTCAGAGAACCTAGAGGGGAAGGATCAGGACCAAACAGTCCAGAAGACCAGAAGCTTTG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GCAACACTCACCATGGCTA'GGCTCTGTGCTTTCCTGATGGTCCTGGCGGTGATGAGCTAC 
IFN-al GCAACACTCACCATGGCTAGGCTCTGTGCTTTCCTGATGGTCCTGGCGGTGATGAGCTAC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGGCCAACCTGCTCTCTAGGATGTGACCTTCCTCAGACTCATAACCTCAGGAACAAGAAA 
I F N - a l T G G C C A A C C T G C T C T C T A G G A T G T G A C C T G C C T C A G A C T C A T A A C C T C A G G A A C A A G A G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y A T C T T G A C A C T C C T G G T A C A A A T G A G G A G A C T C T C C C C T C T C T C C T G C C T G A A G G A C A G G 
I F N - a l G C C T T G A C A C T C C T G G T A C A A A T G A G G A G A C T C T C C C C T C T C T C C T G C C T G A A G G A C A G G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y A A G G  
I F N - a l A A G G A C T T T G G A T T C C C G C A G G A G A A G G T G G A T G C C C A G C A G A T C A A G A A G G C T C A A G C C 
* * * * 
al-9 -T3 primer 
Q u e r y A G G 
I F N - a l - 9 A G G A C A G A A A G G A C T T T G G A T T C C C C C A G G A G A A G G T G G A T G C C C A G C A G A T C C A G G A G G 
* * * 
Query CTCAAGCCATCCCTGTCCTGAGTGAGCTGACCCAGCAGATCCTGACCCTCTTCACATCAA 
I F N-al - 9 CTCAAGCCATCCCTGTCCTGAGTGAGCTGACCCAGCAGATCCTGACCCTCTTCACATCAA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y A G G A C T C A T C T G C T G C T T G G A A T G C A A C C C T C C T A G A C T C A T T C T G C A C T G G C C T C C A C C 
I F N - a l - 9 AGGACTCATCTGCTGCTTGGAATGCAACCCTCCTAGACTCATTCTGCACTGGCCTCCACC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
129 
r 
Q u e r y A G C T G C T C A A T G A C C T G C A A G G C T G T C T G A T G C A G C T G G T C G G G A T G A A G G A A C T G C C C C 
I F N - a l - 9 AGCTGCTCAATGACCTGCAAGGCTGTCTGATGCAGCTGGTCGGGATGAAGGAACTGCCCC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y TGACCCAGGAAGACTCCCAGCTGGCTATGAAGAAATATTTCCACAGGATCACTGTGTACC 
I F N - a l - 9 TGACCCAGGAAGACTCCCAGCTGGCTATGAAGAAATATTTCCACAGGATCACTGTGTACC 
Q u e r y TGAGAGAGAAGAAACACAGCCCCTGTGCCTGGGAGGTGGTCAGAGCAGAAGTCTGGAGAG 
I F N - c x l - 9 TGAGAGAGAAGAAACACAGCCCCTGTGCCTGGGAGGTGGTCAGAGCAGAAGTCTGGAGAG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y C C C T G T C T T C C T C A G T T A A C T T G C T G G C A A G A C T G A G T G A G G A G A A G G A G T G A G T C C T G A 
I F N - a l - 9 CCCTGTCTTCCTCAGTTAACTTGCTGGCAAGACTGAGTGAGGAGAAGGAGTGAGTCCTGA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y -CCAAAATGGAGAGGNCTCTCCTGGACTAGGACACTGTACCTCACTGTGCAAATTCTGGC 
I F N - a l - 9 ACCAAAATGGAGAGGACTCTCCTGGACTAGGACACTGTACCTCACTGTGCAAATTCTGGC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y ATCTCAAAAATATCAGTCATTTTTGCATGAATTGAAAGAA  
I F N - a l - 9 A T C T C A A A A A T A T C A G T C A T T T T T G C A T G A A T T G A A A G A A G T T G C C T A G A T G C A G T A A T G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
al-9 -T7 primer 
Query AGGGCATTTGGAAAATGAAA-TTAGTTTTTTGCCCTATTTAAGACACATCTACAT 
工FN-Cxl-9 T G G A G A G G G C A T T T G G A A A A T G A A A A T T A G T G T T T T G C C C T A T T T A A G A C A C A T C T A C A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y AGGATGGTCTTCAGAGAACCTAGAGGGGAAGGTTCAGGACCAAACAGCCCACAAGAGCAG 
IFN-al-9 AGGATGGTCTTCAGAGAACCTAGAGGGGAAGGTTCAGGACCAAACAGCCCACAAGAGCAG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CAGCATCTTCAAGACTCATAATGGCTAGGCCCTTTGCTTTCCTGATGGTCTTGGTGGTGA 
I F N _ o i l - 9 C A G C A T C T T C A A G A C T C A T A A T G G C T A G G C C C T T T G C T T T C C T G A T G G T C T T G G T G G T G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TAAGCTACTGGGTCAACCTGCTCTCTAGGATGTGACCTGCCTCAAACTCATAACCTCAGG 
IFN-oil_9 T A A G C T A C T G G - T C A A C C T G C T C T C T A G G A T G T G A C C T G C C T C A A A C T C A T A A C C T C A G G 
• * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AACAAGAAAATCTTGACACTCCTGGCACAAATGAGGAGACTCTCCCCTCTCTCTTGCCTG 
IFN-cxl-9 A A C A A G A A A A T C T T G A C A C T C C T G G C A C A A A T G A G G A G A C T C T C C C C T C T C T C T T G C C T G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AAGGACAGAAAGGACTTTGGATTCCCCCAGGAGAAGGTGGATGCCCAGCAGATCCAGGAG 
IFN-al-9 AAGGACAGAAAGGACTTTGGATTCCCCCAGGAGAAGGTGGATGCCCAGCAGATCCAGGAG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GCTCAAGCCATCCCTGTCCTGAGTGAGCTGACCCAGCAGATCCTGACCCTCTTCACATCA 
IFN-cxl-9 G C T C A A G C C A T C C C T G T C C T G A G T G A G C T G A C C C A G C A G A T C C T G A C C C T C T T C A C A T C A 
Q u e r y AAGGACTCATCTGCTGCTTGGGAATGCAACCCTCC  
I F N - a l - 9 A A G G A C T C A T C T G C T G C T T G G - A A T G C A A C C C T C C T A G A C T C A T T C T G C A C T G G C C T C C A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
130 
al -T3 primer 
Q u e r y G G C C N T G A A G G T C 
I F N - a 2 T C T C T A G G A T G C G A T C T G C C T C A C A C T T A T A A C C T C A G G A A C A A G A G G G C C T T G A A G G T C 
* * * * * * * * * * * * 
Q u e r y C T G G C A C A G A T G A G G A G G C T T C C C C T T T C T C T C C T G C C T G A A G G A C A G G C A G G A C T T T G G 
I F N - a 2 C T G G C A C A G A T G A G G A G G C T - C C C C T T T C T C T C C T G C C T G A A G G A C A G G C A G G A C T T T G G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y A T T C C C C C T G G A G A A G G T G G A T A A C C A G C A G A T C C A G A A G G C T C A A G C C A T C C C T G T G C T 
I F N - a 2 A T T C C C C C T G G A G A A G G T G G A T A A C C A G C A G A T C C A G A A G G C T C A A G C C A T C C C T G T G C T 
Query GCGAGATCTTACTCAGCAGACCTTGAACCTCTTCACATCAAAGGCTTCATCTGCTGCTTG 
I F N - C X 2 G C G A G A T C T T A C T C A G C A G A C C T T G A A C C T C T T C A C A T C A A A G G C T T C A T C T G C T G C T T G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y G A A T G C A A C C C T C C T A G A C T C A T T C T G C A A T G A C C T C C A C C A G C A G C T C A A T G A C C T G C A 
IFN-CX2 G A A T G C A A C C C T C C T A G A C T C A T T C T G C A A T G A C C T C C A C C A G C A G C T C A A T G A C C T G C A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AACCTGTCTGATGCAGCAGGTGGGGGTGCAGGAACCTCCTCTGACCCAGGAAGACGCCCT 
工FN-0t2 A A C C T G T C T G A T G C A G C A G G T G G G G G T G C A G G A A C C T C C T C T G A C C C A G G A A G A C G C C C T 




I F N - a 2 C C C C T G T G C C T G G G A G G T G G T C A G A G C A G A A G T C T G G A G A G C C C T G T C T T C C T C A G T C A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y C T T G C T G C C A A G A C T G A G T G A A G A G A A G G A G T G A G T G T G A G A C A A A G T G T G G A G A G A C C T 
IFN-ci2 CTTGCTGCCAAGACTGAGTGAAGAGAAGGAGTGAGTGTGAGACAAAGTGTGGAGAGACCT 
Q u e r y C C C C T G G A C T A G A A A C T G C A T C T C A T T T T A T G G G — — 
I F N _ a 2 C C C C T G G A C T A G A A A C T G C A T C T C A T T T T A T A A G C T C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
a-2 -T7 primer 
GGAAGCAAGGGGAGGGTATTTGGAA 
IFN - Ct2 CAGAGAGTGAAGTAAAGAAAGTGAAAAGAGAATTAGGAAGCAAGGGGAGGGTATTTGGAA 









* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query T C T C T A G G A T G C G A T C T G C C T C A C A C T T A T A A C C T C A G G A A C A A G A G G G C C T T G A A G G T C 
I F N - C X 2 T C T C T A G G A T G C G A T C T G C C T C A C A C T T A T A A C C T C A G G A A C A A G A G G G C C T T G A A G G T C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y CTGGCACAGATGAGGAGGCTCCCCTTTCTCTCCTGCCTGAAGGACAGGCAGGACTTTGGA 
IFN_a2 CTGGCACAGATGAGGAGGCTCCCCTTTCTCTCCTGCCTGAAGGACAGGCAGGACTTTGGA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTCCCCCTGGAGAAGGTGGATAACCAGCAGATCCAGAAGGCTCAAGCCATCCCTGTGCTG 
IFN_cx2 TTCCCCCTGGAGAAGGTGGATAACCAGCAGATCCAGAAGGCTCAAGCCATCCCTGTGCTG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CGAGATCTTACTCAGCAGACCTTGAACCTCTTCACATCAAAGGCTTCATCTGCTGCTTGG 
I F N - a 2 C G A G A T C T T A C T C A G C A G A C C T T G A A C C T C T T C A C A T C A A A G G C T T C A T C T G C T G C T T G G 
Query AATGCAACCCTCCTAGACTCATTCTGCAATGA  
I F N - a 2 AATGCAACCCTCCTAGACTCATTCTGCAATGACCTCCACCAGCAGCTCAATGACCTGCAA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
a4 -T3 primer 
Query —TGTAAAATAA-TTACAAAACTTTAAAATACAGTCATAGGGTAAATTTTGTGTTTGCA 
I F N _ c t 4 G G T T G T A A A A T A A A T T A C A A A A C T T T A A A A T A C A G T C A T A G G G T A A A T T T T G T G T T T G C A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GTAGATGTGCAGTTTTCACACAGAGACTGTATATCTGTGGAGTAGTGGT-AATGACAATT 
I F N - a 4 GTAGATGTGCAGTTTTCACACAGAGACTGTATATCTGTGGAGTAGTGGTTAATGACAATT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TAAGTGTAATTTAAAGAGAAACCCTGGAGAGTAGCTTTCTGAGGGCAGCAGTGAAACTGA 
I F N - a 4 T A A G T G T A A T T T A A A G A G A A A C C C T G G A G A G T A G C T T T C T G A G G G C A G C A G T G A A A C T G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AAGCAATGATCGAACCCACATCCCCAGGGGGGGAAGGGGAGGGGAGGACAAAATCCCAGA 
工FN-a4 AAGCAATGATTGAACCCACATCCCCAGGGGGGGA-GGGGAGGGGAGGACAAAATCCCAGA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CACAAGCAGAGAGTGAAGTAAAGAAAGTGAAAAGAGAATTGGAAAGCAAGGGGAGGGTAT 
IFN_0t4 CACAAGCAGAGAGTGAAGTAAAGAAAGTGAAAAGAGAATTGGAAAGCAAGGGGAGGGTAT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TCCGAAAGGAGAAACTTCTATTTGTCCCTATTTAAGAGAGATGTACACAGCAGGCTCTCA 
IFN_CX4 T C C G A A A G G A G A A A C T T C T A T T T G T C C C T A T T T A A G A G A G A T G T A C A C A G C A G G C T C T C A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GAGAACCTGTAGGAGAAGACTCAAACCCACAGCCCAGGGAGCGACCAGCATCTACAAGAC 
I F N - a 4 G A G A A C C T G T A G G A G A A G A C T C A A A C C C A C A G C C C A G A G A G C G A C C A G C A T C T A C A A G A C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CCACAATGGCTAGGCTCTGTGCTTTCCTCATGATCCTGGTAATGATGAGCTACTACTGGG 
IFN_cx4 CCACAATGGCTAGGCTCTGTGCTTTCCTCATGATCCTAGTAATGATGAGCTACTACTGGT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
132 
Q u e r y TCACCTGTTCTCTAGGATGTGACCTGCCTCACACTTATAACCTCGGGAACAAGA  
I F N - a 4 CAGCCTGTTCTCTAGGATGTGACCTGCCTCACACTTATAACCTCGGGAACAAGAGGGCCT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
cx4 -T7 primer 
Query CAGCTCAATGA 
工FN-ot4 TACTTGGAATGCAACTCTCCTAGACTCATTCTGCAATGACCTCCATCAGCAGCTCAATGA 
* * * * * * * * * * * 
Query -CTCAAAGCCTGTGTGATGCAGGA-CCTCCTCTGACCCAGGA-GA-TCCCTGCTGGCTGT 
I F N - C X 4 T C T C A A A G C C T G T G T G A T G C A G G A A C C T C C T C T G A C C C A G G A A G A C T C C C T G C T G G C T G T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GAGGACATACTTCCACAGGATCACTGTGTACCTGAGAAAGAAGAAACACAGCCTCTGTGC 
I F N - a 4 G A G G A C A T A C T T C C A C A G G A T C A C T G T G T A C C T G A G A A A G A A G A A A C A C A G C C T C T G T G C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CTGGGAGGTGATCAGAGCAGAAGTCTGGAGAGCCCTCTCTTCCTCAACCAACTTGCTGGC 
工FN_cx4 C T G G G A G G T G A T C A G A G C A G A A G T C T G G A G A G C C C T C T C T T C C T C A A C C A A C T T G C T G G C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AAGACTGAGTGAGGAGAAGGAGTGAGTCCTGAGACAAAGTGTGGAGAGGACTTTTCTGGA 
I F N - A 4 A A G A C T G A G T G A G G A G A A G G A G T G A G T C C T G A G A C A A A G T G T G G A G A G G A C T T T T C T G G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CCAGAACACTGCATCTCACTTTATAAGCTCTCCTTTAAAAACTCTCATAACTTTCATATA 
I F N _ C X 4 C C A G A A C A C T G C A T C T C A C T T T A T A A G C T C T C C T T T A A A A A C T C T C A T A A C T T T C A T A T A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGAGTACAAACAACCTGCATAGATGTTTCAGCAATCTTGAGCAATTCTTCTCAATATGCA 
IFN-0i4 T G A G T A C A A A C A A C C T G C A T A G A T G T T T C A G C A A T C T T G A G C A A T T C T T C T C A A T A T G C A 
Query AAACCGTGTTTGTATCTGAATCCATTTGCTCTTTCTTATTTGTTTGTTTGTTTACATTAT 
工FN一 CX4 A A A C C G T G T T T G T A T C T G A A T C C A T T T G C T C T T T C T T A T T T G T T T G T T T G T T T A T - T T A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTATTTATTTATTTATTTATTGTGCTATTAATATAATTTAAGGTAATTATGTTAAATATT 
I F N _ O T 4 T T A T T T A T T T A T T T A T T T A T T G T G C T A T T A A T A T A A T T T A A G G T A A T T A T G T T A A A T A T T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y T C A G T C T C C A T A T T T T T A A T A T A T C A T G T T A T C A T T T G T A A T T A A - T T A T T T T C T N A T T C 
工FN_a4 T C A G T C T C - A T A T T T T T A A T A T A T C A T G T T A T C A T T T G T A A T T A A C T T A T T T T C T A - T T C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AAATAAATTTGATTCATAAGACNCTTAGGATTAGTTAATTTGATATCTCCTTTTTTTTTT 
I F N _ a 4 AAATAAATTTGATTCATAAGACACTTAGGATTAGTTAATTTGATATCTCCTTTTTTTTTT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y T T T T T T T T T T T T T T G G T T T G G T T T T T C G A G A C A G G G G C T G C A G - G A A T T C G A T A T C 
I F N - ( X 4 T T T T T T T T T T T T — G G T T T G G T T T T T C G A G A C A G G G T T T C T C T G T A T A G C C T T G G C T G T C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
133 
ct5 — T3 primer 
Q u e r y A C T T C A A T G T A T A T T A A T T G A G A G A C A C T T G C A A C A A T A C C T T G C A T 
I F N - a 5 T T T G T A C A C C T T T A C T T C A A - G T A T A T T A A T T G A G A G A C A C T T G C A A C A A T A C C T T G C A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TATTATTTACATACTTTGTAAACAATACAAATAAAACAAAAATTGTCAATTCAATATAGT 
I F N - a 5 TATTATTTACATACTTTGTAAACAATACAAATAAAACAAAAATTGTCAAT-CAATATAGT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TAACGTTTACAGAATATATTACAGGAAATTTTGATTTACAATAAATATGTAAATTACAAA 
I F N - a 5 T A A C G T T T A C A G A A T A T A T T A C A G G A A A T T T T G A T T T A C A A T A A A T A T G T A A A T T A C A A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CAAAGACAGTTTATTGGTGCTGGAACAGTTAATGAAAATTCAAATTAGGAAGAAAA-CCC 
IFN-a5 CAAAGACAGTTTATTGGTGCTGGAACAGTTAATGAAAATTCAAATTAGGAAGAAAAACCC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TCAAAACCAGCTTTGGGGTATGGAGCAGTGAAAGAGGAAGCAT—ATGGGAATCTCA-TG 
工FN-CX5 T C A A A A C C A G C T T T G G G - T A T G G A G C A G T G A A A G A G G A A G C A A T A A T G G A A A T C T C A A T G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GGTTAGAAAA-TGCC~AACACAAGTGGAGAATGAGTTAAAGAA-GTGAAA-GACA-GTG 
I F N - a 5 G G T T A G A A A A A T G C C C A A A C A C A A G T G G A G A A T G A G T T A A A G A A A G T G A A A A G A C A A G T G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
a5 一 T7 primer 
q ^ q j ^ Y G C A T C T C A C T T - A T A A G A T C T C 
IFN-a5 GACAAAGTGTGGAGAGGACTTTTCTGAACCAGAACACTGCATCTCACTTTATAAGATCTC 
* * * * * * * * * * * * * * * * * * * * * 
Query CTTTAAAA-CTTTCATAACTTTCACATATGAGTACAAACAACCTGCACAG-TGTTTCAG 
I F N _ a 5 C T T T A A A A A C T C T C A T A A C T T T C A C A T A T G A G T A C A A A C A A C C T G C A C A G A T G T T T C A G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CAATCTTGAGCGATCATTTTCAATATGTAAAACCATGTTGGTATCTGAATCCACTTGTCC 
I F N - a 5 C A A T C T T G A G C G A T C A T T T T C A A T A T G T A A A A C C A T G T T G G T A T C T G A A T C C A C T T G T C C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTTCTTATTTGTTTGTTTATTTATTTATTTATTATTCTGCTTTTAATAATTTAAGGTAAT 
I F N _ a 5 T T T C T T A T T T G T T T G T T T A T T T A T T T A T T T A T T A T T C T G C T T T T A A T A A T T T A A G G T A A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TATGCTAAATCTTCAGTCTTATATTTTTAATTTAGCAAATTATTATGTGCAATTAACTTA 
I F N _ o t 5 T A T G C T A A A T C T T C A G T C T T A T A T T T T T A A T T T A G C A A - T T A T T A T G T G C A A T T A A C T T A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTTTGTATTCAAATAAATTTGCATTATAAGACACTTGGGATTTGTTAATTTGGTATCTCT 
工FN-CX5 T T T T G T A T T C A A A T A A A T T T G C A T T A T A A G A C A C T T G G G A T T T G T T A A T T T G G T A T C T C T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTAACATTATCAAATATTTTTAACATTAGAGCATACTGCATAAGTACTGTACAAATGAAC 
I F N _ a 5 T T A A C A T T A T C A A A T A T T T T T A A C A T T A G A G C A T A C T G C A T A A G T A C T G T A C A A A T G A A C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
134 
Q u e r y A G T T T C C A A A T A C C A G A G A G G A T A C A C A C A T A C A C T G C A C A G T A T T T A G A C A A A C A T — — 
I F N - a 5 A G T T T C C A A A T A C C A G A G A G G A T A C A C A C A T A C A C T G C A C A G T A T T T A G A C A A A C A T C A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y A T T C C T C T T C T C T G C A T G T A G T G T T C C T C G G A A C G T G T A G A C A C C A T G C T G T G C A G 
I F N - a 5 A C A T A T T C C T C T T C T C T G C A T G T A G T G T T C C T C G G A A C G T G T A G A C A C C A T G C T G T G C A G 
Q u e r y T A G A A A A C C A G A G A A - C C T T T T G T T T G T T T G T T T G G T T T G G G T T T T G T T T T G T T T T G T T T 
I F N - a 5 T A G A A A A C C A G A G A A A C C T T T T G T T T G T T T G T T T G G T T T G G G T T T T G T T T T G T T T T G T T T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y T T G A G T C A G G G T T T T T C T G T G T A G C C C T G G C T G T C C T G G A A C T C A C T T T A T A G A C C A G G 
工FN-CX5 T T G A G T C A - G G G T T T T T C T G T G T A G C C C T G G C T G T C C T G G A A C T C A C T T T A T A G A C - A G G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y C T G G C C T C C A A C T A A G A A A T C C A C C T G A C T C G G G C T G C - A G G A A T T C G A T A T C A A G - C T T 
I F N - a 5 C T G G C C T C C A A C T A A G A A A T C C A C C T G A C T C T G C C T C C C A A G T G C T G G A A T T A A A G G C A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
al -T3 primer 
Q u e r y — C T C T C T C C T G C C T G A A G - A C C G G A A G G A 
工FN-CX7 A A C C C T C C T G G T A A A A A T G A G G A G A C T C T C C C C T C T C T C C T G C C T G A A G G A C C G G A A G G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CTTTGGATTTCCCCAGGCAAAGGTGGATGCCCAGCAGATCCAGGAGGCTCAAGCCATCCC 
I F N - a 7 C T T T G G A T T T C C C C A G G C A A A G G T G G A T G C C C A G C A G A T C C A G G A G G C T C A A G C C A T C C C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGTCCTGAGTGAGCTGACCCAGCAGATCCTGAACATCTTCACATCAAAGGACTCATCTGC 
工 F N - C X 7 T G T C C T G A G T G A G C T G A C C C A G C A G A T C C T G A A C A T C T T C A C A T C A A A G G A C T C A T C T G C 
Query TGCTTGGAATGCAACCCTCCTAGACTCAGTCTGCAATGACCTCCACCAGCAGCTCAATGA 
工FN-(X7 T G C T T G G A A T G C A A C C C T C C T A G A C T C A G T C T G C A A T G A C C T C C A C C A G C A G C T C A A T G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CCTGCAAGGCTGTCTGATGCAGGAGGTGGGGGTGCAGGAACTTTCCCTGACCCCAAGAAG 
IFN-cx7 C C T G C A A G G C T G T C T G A T G C A G G A G G T G G G G G T G C A G G A A C T T T C C C T G A C C C - A A G A A G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query ACTCCCTGCTGGCTGTGAGGAAATACTTCCACAGGATCACTGTGTTCCTGAGAGAGAAGA 
I F N - a 7 A C T C C C T G C T G G C T G T G A G G A A A T A C T T C C A C A G G A T C A C T G T G T T C C T G A G A G A G A A G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AACACAGCCCCTGTGCCTGGGAGGTGGTCAGAGCAGAAATCTGGAGAGCCCTGTCTTCCT 
工FN-(X7 A A C A C A G C C C C T G T G C C T G G G A G G T G G T C A G A G C A G A A A T C T G G A G A G C C C T G T C T T C C T 
Query CAGCCNAATTGCTGGCAAGACTGAGTGAGAAGAAGGAGTGAGTCCTGAGACAAAGTAGAG 
I F N - a 7 C A G C C A A C T T G C T G G C A A G A C T G A G T G A G A A G A A G G A G T G A G T C C T G A G A C A A A G T A C A C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AGGATCTCCNAGGATTAGGACACTGCACCTCTCTGTCCAGATTCTACCATCTCAAAAATA 
I F N - a 7 A C C A T C T C C A - G G A T T A G G A C A C T G C A C C T C T C T G T C C A G A T T C T A C C A T C T C A A A A A T A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
135 
al -T7 primer 
Query ATCGAATTCCTGCAGCCCTTAGTTATATGTAATTCTCTACTGGAATCTACATGAGTGCTG 
I F N - a 7 A G G A - T T A G T T A T A T G T A A T T C T C T A C T G G A A T C T A C A T G A G T G C T G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GGAAACCAATGAGATACTCATGTGTGTGCTGGTAAGAATACTGATGACTGAGCCATTCAA 
I F N - C t 7 G G A A A C C A A T G A G A T A C T C A T G T G T G T G C T G - T A A G A A T A C T G A T G A C T G A G C C A T T C A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CAGCCATTAAGAACATATTTTGGGTGAAATTCTTTTCATTCTTTATATTAGATTAGATTT 
IFN_ot7 C A G C C A T T A A G A A C A T A T T T T G G G T G A A A T T C T T T T C A T T C T T T A T A T T A G A T T A G A T T T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y T A C A T A C A T G A T A C A C A C A C A C A T A T A G T G A A A T T T A A T G A A A A T T C A G T C C G T G G C T T T 
I F N _ a 7 T A C A T A C A T G A T A C A C A C A C A C A T A T A G T G A A A T T T A A T G A A A A T T C A G T C C G T G G C T T T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GTTGAGAAGAGCAGAGAAAGTTGACACAATAATGAAAACGAAAATGATTGATAAAAAAAA 
I F N _ a 7 G T T G A G A A G A G C A G A G A A A G T T G A C A C A A T A A T G A A A A C G A A A A T G A T T G A T A A A A A A A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGCCCAGACACAAAACGAAAATGAGTTAAAGAAAGCATAAAAAGAATTGGAATGAGAGGG 
I F N _ a 7 T G C C C A G A C A C A A A A C G A A A A T G A G T T A A A G A A A G C A T A A A A A G A A T T G G A A T G A G A G G G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GAAGACATTCCAAAAAAAAAATAGAAACTAGTGTTTTTCTCCTATTTAAGACACATTCAC 
j F N - a 7 G A A G A C A T T C C A A A A A A A A A A T A G A A A C T A G T G T T T T T C T C C T A T T T A A G A C A C A T T C A C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CCAGGATGGTCTTCAGAGAACCTAGAGGGGAAGGATCAGGACCAAACAGCCCAGAAGACC 
IFN_cx7 CAGGGATGGTCTTCAGAGAACCTAGAGGGGAAGGATCAGGACCAAACAGCCCAGAAGACC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AGCAGCATTGGCAACATTCACCATGGCTAGGCTCTGT  
I F N - a 7 A G C A G C A T T G G C A A C A T T C A C C A T G G C T A G G C T C T G T G C T T T C C T G A T G G T T C T G G C G G T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
a8 -T3 primer 
^ G T T C C T G A G A G 
Q u e r y  
T F N - a 8 A G G A A G A C T C C C T G C T G G C T G T G A G G A C A T A C T T C C A C A G G A T C A C T G T G T T C C T G A G A G 1 *********** 
Query AGAAGAAACACAGCCCCTGTGCCTGGGAGGTGGTCAGAGCAGAAGTCTGGAGAGCCCTGT 
I F N - 0 1 8 A G A A G A A A C A C A G C C C C T G T G C C T G G G A G G T G G T C A G A G C A G A A G T C T G G A G A G C C C T G T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CTTCCTCAGCCAAGTTGCTGGCAAGACTGAATGAGGACGAGTGAGTCCTGAGACCAAGTG 
I F N - a 8 C T T C C T C A G C C A A G T T G C T G G C A A G A C T G A A T G A G G A C G A G T G A G T C C T G A G A C C A A G T G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGGAGAGACCTCCCCTGGACTAGAACACTGCACCT-CACTTTATAAGCTCCCTTTACAAC 
工TGGAGAGACCTCCC-TGGACTAGAACACTGCACCTGCACTTTATAAGCTCCCTTTACAAC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
136 
Q u e r y TCTCATTACCTTTCAGTGTGAACACAATCAACCTGCCAAGACGCTGCAGCAAATATTGAG 
IFN-a8 TCTCATTACCTT-CAGTGTGAACACAATCAACCTGCCAAGACGCTGCAGCAA-TATTGAG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CAAATTATTTTCAGCATGTATAGCCACTTTTGTATCTGCACCATTTGTCTCTATTTATTT 
IFN_cx8 CAA-TTATTTTCAGCATGTATAGCCACTTTTGTATCTGCACCATTTGTCTCTATTTATTT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query ATTTATTATTTATGTATTCTGCTATTAATATAATTTAAGGTATTTATGTTAAATCTTCAG 
I F N - C X 8 ATTTATTATTTATGTATTCTGCTATTAATATAATTTAAGGTATTTATGTTAAATCTTCAG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TCTTATATTTTTAATTTCTCAAATTATCATGTGCAATTAA-TTATTTTGTATTCAA-TAA 
工FN_ct8 T C T T A T A T T T T T A A T T T C T C A A A T T A T C A T G T G C A A T T A A C T T A T T T T G T A T T C A A A T A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query ATT-GCATTATAAGACACTTGGGATTTGTTAATTTGGTATCTCTTTAACATTATCAAATA 
I F N _ a 8 A T T T G C A T T A T A A G A C A C T T G G G A T T T G T T A A T T T G G T A T C T C T T T A A C A T T A T C A A A T A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Q u e r y T T T T T A A C A T T A G A G C A T A C A G C A T A A G G G G G  
I F N - a 8 T T T T T A A C A T T A G A G C A T A C A G C A T A A A T A T T G C A C A A A T G A A A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * 
a8 一 T 7 primer 
Query ACCTTTACTTCAATGTTTATTAATTGAGAGACACTTGAAACAATACCTTGCATTATTATT 
I F N - C t 8 A C C T T T A C T T C A A T G T T T A T T A A T T G A G A G A C A C T T G A A A C A A T A C C T T G C A T T A T T A T T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TACATACTTTGTAAACAATACAAATAAAACAAAA-TTGTCAATTCAATATAGTTAATGTT 
I F N _ C X 8 T A C A T A C T T T G T A A A C A A T A C A A A T A A A A C A A A A A T T G T C A A T T C A A T A T A G T T A A T G T T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TACAAAATACATTACAGGGAATTTTGATTTACAATAAATATGTAAATTATAAACAAAGAC 
IFN_0i8 T A C A A A A T A C A T T A C A G G G A A T T T T G A T T T A C A A T A A A T A T G T A A A T T A T A A A C A A A G A C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AGTTTATTGGAGCTGAAATAGTTATTGAAAGTTCAAATTAGGAAGAAAAACCCTCAAAAC 
I F N - ( X 8 A G T T T A T T G G A G C T G A A A T A G T T A T T G A A A G T T C A A A T T A G G A A G A A A A A C C C T C A A A A C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CAACTTTGGGGTGTGGAGCAGTAAAGAGGAAGCAATAATGAAAATCTCAATGGGTTAGAA 
j F N - a 8 C A A C T T T G G G - T G T G G A G C A G T A A A G A G G A A G C A A T A A T G A A A A T C T C A A T G G G T T A G A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AAATGCCCAAACACAAGTGGAGAATGAGTTAAAGAAAATGAAAAGACAAGTGGAAAGTGA 
I F N - o t 8 A A A T G C C C A A A C A C A A G T G G A G A A T G A G T T A A A G A A A A T G A A A A G A C A A G T G G A A A G T G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGGAAGGGCATTCAGAAAGTAAAAACTAGTGTTTGCCCTATTTAAGACACATTCACCCAG 
工TGGAAGGGCATTCAGAAAGTAAAAACTAGTGTTTGCCCTATTTAAGACACATTCACCCAG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GATGGTCTTCAGAGAACCTAGAGGGGAAGGATCAAGATCAAACAGCCCAGAAGACCAGAA 
I F N - C X 8 G A T G G T C T T C A G A G A A C C T A G A G G G G A A G G A T C A A G A T C A A A C A G C C C A G A A G A C C A G A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
137 
Q u e r y G C A T T G G C A A C A T T C A  
I F N - a 8 G C A T T G G C A A C A T T C A C C A T G G C T A G G C T C T G T G C T T T C C T G A T G G T T C T G G C G G T G C T G 
* * * * * * * * * * * * * * * * 
all 一 T 3 primer 
Q u e r y T A T A T T C A A A T A A A T T T G C T T T A G 
I F N - a l 1 C A T A A T A C A A A T T A T C A T T T C T A T T A A A C T T A T T T T A T A T T C A A A T A A A T T T G C T T T A G 
* * * * * * * * * * * * * * * * * * * * * * * * 
Query AAGATACTTTGAATTAGTTAATTTGCTATCTGTAACATTATCAAATATTTTTAACATTAA 
IFN-al 1 AAGATACTTTGAATTAGTTAATTTGCTATCTGTAACATTATCAAATATTTTTAACATTAA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AGCCTACACTATAAATATTGTACAAATGGACAGTTTCCAAATATCAGAGAAGATAGACAC 
工FN-Ctl  A G C C T A C A C T A T A A A T A T T G T A C A A A T G G A C A G T T T C C A A A T A T C A G A G A A G A T A G A C A C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query ATACACTACACAGTATTTAGACAATCCTTAAGTATTTTTATATTTTCTTTCCAGTATGCA 
IFN-al1 ATACACTACACAGTATTTAGACAATCCTTAAGTATTTTTATATTTTCTTTCCAGTATGCA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GTATTCTTCTGGATGTATAGACAGCATGCTGTGCAGTAGAGAGAAAAAGAATCTTGCTCC 
IFN-cxl l G T A T T C T T C T G G A T G T A T A G A C A G C A T G C T G T G C A G T A G A G A G A A A A A G A A T C T T G C T C C 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGTCTTATTCCTTATTCCACTTTGACCCAAATATTCCCTGGATCAATTCAGTATCTTGAT 
工FN_all T G T C T T A T T C C T T A T T C C A C T ^ T T G A C C - A A A T A T T C C C T G G A T C A A T T C A G T A T C T - G A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTCCCGGATGTCATACCCAATCATCCACTCTTATCATTAATGAGCTTCATTGTTTTGGGT 
I F N - a l l T T C C C G G A T G T C A T A C C - A A T C A T C C A C T C T T A T C A T T A A T G A G C T T C A T T G T T T T G G G T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TCTAAATATGCGTGAGATCATGTAAAGTAATGGAGAAGAGATCAAGAAAAATGAGTAGCC 
IFN-al1 TCTAAATATGCGTGAGATCATGTAAAGTAATGGAGAAGAGATCAAGAAAAATGAGTAGCC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGCCGATATAGCAGAGAAAAGCAAGACAAGAAGAACCTGGGAT—AACCCCNCTCATAAT 
I F N - a l l T G C C G A T A T A G C A G A G A A A A G C A A G A C A A G A A G A A C C T G G G A A T A A A C C C C A C T C A T A A T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AGCCTCATAAGCCAGTCCATAATAGCCTCATAAGCCAATCCATAATAGCCNTCATAAGCC 
IFN-al1 AGCCTCATAAGCCAGTCCTGGGAAGAATTC  
* * * * * * * * * * * * * * * * * * * * * 
a l l -T7 primer 
Query ATATCGAATT—CCTGCA—GCCCCCAGGATGCCATGACAATCATAGGA 
IFN-al1 AAGCTTGAACATAAGGATTTTTGCATACATAGCCCCCAGGATGCCATGACAATCATAGGA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query T A A A T A G C T A A T A T A C A G T G A T G G C A T A A C T A A C C T T T T A T G A A A - T T A A T A T - A G A G T -
IFN_Cxll TAAATAGCTAATATACAGTGATGGCATAACTAACCTTTTATGAAAATTAATATTAGAGTT 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
138 
Query AGTGGAGGTAATATTTAAAAAACCTTAATTTTTAGCCTCTAAAAATTTGAAAATTTTGAA 
IFN-al 1 AGTGGAGGTAATATTTAAAAAACCTTAATTTTTAGCCTCTAAAAATTTGAAAATTTTGAA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TCATTACATCAGTATGATTTTTGTAGACAAAGGGTTTTCTTCTGTGAGGTCCTCATAGTC 
IFN-all TCATTACATCAGTATGATTTTTGTAGACAAAGGGTTTTCT-CTGTGAGGTCCTCATAGTC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CTGGAACTTGCTCTGTAAAACTANGGCNGGGCCNTTGAACCNCANAAAAACCCAACTGGC 
IFN-all CTGGAACTTGCTCTGTAGA-CTAGG-CTGG--CCTTGAAC-TCAGACA--CCCATCTGCC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
aB -T3 primer 
Query TAGTGGATCCCCCTACTCATGTGTGTGCTGTAAGAATACTGATGA 
IFN-aB GAATTCACAGGAGTGCTGGGAAACCAGGTACTCATGTGTGTGCTGTAAGAATACTGATGA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CTGAGCCATTCAACAGCTTTTAAGAACATATTTTGGGTGAAATTATTT-CATTCTTTATA 
IFN-CXB C T G A G C C A T T C A A C A G C T T T T A A G A A C A T A T T T T G G G T G A A A T T A T T T T C A T T C T T T A T A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TTAGATGAGTAAATTTTATATACATGATACACACATACACACACATATAGTGAAAGT-AA 
工 FN_OtB T T A G A T G A G T A A A T T T T A T A T A C A T G A T A C A C A C A T A C A C A C A C A T A T A G T G A A A G T T A A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGAAAATTCATTCAGTGGAGAAGTTCTAAATATCTTTGTTGAAAAGAGCAGAGAAAGTTG 
IFN-aB TGAAAATTCATTCAGTGGAGAAGTTCTAAATATCTTTGTTGAAAAGAGCAGAGAAAGTTG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query ACACAATAATGAAAACTAAAATGATTGATAAAAAAATGCCCAGACACAAAATGAAAATGA 
工 FN_CXB A C A C A A T A A T G A A A A C T A A A A T G A T T G A T A A A A A A A T G C C C A G A C A C A A A A T G A A A A T G A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GTTAAAGAAAGCGAAAACAGAGTTGGAAAGAGAGGGGAAGACATTCAGAAAATAGAAACT 
IFN_otB G T T A A A G A A A G C G A A A A C A G A G T T G G A A A G A G A G G G G A A G A C A T T C A G A A A A T A G A A A C T 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query CGTGTTTTTCTCCTATTTAAGACACATTCACCCAAGATGGTCTTCAGAGAACCTAGAGGG 
IFN-OIB C G T G T T T T T C T C C T A T T T A A G A C A C A T T C A C C C A A G A T G G T C T T C A G A G A A C C T A G A G G G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GAAGGATAAGAACCAAACAGCCCAGAAGACCACCAGCATTGGCAATATTCACCATGGCTA 
I F N _ C T B A A A G G A T A A G A A C C A A A C A G C C C A G A A G A C C A G C A G C A T T G G C A A T A T T C A C C A T G G C T A 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query GGCTCAGCACTTTCCTAATGGGCCTGGCAGTGATGAGCTACTGGTCAACCTGCCCTCTAG 
IFN-cxB G G C T C A G C A C T T T C C T A A T G G T C C T G G C A G T G A T G A G C T A C T G G T C A A C C T G C C C T C T A G 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
139 
aB 一 T 7 primer 
Query AGGACAGGAAG-ACTTCGGATTCCCCC 
IFN-aB AAATGAGGAGACTCTCCCCTCTCTCCTGCCTGAAGGACAGGAAGGACTTCGGATTCCCCC 
* * * * * * * * * * * * * * * * * * * * * * * * * * 
Query AGGAGAAGGTGGATGCCCAGCAGATCCAGGAGGCTCAAGCCATCCCTGTCCTGACTGAGC 
IFN-aB AGGAGAAGGTGGATGCCCAGCAGATCCAGGAGGCTCAAGCCATCCCTGTCCTGACTGAGC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Query TGACCCAGCAGATGCTGACCCTCTTCACATCAAAGGCTTCATCTGCTGCTTGGAATGCAA 
工FN_aB TGACCCAGCAGATGCTGACCCTCTTCACATCAAAGGCTTCATCTGCTGCTTGGAATGCAA 
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